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Abbreviations 
 
BSA Bovine serum albumin 
cDNA  Complementary DNA 
cGH Chicken growth hormone 
DmGluRA Drosophila metabotropic glutamate receptor A 
DRMs Detergent resistant membranes 
ECD  Extracellular domain 
GABA Gamma amino butyric acid 
GBR1bNT Metabotropic GABAB1b receptor 
GPCR G protein coupled receptor 
GPI Glycosyl-phosphatidyl inositol 
GST  Glutathione S-transferase 
IC50 Inhibitory concentration at 50% 
kDa Kilo Dalton 
LBD Ligand binding domain 
LIVbp Leucine, Isoleucine, Valine binding protein 
MOI Multiplicity of infection 
MβCD Methyl β -cyclo dexrin 
pCBM Putative cholesterol binding motif 
PCR Polymerase chain reaction 
PERL Practical Extraction and Report Tool 
PMSF Para-methyl sulphonate 
RBV Recombinant baculovirus 
RMSD Root mean square deviation 
SDS Sodium dodecyl sulphate  
SEM Standard Error of Mean 
TEV Tobacco etch virus 
TM Transmembrane 
VS Viral stocks 
 
Summary 
G-protein coupled receptor (GPCRs) is a multigene family consisting of more than 1000 
genes. They are the most abundant membrane proteins found on a cell surface and are 
involved in several signaling pathways. In a cell, the signal is transduced by diverse 
activating endogenous ligands binding on the extracellular surface. This results in the 
uncoupling of G-proteins from the cytoplasmic loops, leading to the activation of the 
second messengers. GPCRs have enormous therapeutic importance due to their 
involvement in basic physiological processes including sensory perception, 
neurotransmission, metabolism, hormonal balance, etc.  Structural and biochemical data 
are the pre-requisites for designing the drugs involving GPCRs.  
 
The current study was focused on the optimization of expression, purification and 
functional characterization of class-C GPCRs involved in neurotransmission. The first 
part of the study was aimed at optimizing the expression and purification of the ligand 
binding extracellular domain (ECD) of rat metabotropic GABAB1b receptor (GBR1bNT) 
in the recombinant baculovirus (RBV) and E.coli expression systems. GBR1bNT was 
modeled based on the crystal structure coordinates of ECD of metabotropic glutamate 
receptor (mGluR). Depending on this GBR1bNT model, molecular cloning strategies 
were developed for the expression of GBR1bNT. In both systems, GBR1bNT was well 
expressed and purified. 
 
The second part of the study was aimed at biochemical characterization of a 
putative cholesterol binding motif (pCBM) in Drosophila metabotropic glutamate 
receptor (DmGluRA). This pCBM might be involved in regulating the binding of 
DmGluRA to glutamate with high affinity. During the study, it was inferred that a 12- 
amino-acid amphipathic peptide containing the pCBM might be crucial for the activity of 
the receptor.  Upon conducting [3H]-glutamate binding and detergent-resistant-membrane 
(DRM) association studies on different truncation constructs of DmGluRA (1-910 amino 
acids), the N-terminal construct (1-624 amino acids) containing the ECD with one single 
pCBM was found to be capable of binding glutamate in high affinity state as observed 
with the full length DmGluRA.  
 
Together this study shows that 1) Using an interdisciplinary approach (computational and 
experimental strategies) GBR1bNt was efficiently expressed and purified in both E.coli 
and RBV expression systems and 2) the role of pCBM was studied in DmGluRA receptor 
regulation. 
Zusammenfassung 
 
G-Protein gekoppelte Rezeptoren (GPCRs) gehören zu einer Multigen-Familie mit mehr als 
1000 Genen. Sie bilden die größte Gruppe der Membranproteine auf der Zelloberfläche und 
sind an einer Vielzahl von Signaltransduktions-Wegen beteiligt. In einer Zelle wird ein Signal 
übertragen, indem aktivierende endogene Liganden extrazellulär an die GPCRs binden. Dies 
führt zu einer Abspaltung von G-Proteinen von den cytoplasmatischen loops des Rezeptors 
und damit zur Aktivierung von sekundären Signalmolekülen (second messengers), welche die 
Signalkaskade fortsetzen. GPCRs sind an grundlegenden physiologischen Prozessen beteiligt 
und spielen somit eine wichtige Rolle bei therapeutischen Ansätzen. Die Aufklärung der 
Struktur und das Sammeln biochemischer Daten der GPCRs sind Voraussetzung für die 
Entwicklung von Medikamenten, die diese Prozesse beeinflussen. 
Der Schwerpunkt dieser Studie lag auf der Optimierung der Expression, Aufreinigung 
und der funktionellen Charakterisierung von GPCRs der Klasse C welche an der neuronalen 
Signalübertragung beteiligt sind. Der erste Teil der Studie zielte auf die Optimierung der 
Expression und Aufreinigung der extrazellulären Ligandenbindungsstelle (extracellular 
domain, ECD) des GABAB1B-Rezeptors (Rattus norvegicus) (GBR1bNT) in rekombinanten  
Baculovirus- (RBV) und E.coli-Expressionssystemen. Basierend auf den Daten der 
Kristallstruktur der ECD des Glutamatrezeptors mGluR wurde ein Modell für GBR1bNT 
generiert. Dieses Modell war Grundlage für die Entwicklung molekularer 
Klonierungsstrategien für die Expression von GBR1bNT. In beiden Systemen konnte 
GBR1bNT gut exprimiert und aufgereinigt werden. 
Der zweite Teil der Studie befasste sich mit der funktionellen Charakterisierung eines 
putativen Cholesterin-Bindemotivs (putative cholesterol binding motif, pCBM) des 
Drosophila Glutamat-Rezeptors DmGluRA. Dieses Bindemotiv scheint an der Regulation der 
Bindung zwischen DmGluRA und Glutamat beteiligt zu sein. Während der Studie konnte ein 
12 Aminosäure langes, amphipatisches Peptid identifiziert werden, welches das pCBM enthält 
und eine entscheidende Rolle bei der Aktivierung des Rezeptors zu spielen scheint. Basierend 
auf Studien über [3H]-Glutamat-Bindung und Detergenz-resistente Membranassoziation 
(DRM) für verschiedene verkürzte Formen des DmGluRA (1-910 Aminosäuren) fand man 
heraus, dass die N-terminale Form (1-624 Aminosäuren), welche die ECD und ein einziges 
pCBM enthält, mit hoher Affinität an Glutamat binden kann so wie dies auch bei der 
vollständigen Form des DmGluRA der Fall ist.    
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I. Introduction 
 
I.1 G-Protein Coupled Receptors 
 
G-protein coupled receptors or GTP-binding protein coupled receptors or GPCRs 
form a large and diverse multigene super-family of integral membrane proteins 
(receptors). They act as cell surface receptors responsible for the transduction of 
endogenous signals into cellular response via activation of G-proteins. In human, 
more than 1000 genes encode for GPCRs (Marinissen and Gutkind, 2001) and are 
classified into over 100 sub-families based on sequence homology, ligand structure 
and receptor functions. GPCRs are involved in the regulation of various 
physiological activities such as neurotransmission, vision, pain perception, hormone 
secretion, taste, smell and metabolism. There is an enormous therapeutic application 
for GPCRs in the field of drug discovery. 
  
A number of diseases are known to be associated with mutations in GPCR genes. 
Such mutations induce one of two phenotypes caused by a loss-of-function or gain-
of-function. The diseases caused by GPCR loss-of-function include color blindness, 
retinitis pigmentosa, Hirschsprung disease and diabetes mellitus. The diseases 
caused by GPCR gain-of-function include thyroid adenomas, cogenital eye 
blindness and hyperthyroidism (Spiegel and Weinstein, 2004). 
  
By single-site directed mutagenesis experiments, it is possible to map the ligand-
binding domain of these receptors, which would serve as a lead to design synthetic 
ligands based on knowledge of the structure of the receptor site.  
 
So far, the molecular structure of GPCRs (except bovine rhodopsin) could not be 
defined by any structure determination techniques such as X-ray crystallography 
nor NMR. Molecular modelling approaches based on bovine rhodopsin as the 
structure template has given very few successes (Flower, 1999). Still there are 
limitations in these molecular modelling approaches such as defining the oligomeric 
state of the receptor to understand the mechanism of activation and in identifying 
the allosteric sites involved in the regulation to design ligands for the same. 
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I.1.1 General description of GPCRs and its classification 
There are 2 main criteria for a protein to be classified as a GPCR ((Marinissen and 
Gutkind, 2001).  
First criterion: All GPCRs have an extracellular N-terminal segment, seven 
transmembrane (TM) helices (that form the TM core), three exoloops, three 
cytoloops, and a C-terminal segment. A fourth cytoplasmic loop is formed when the 
C-terminal segment is palmitoylated at the Cysteine residue (Cys322 residue in 
bovine rhodopsin). Each of the seven TM helices is generally composed of 
characteristic sequence motif, consisting of 20-27 consecutive residues with a 
relatively high degree of hydrophobicity. These sequences form seven α-helices 
that span the plasma membrane in a counter-clockwise manner. Hydrogen bonds, 
salt bridges and disulphide bonds hold the TM core tightly. Moreover, to elicit 
diverse function, the N-terminal segments (7-595 amino acids), loops (5-230 amino 
acids), and C-terminal segments (12-359 amino acids) vary in size. 
 
Second criterion: The second principle criterion is the ability of the receptor to 
interact with a G-protein using its cytoloops. 
 
fig 1. Crystal structure of bovine 
rhodopsin (PDB code: 1HZX) 
monomer prepared using PyMOL 
software; a representative 
structure of GPCR showing its 
orientation in the cell membrane. 
These evidences suggest that overall structure of GPCRs is similar to that of bovine 
rhodopsin (Palczewski et al., 2000). The structure of bovine rhodopsin has been 
solved experimentally and is composed of seven TM helices forming a flattened 
two-layered structure (see fig. 1). Despite a common pattern of hydrophobic 
residues and some similarity in function, there is no homology between bovine 
rhodopsin and GPCR sequences. 
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GPCRs are divided into Six distinct classes and into to several families within a 
particular class. There is considerable sequence homology between the members of 
family under one class, but were less between different classes (Horn et al., 2001). 
 
Class A: Rhodopsin-like receptors 
Family I: Olfactory receptors, adenosine receptors, melanocortin receptors, 
and others 
Family II: Biogenic amine receptors 
Family III: Vertebrate opsins and neuropeptide receptors 
Family IV: Invertebrate opsins 
Family V: Chemokine, chemotactic, somatostatin, opioids and others 
Family VI: Melatonin receptors and others 
 
Class B: Calcitonin and related receptors 
Family I: Calcitonin, calcitonin-like, and CRF receptors 
Family II: PTH/PTHrP receptors 
Family III: Glucagon, secretin receptors and others 
Family IV: Latrotoxin receptors and others 
 
Class C: Metabotropic glutamate and related receptors 
Family I: Metabotropic glutamate receptors 
Family II: Calcium receptors 
Family III: GABA-B receptors (metabotropic receptor) 
Family IV: Putative pheromone receptors 
 
Class D: Fungal Pheromone receptors 
 Family I: fungal pheromone A-factor like, B like, M- and P- factor 
 
Class E: cAMP receptors (Dictyostelium) 
 
Class F: Frizzled/smoothened family 
 Frizzled receptors 
 
 
Chapter 1                                                                                              Introduction 
 
 4 
Class A: Rhodopsin-like receptors 
 
 
Consists of a short N-terminal 
extracellular and C-terminal intracellular 
tails. Ligand binding occurs in the 
pocket formed by the transmembrane 
helices 
Class B: Calcitonin and related receptors 
 
 
Apart from the features of Class A 
GPCR topology, Class B GPCR consists 
of an N-terminal extracellular cysteine 
rich domain involved in ligand binding. 
Class C: Metabotropic glutamate and related receptors 
 
 
Consists of an N-terminal extracellular 
domain homologous to Leucine-
isoleucine-valine binding proteins 
(LIVbp like domain) that contributes to 
ligand binding. Metabotropic glutamate 
receptors consist of cysteine rich domain 
between the ligand binding domain and 
the transmembrane domain on the 
extracellular domain. 
fig 2. Classification of GPCRs: All GPCRs share a set of seven transmembrane helices 
which are weakly homologous to each other and span across the membrane. 
Extracellular 
Extracellular 
Extracellular 
Intracellular 
Intracellular 
Intracellular 
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I.1.2 Mechanism of GPCR activation, desensitization and 
internalisation 
ß2-adrenergic receptors are the first among the GPCR to be cloned and fully 
characterized. Site-directed mutagenesis experiments show that the long third 
cytoplasmic loop is the region of the molecule that couples to the G-protein. Any 
deletion or modification of this region results in receptors that are still capable of 
binding the ligand but cannot associate with G-proteins to produce any response.  
 
In class A GPCRs (for example in the Histamine receptors) the receptor activation 
is achieved by binding of Histamine molecule to the cleft between the α-helical 
segments within the membrane and uncoupling of the G-protein in the cytoplasmic 
region.  
 
 I.1.3 G-proteins and GPCR activation 
G-proteins are heterotrimeric proteins composed of three subunits, α, β and γ. 
Guanine nucleotides bind to the α-subunit, which possesses enzymatic activity, 
catalysing the conversion of GTP to GDP. The β- and γ- subunits remain together as 
a βγ-complex (see fig 3). The three subunits are anchored to the plasma membrane 
through a fatty acid modification, coupled to the G-protein through a reaction 
known as prenylation. G-proteins are diffusible in the plane of the membrane 
leading to an interaction of a single G-protein with several receptors and effectors 
involved in several signalling pathways.  
 
fig 3. Crystal structure of 
a G-protein heterotrimer.  
G-protein heterotrimer is 
composed of 3 subunits 
Gα-subunit in yellow with 
bound GDP shown in ball 
and stick, Gβ-subunit in 
blue and Gγ-subunit in 
green. The figure was 
prepared using PyMOL 
PDB code : 1GP2 .  
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In the resting state, the G-protein exists as an unattached αβγ-trimer, with Gα-
subunit in GDP bound state. When an agonist molecule binds to GPCR, a 
conformational change occurs involving the cytoplasmic domain of the receptor 
causing it to acquire high affinity for the G-protein αβγ-trimer. Association of αβγ-
trimer with the receptor causes the bound GDP to dissociate and exchange with 
GTP followed by the dissociation of the trimeric complex, releasing the Gα-GTP 
complex and βγ-subunits; these are the active forms of the G-protein (Marinissen 
and Gutkind, 2001) (see fig a). 
 
Fig. 4a. Mechanism of GPCR activation and effector systems of G-proteins.  
G-proteins exist as unattached αβγ-trimer, with Gα-subunit in GDP bound state, 
in the resting state. Upon agonist molecule binds to GPCR, a conformational 
change occurs involving the cytoplasmic domain of the receptor causing it to 
acquire high affinity for the G-protein αβγ-trimer. Association of αβγ-trimer with 
the receptor causes the bound GDP to dissociate and exchange with GTP 
followed by the dissociation of the trimeric complex, releasing the Gα-GTP 
complex and βγ-subunits. (Adopted from Rang and Dale, Pharmacology, 5th ed.) 
 
The Gα−GTP complex diffuse in the membrane and associate with various effector 
enzymes, such as adenylyl or guanylyl cyclase, phospholipase A2 or C, inhibiting 
or stimulating production of second messengers including cAMP, cGMP, diacyl 
glycerol, and IP3, which in turn cause downstream effects including the opening of 
Ca2+ or K+ channels (Hamm, 1998) and generation of other messengers, such as 
arachidonic and phosphatidic acid (see fig 4, bottom).  
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Fig. 4b. Various effector system associated with G-proteins.  
The Gα−GTP complex triggers the signaling cascade by associating with the 
target enzymes; that further triggers the second messengers leading to the 
activation of protein kinases and finally reaching the effectors. (adopted from 
Rang and Dale, Pharmacology, 5th ed.) 
 
Many GPCRs are also known to activate MAP kinase signalling pathways. This 
process is dependent upon GPCR endocytosis and involves a G-protein mediated 
pathway involving tyrosine kinase phosphorylation of a series of adaptor proteins. 
GPCR signaling is a complex system involving a variety of mechanisms that 
include regulatory feedback desensitization mediated by protein kinase 
phosphorylation of different types since a particular GPCR can interact with more 
than one kind of G-protein. 
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I.2 Class C G-Protein Coupled Receptor 
Class C GPCRs have several characteristic features, which include a large 
extracellular N-terminus often referred to as Venus flytrap that plays a critical role 
in ligand binding, followed by seven closely spaced putative transmembrane 
domains, typical of GPCRs. The metabotropic glutamate receptor (mGluR) and the 
metabotropic GABAB receptor (GABABR) belong to this class of GPCRs. The third 
intracellular loop in this class of GPCR is short and highly conserved and known to 
be crucial for G-protein activation, whereas the second intracellular loop is crucial 
for G-protein coupling selectivity. The carboxy-terminal intracellular tail is the 
most variable region of these receptors and is subject to natural truncations by 
alternative splicing of the mRNA. Moreover, this region of mGluRs is shown to 
interact with multiple interacting proteins such as the Homer proteins. When 
compared with mGluRs, GABABR1 shares only 18-23% sequence similarity, but 
structural architecture indicates clear conservation between these receptors.  
 
Sequence analysis by O’Hara and co-workers on the ligand binding domain (LBD) 
of mGluRs and GABABRs showed that these domains possessed a considerable 
similarity with the Leucine, Isoleucine, Valine binding protein (LIVbp) (Olah et al., 
1993). LIVbp is a bacterial periplasmic protein (PBP) capable of binding the amino 
acids leucine, isoleucine and valine. LIVbp is expressible in soluble form and the 
X-ray structure reveals a binding pocket that is made up by two globular lobes 
(lobes I and II) separated by a hinge region. The two lobes close upon ligand 
binding, similar to a Venus flytrap when touched by an insect (Quiocho and 
Ledvina, 1996). The crystal structure of LIVbp served as a template in the 
construction of a theoretical three-dimensional model for the LBD of mGluRs and 
GABABRs. Thus, derived theoretical model gave considerable amount of 
information in understanding the architecture/scaffold of the receptor at the binding 
pockets and the key residues involved in the selectivity for binding the ligands, 
Glutamate and GABA to the LBD of mGluR and GABA1bR respectively. 
 
I.2.1 GPCR dimerization- Dimers in class C GPCRs 
For many years it was assumed that GPCRs exist and function in monomeric 
species. Studies on GPCR-GPCR interactions show that all GPCRs may not be 
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monomeric but can exist as dimers or higher order oligomers. There have been 
evidences reporting that GPCR-GPCR interactions occur initially during 
biosynthesis, get N-terminally glycosylated to form the mature form before being 
exported from the golgi apparatus (Robbins et al., 1999). 
 
Modelling approaches in understanding the mechanism of activation and structural 
organisation of rhodopsin also support the fact that it exists as dimer. It is proposed 
that a dimer of rhodopsin would be required to bind single heterotrimeric G protein 
consisting of transducin α and β1 + γ1complex (Liang et al., 2003). 
 
Class C GPCRs are classical examples of GPCRs that function as dimers. 
Metabotropic glutamate receptors exist as homodimers (see fig. 5a) formed by 
covalent and noncovalent interactions and that each dimeric unit can couple to two 
sets of G-proteins to trigger the signalling pathway. Romano et al were the first to 
show that mGlu5 receptor exist in a dimeric form not only in heterologous 
expression systems but also in the brain (Romano et al., 2001). Since then this has 
been confirmed with many other class-C GPCRs, including most other mGluRs, the 
Ca2+ sensing receptor, the GABAB receptor and the taste receptors.  
 
 
 
A. Metabotropic GABAB receptor 
(Heterodimers) 
B. Metabotropic Glutamate receptor 
(Homodimers) 
Fig 5. Types of dimers observed in Class C GPCRs and the domains involved 
in the dimerzation.  
 
In many cases, only homodimers have been described, but the GABAB receptors as 
well as the taste receptors were found to form heteromers (see fig. 5b). In all class-
C GPCRs except the GABAB receptor, the two subunits are linked by a disulfide 
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bridge at the extracellular level, which indicates that such dimers are likely to be 
constitutive. Mutation of the cysteines involved in the disulphide bridge does not 
prevent the receptors from dimerizing, indicating the other regions are involved in 
the formation of the dimer and that the disulphide bridge firmly stabilizes the dimer.  
 
The functional heterodimeric metabotropic GABAB receptor unit is formed by 
interactions between the alternatively splice variants GABAB1b and GABAB2 
receptors. Chimeric and truncation constructs on GABAB1b and GABAB2 show 
that the heterodimeric receptor is activated by a phenomenon called transactivation, 
wherein the ligand binds the extracellular domain (ECD) of the GABAB1b unit and 
the G-protein is uncoupled from the cytosolic loop region of the GABAB2 subunit. 
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I.3 Metabotropic GABAB receptor 
Gamma-amino butyric acid (GABA) is a primary inhibitory neurotransmitter in the 
mammalian central nervous system and mediates its action via distinct receptor 
systems, the ionotropic GABAA and metabotropic GABAB receptors.  It exerts fast 
and powerful synaptic inhibition by acting on GABAA receptors. These receptors 
are directly coupled to an integral chloride channel and produce inhibition by 
increasing the membrane chloride conductance. This form of synaptic inhibition is 
critical for maintaining and shaping the neuronal communication.  
 
However, like other neurotransmitters that activate fast, ionotropic responses lasting 
for milliseconds, GABA can also activate a second class of receptors that produce 
slow synaptic responses capable of lasting for seconds. The receptors producing 
these slow, metabotropic responses are called GABAB receptor (GABABRs). They 
play an important role in regulating neurotransmission, which makes them 
potentially important therapeutic targets in the treatment of a variety of neurological 
conditions including epilepsy, spasticity, pain and psychiatric illness.  
 
Fig.6.GABA is formed from glutamate by the action of glutamic acid 
decarboxylase (GAD), an enzyme found only in GABA-synthesizing neurons in the 
brain. GABA is destroyed by a transamination reaction, in which the amino group is 
transferred to α-oxoglutaric acid (to yield glutamic acid), with the production of 
succinic semialdehyde, and then succinic acid. This reaction is catalysed by GABA 
transaminase. GABA-ergic neurons and astrocytes take up GABA by specific 
transporters and GABA transaminase that removes the GABA after it is released. 
(Adopted from Fundamental neuroscience, 1999) 
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I.3.1 Discovery of the GABAB receptor 
A high affinity GABAB antagonist [125I] CGP64213 was developed (Kaupmann et 
al., 1997) and upon photoaffinity labelling resulted in two receptor proteins in the 
cortex, cerebellum and spinal cord of mammals. The 4.4 kb cDNA insert in a rat 
cortex were transfected into mammalian COS-1 cells by expression cloning leading 
to the identification of GABAB1aR (100 kDa) and GABAB1bR (130 kDa). 
GABAB1aR and GABAB1bR were the GABABR1 isoforms to be first discovered, 
which are pharmacologically identical with similar ligand binding affinities and 
differ only in the length of their N-terminal sequences. The primary protein 
sequences of GABABR1a and GABABR1b isoform shares no significant sequence 
similarity with either GABAA or GABAC receptors; and that it was distantly related 
to class C GPCRs (Bettler et al., 1998).  
 
The first 147 amino acids of the mature GABABR1a isoform are replaced in 
GABABR1b with a sequence of 18 amino acids. GABABR1a and GABABR1b are 
not generated by N-terminal alternative splicing but result from the presence of an 
alternative transcription initiation site within the GABABR1a (Pfaff et al., 1999). 
Presumably, GABAB1a and GABAB1b use different promoters, with the GABAB1b 
promoter being buried within GABAB1a intron sequences. GABAB1a and 
GABAB1b primarily differ by the presence of a pair of sushi repeats in the 
GABAB1a -specific domain. Sushi repeats, also known as short consensus repeats 
(SCRs) (Hawrot et al., 1998), were originally identified in complement proteins as a 
module that is involved in protein-protein interactions. They are mostly found in 
proteins that are involved in cell-cell adhesion and were never before observed in a 
neurotransmitter receptor. Sushi repeats have yet to exhibit a function in the context 
of the GABAB receptor.  
 
I.3.2 Heterodimerization in GABAB receptors 
While GABABR1 subunit displays binding and biochemical characterisation similar 
to those of native heterodimeric GABAB receptors, discrepancies were noted 
between these cloned receptors and native GABAB receptors (Marshall et al., 1999). 
There was a 100- to 150-fold lower affinity for agonists that is observed with 
recombinant GABABR1 subunits compared with native GABAB receptors 
(Kaupmann et al., 1997). When expressed in cell lines GABABR1 coupled only 
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weakly to adenylyl cyclase and did not couple to other effector systems, such as 
Ca2+ or K+ channels. Moss and colleagues (Couve et al., 1998) examined the 
receptor using epitope tagged versions of GABABR1 subunit to study the cellular 
distribution of the receptor in a variety of cell types. The studies showed that the 
GABABR1 retained in the endoplasmic reticulum (ER) when expressed in the 
heterologous cells and therefore failed to reach the cell surface.  
 
The failure of GABABR1 subunit alone to produce functional GABAB receptor, 
lead to the discovery of a second GABAB receptor gene GABABR2. This finding 
represented the first evidence for heteromerization among the GPCRs. Recombinant 
heteromeric GABABR1-GABABR2 receptors are known to couple to all prominent 
effector systems of native GABAB receptors, that is, adenylyl cyclase, Kir3-type K+ 
channels, and P/Q- and N-type Ca2+ channels (Easter and Spruce, 2002), (Filippov 
et al., 2000) and (Marshall et al., 1999). When the GABABR2 subunit was co-
expressed with GABABR1, agonist potency more closely approximates that of 
native receptors (Marshall et al., 1999).  
 
The reason for the intracellular retention of GABABR1 subunits is due to the 
presence of a four-amino acid motif RSRR, an Endoplasmic Retention (ER)-
retention signal, in its cytoplasmic tail (Margeta-Mitrovic et al., 2000) and (Pagano 
et al., 2001). The other proteins were the ER-retention signals of the RXR type were 
observed are, the KATP channels (Zerangue et al., 1999) or N-methyl-D-aspartate 
(NMDA) (Scott et al., 2001) receptors. It was recently proposed that the sequence 
context of the RSRR motif in GABABR1 is crucial for ER retention, and the RSRR 
motif was extended to include the sequence QLQXRQQLRSRR (Grunewald et al., 
2002). The ER-retention signal in GABABR1 is masked from its ER-anchoring 
mechanism through the interaction with the C-terminus of GABABR2, thus 
allowing for delivery of the GABABR (GABABR1-GABABR2) complex to the cell 
surface. This ER retention mechanism is suggested to prevent incorrectly folded 
GABAB complex from reaching the cell surface and to represent a quality control 
mechanism. Thus, it was understood that a fully functional GABAB receptors 
require coupling between GABABR1 and GABABR2.  
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I.3.3 Extracellular domain of GABABR1 is crucial for ligand binding 
 
Fig. 7. Domain structure of metabotropic GABAB receptor. 
 
The GABABR1 and GABABR2 subunits are consists of a large extracellular domain 
(ECD, around 50 kDa) that is homologous to leucine, isoleucine and valine binding 
protein (LIVbp, refered to as the Venus fly trap) and the seven transmembrane 
(TM) helix domain. The protein sequence of GABABR2 possessed a 35% identity 
with that of GABABR1 and exhibited many of the structural features of GABABR1, 
including a large molecular weight (110 kDa), an extended extracellular N-terminus 
and seven transmembrane spanning domains. In contrast, the intracellular carboxy-
terminus of GABABR2 was longer than that of GABABR1.  
 
All GABAB receptor agonists and competitive antagonists bind to the extracellular 
(ECD) of the GABABR1 subunit only and not to GABABR2 (Malitschek et al., 
1999). The ECD of GABABR1 when expressed alone without its TM domain 
retains the binding properties of wild-type receptors, indicating that it folds 
independently from the transmembrane domains. Sequence analysis of the 
GABABR1 ECD reveals a weak sequence homology with LIVbp. In all GABAB 
subunits the LIVbp-like domain is linked to the first transmembrane domain via a 
short sequence that lacks the cysteine-rich region conserved between the other 
members of Class C GPCRs. In the mGlu receptors, this cysteine-rich region 
appears to be necessary for the LIVbp-like domain to bind glutamate (Okamoto et 
al., 1998b). 
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The inability of GABABR2 to bind antagonists results due to a single aminoacid 
difference in the binding pocket of GABABR2; the substitution of a proline in 
GABABR2 for a critical serine (S246) in GABABR1a.  
 
I.4 Expression systems and overexpression of GPCRs 
In recent years there have been several expression systems that are developed for 
the over-expression of GPCRs. the expression systems include E.coli, yeast, insect 
and mammalian cell system (Grisshammer and Tate, 1995). E.coli has an advantage 
of ease of handling, low cost and ease of scale up. The disadvantage of it being, 
prokaryotic, and lacking most of the targeting and post-translational modification 
machinery. There have been successes in the expression of  5HT4 receptor,  when 
refolded from inclusion bodies (Baneres et al., 2005). Very recently, an NMR 
structure of Vasopressin V2 receptor was determined by refolding the protein from 
inclusion bodies (Tian, C., 2005). Yeast is yet another cheap and versatile 
expression system containing the machinery required for the post-translation 
modification. But the disadvantage of this system is that it possesses different post-
translational patterns than that of mammalian system. It has also been reported that 
there is heterogeneity of GPCRs due to incomplete maturation of the protein 
(Reilander and Weiss, 1998). 
The insect and mammalian systems have proven to be the most efficient system 
suitable for expression of the receptors. The insect cell system has been shown 
efficient in expressing several proteins. 
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I.1.5 Metabotropic Glutamate receptor (mGluR) 
L-Glutamate is the principle neurotransmitter of the fast excitatory synapses in the 
mammalian CNS and plays an important role in a wide variety of CNS functions. 
Like other transmitters, glutamate is stored in synaptic vesicles and released by 
calcium dependent exocytosis; specific transporter proteins account for its uptake 
by neurons and other cells, and for its accumulation by synaptic vesicles (see fig.8). 
Glutamate taken up by astrocytes is converted to glutamine and recycled via 
transporters, back to the neurons, which convert the glutamine back to glutamate. 
Glutamine, which lacks the pharmacological activity of glutamate, thus serves as a 
pool of inactive transmitter under the regulatory control of the astrocytes. Until 
recently, the actions of glutamate in mammalian brain were thought to be mediated 
exclusively by activation of glutamate-gated cation channels termed ionotropic 
glutamate receptors (iGluRs).  
 
Fig. 8. Storage and release of glutamate in the neurons (adopted from Rang 
and Dale, Pharmacology, 5th ed.).  
 
The excitatory neurotransmitter glutamate plays important roles in the mammalian 
brain, ranging from synaptic plasticity to memory. To mediate these functions, 
glutamate activates two types of receptors: ligand-gated channels and metabotropic 
receptors coupled to G-proteins (Tanabe et al., 1992). Both families of glutamate 
receptors share no homology and possess original structural features compared with 
other ligand-gated channels and G-protein coupled receptors, respectively. On the 
basis of studies with selective agonist and antagonists the ligand-channels can be 
divided into three main subtypes of EAA receptors, namely, NMDA; AMPA, and 
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kainite receptors. In the mid 1980s, however, evidence for the existence of 
glutamate receptors directly coupled to second messenger systems via G-proteins 
began to appear with the discovery of glutamate receptors coupled to activation of 
phosphoinositide hydrolysis (Nakanishi, 1994). Since that time, it has become clear 
that glutamate activates a large family of receptors, termed metabotropic glutamate 
receptors (mGluRs) that are coupled to effector systems through GTP-binding 
proteins. 
 
The cloning of eight mGluR subtypes expanded the study of mGluRs as these were 
expressed in heterologous systems to determine coupling to second-messenger 
systems, establish pharmacological profiles with glutamate analogues, and screen 
for novel subtype-specific pharmacological agents (Houamed et al., 1991) and 
(Masu et al., 1991). Based on sequence homology, pharmacological profile and 
second messenger coupling, mGluR subtypes can be classified into three different 
groups. mGluRs of the same group show about 70% sequence identity, whereas 
between groups this percentage decreases to about 45% (Conn and Pin, 1997).  
 
Fig. 9. Classification of mGluRs. Based on sequence homology, the mGluRs can 
be broadly classified into 3 groups. The classification gives more insight into the 
specificity of the agonist and the transduction elicited. Adapted from (Conn and Pin, 
1997). 
 
Group I mGluRs includes mGluR1 and mGluR5 are localized in the peripheral parts 
of postsynaptic densities and contribute to the regulation of synaptic plasticity 
(Baude et al., 1993). Group II mGluRs includes mGluR2 and mGluR3 are found in 
the presynaptic and glial cells. The presynaptic mGluRs negatively regulate 
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glutamate release whereas glial mGluR3 exerts neuroprotective effects through 
paracrine mechanism based on the production of neurotrophic factors. When 
expressed in mammalian cells, group II mGluRs (mGluR2 and mGluR3) inhibit 
cAMP formation stimulated by either forskolin or αGS-coupled receptor. This effect 
is inhibited by pertussis toxin (PTX) treatment of the cells, which indicates the 
involvement of a Gi-type of G-protein. Group III mGluRs include mGluR4, 
mGluR7 and mGluR8 that are presynaptically localized and inhibit the release of 
glutamate or GABA, whereas mGluR6 receptors are exclusively expressed by optic 
nerve bipolar cells in the retina and play an important role in the amplification of 
visual inputs. Like group II mGluRs, all group III mGluRs inhibit adenylyl cyclase 
via a PTX-sensitive G-protein when expressed in CHO or BHK cells.  
 
I.5.1 Domain structure of Metabotropic glutamate receptors  
Metabotropic glutamate receptors (mGluRs) like the other receptors of the class C 
GPCRs possess a very large extracellular domain besides the characteristic seven 
transmembrane domains, separated by short intra- and extra-cellular loops, and a 
cytoplasmic carboxyl-terminal domain variable in length. Nineteen cysteine 
residues that are located in the N-terminal extracellular are conserved in all 
members of this receptor family, which suggests important roles for these residues 
either in the three dimensional structure of the molecule or in the intramolecular 
transduction. The agonist-binding site for small ligands in most GPCRs is located in 
a pocket defined by the seven transmembrane domain segments, but in the case of 
mGluRs it is found in the ECD.  
 
The glutamate binding site is proposed to be equivalent to the known amino acid 
binding sites of LIVbp (O’Hara et al., 1993). This model allowed the identification 
of two residues, S165 and T188, in the extracellular domain of mGluR1, mutation 
of which affects glutamate affinity. 
 
The extracellular domain (ligand binding domain) of mGluRs can be expressed as 
secreted receptors. The crystal structure from the glutamate-binding domain of 
mGluR1 has been solved, which confirms the predicted LIVbp-like fold (two 
globular domains separated by a hinge region often referred to as “venus trap” 
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(Kunishima et al., 2000) (see fig. 10, left). The structure of the soluble receptor 
revealed the fact that the receptor is present in equilibrium between two different 
conformations, ‘open’ (resting) and ‘closed’ (active), in ligand free form. Upon 
glutamate binding the receptor is stabilized in the ‘closed’ conformation. As 
predicted by the modeling studies, the α-amino acid moiety of glutamate interacts 
via hydrogen bonds with Ser165 and Thr188 from lobe I (see fig. 10, right), and the 
amino group interacts with Tyr236 and Asp308 from lobe II. These 4 residues are 
conserved in much class–C GPCRs and bacterial LIVbps. The distal carboxylic 
group of the glutamate interacts with Lys409 as well as with Arg78 via a water 
molecule.  
 
Fig. 10a. Domain structure of mGluR 
  
 
Fig. 10b. X-Ray crystal structure of the ligand binding domain of mGluR. 
Left,The X-ray crystal structure of mGluR1 represented as ribbons and the bound 
ligand glutamate in ball and stick representation. The figure prepared using 
PyMOL software (1EWK). Right, the residues involved in the glutamate binding 
to the ligand binding domain of mGluR. The figure prepared using LigPlot. 
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I.5.2 Drosophila metabotropic glutamate receptor (DmGluRA) 
In arthropods, glutamate is well known as the most common transmitter at the 
neuromuscular junction ((Delgado et al., 1989). It is also recognized as a 
neurotransmitter in the CNS of invertebrates. Fast glutamatergic transmission is 
mediated by ionotropic glutamate receptors (iGluRs), but synaptically released 
glutamate also activates metabotropic glutamate receptors, which signal via slower 
G-protein coupled pathways. In vertebrates, several groups of metabotropic 
glutamate receptors (mGluRs) are known to modulate synaptic properties (Schuster 
et al., 1991). In contrast, the Drosophila genome encodes a single functional mGluR 
(DmGluRA), an ortholog of vertebrate group II mGluRs, greatly expediting the 
functional characterization of mGluR-mediated signalling in the nervous system. 
This receptor displays 45 and 43% amino acid sequence identity with its 
mammalian homologs mGluR3 and mGluR2, respectively. Moreover, its 
pharmacology and transduction mechanisms are surprisingly similar to those of 
mGluR2 and mGluR3. DmGluRA is expressed in the in the CNS of the late 
embryo.  
 
DmGluRA is a 2.4 kilobase open reading frame encoding 977 amino acid protein 
(108 kDa) (Parmentier et al., 1996). It contains all the structural features 
characteristic of mammalian mGluRs such as the glutamate binding domain, 
cysteine rich domain with all of the cysteines observed conserved as in mammalian 
mGluRs and the seven transmembrane helical domains spanning the membrane. In 
one study, the DmGluRA was expressed in the fly system where in the receptor was 
expressed in the rhabdomeres of the fly eye (Eroglu et al., 2002). Biochemical 
characterisation of the receptor expressed in the fly eye and insect cells showed that 
the receptor had a 10 lower affinity for binding glutamate when expressed in the 
rhabdomeres. Lipid analysis data on the sterol content showed that the rhabdomeres 
contained ergosterol and the insect cell contained cholesterol. Further 
characterisation of the receptor showed that, the affinity of DmGluRA to glutamate 
can be regulated by the receptor association with specialised domains of the cell 
membranes, referred to as lipid microdomains or detergent resistant membranes 
(DRMs) dictated by the cholesterol content at the membrane (Eroglu et al., 2003). 
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I.6 Organisation of lipid membranes and regulation of membrane 
proteins 
Cell membrane consists of more than 2000 species of lipid molecules, including 
sphingolipids and sterols. For many years, the lipid bilayer of the eukaryotic plasma 
membranes has been referred as a two-dimensional “fluid mosaic”. Apart from 
glycerophospholipids that are sufficient to form bilayers, most eukaryotic cells 
contain two additional classes of lipids: sterols and sphingolipids.  
 
The lipidic part of sphingolipids consists of a sphingoid base. Based on the type of 
headgroup attached, sphingolipids are classified as phosphosphingolipids or 
glycosphingolipids. The sterols are based on a rigid four-ring structure, with 
cholesterol being the principle form found in the vertebrates. Sterols and 
sphingolipids are present at low levels in internal membranes and synthesized in the 
endoplasmic reticulum (ER) and golgi respectively, but are at high levels in the 
plasma membrane (30-40 mol%) and endosomes.  
 
In vivo approaches to understand the importance and specificity of phospholipids 
and sterols are studied by disrupting the pathway responsible for the synthesis of 
specific phospholipids. The other approach involves the reconstitution of the 
delipidated and purified membrane protein into proteoliposomes of a defined 
composition. Delipidation of membrane proteins leads to protein inactivation and 
can be reversed by addition of selective external lipids that can restore the activity 
of the membrane protein. 
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In a review, a list of membrane protein with a requirement of specific phospholipids for its activity was published as follows ( 
Membrane protein Lipid Effect/activity Reference 
P-glycoprotein 
 
PC, PE 
 
Restore activity of delipidated ATPase 
Headgroup and acyl chains affect drug binding 
affinity 
(Sharom, 1997) 
Ca2 + ATPase 
 
PI-4 
phosphate 
PE 
2- to 4-fold increase in ATPase activity 
 
Stimulates catalytic activity 
(Varsanyi et al., 1983) 
(Lee, 1998; Hunter et al., 1999) 
Phosphate carrier-Mitochondria CL 30-fold increase of specific activity (Kadenbach et al., 1982) 
(Schlame et al., 2000) 
Pyruvate carrier-Mitochondria  Requirement for activity and stability (Schlame et al., 2000) 
(Nalecz et al., 1986) 
ADP/ATP carrier 
Mitochondria-Mammals 
CL Strong effect on conformational transition and ADP 
binding 
(Schlame et al., 2000) 
(Beyer and Nuscher, 1996) 
Lac permease 
E.coli 
PE Required for H+-coupled transport, not for energy-
independent translocation 
Acts as a molecular chaperone for correct folding and 
membrane topology 
(Chen and Wilson, 1984) 
(Bogdanov and Dowhan, 1995) 
(Bogdanov and Dowhan, 1998) 
(Bogdanov and Dowhan, 1999; 
Bogdanov et al., 2002) 
ABC-transporter OpuA-L.lactis PG/PS Osmotic stress sensed via alterations in ionic 
interaction with lipids 
(van der Heide et al., 2001) 
Pore protein PhoE-E.coli PE Required for trimerization of PhoE in vitro (de Cock et al., 2001) 
SecYEG translocase 
E. coli; B. subtilis 
PG 
PE 
Essential for preprotein translocation 
Stimulatory in E. coli; essential in B. subtilis 
(van der Does et al., 2000) 
(Rietveld et al., 1995) 
Hyaluronan synthase-Streptococcus CL Pore formation together with the protein postulated (Tlapak-Simmons et al., 1999) 
Monoglucosyl-diacylglycerol synthase 
A. laidlawii 
PG, CL 
 
Strong activation 
 
(Berg et al., 2001) 
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Chitin synthase-S. cerevisiae PS Required for activity in vitro (Duran and Cabib, 1978) 
Plasma membrane ATPase-S. cerevisiae PI, PG Required for activity in reconstituted system (Kruse et al., 2000) 
Photosystem II Spinach-Synechocystis 
 
PG 
 
Involved in dimer –monomer interconversions 
essential for photosynthetic activity in vivo 
(Hagio et al., 2000) 
PC- Phosphatidyl choline; PE- Phosphatidiyl ethanolamine ; CL- Cardiolipin; PG- Phosphatidyl glycerol; PS- Phosphatidyl serine 
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Following biochemical experiments involving interactions between lipids and membrane proteins, the strongest evidence comes for highly 
specific protein-phospholipid and/or sterol interaction comes from 3D structures of membrane proteins (Adopted from. 
Protein  Lipids  Remarks  Function  Reference  
Cytochrome c oxidase 
Bovine  
3 PE, 7 PG, 1 PC, 3 CL  5 molecules at the outer leaflet of the inner 
mitochondrial membrane, 9 at the matrix side 
CL essential for activity  (Robinson, 
1982) 
Cytochrome c oxidase  
P. denitrificans  1 PC  
Forms two ion pairs with Arg233 and Asp74 
of subunit III 
 (Iwata et al., 
1995) 
Cytochrome bc1  
S. cerevisiae  
2 PEa,1PIa,1PCa,1CLa  
a
-per monomer 
 
1 PE interacts with both monomers PI is in 
interhelical position All lipids except PI are 
on the matrix side of the mitochondrial 
membrane 
Dimer stabilization. Stabilizes 
complex via interaction with 
Lys272 One of the CL 
phosphodiesters may be part of 
the proton translocation path  
(Lange et al., 
2001) 
Photosystem I  
Syn. elongatus  
3 PG, 1 MGD  All located at the stromal side of the 
membrane Phosphodiester of one PG binds 
one antenna chorophyll α 
 (Jordan et al., 
2001) 
Reaction center 
R. sphaeroides  
1 CL  One phosphodiester of CL interacts with 
His145 and Arg267 of subunit M 
 (McAuley et 
al., 1999) 
K+ channel KcsA  
Strep. lividans  2 PG  
  
 
Bacteriorhodopsin  
H salinarum  
6 dietherlipids/trimer 
[sulfated triglyceride 
lipid (S-TGA-1)] 1 
squalene and 5 
PGP/monomer 18 
phytanyl lipids/trimer  
 Stabilization of BR-trimer 1 
squalene and 1 PGP essential 
for normal photocycle 
characteristics Form annulus 
around trimer In part fill 
grooves of the proteins  
(Joshi et al., 
1998) 
(Luecke et al., 
1999) 
(Belrhali et 
al., 1999) 
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1.6.1 Membrane phases and lipid rafts – Role of cholesterol  
It is a very well known that lipid compositions of the two leaflets are not homogenous 
and are dynamic due to rapid flip-flop of sterols and lateral diffusion of the lipids. The 
outer leaftlet generally consists of sphingolipids, while the inner leaflet is composed of 
glycerophospholipids such as phosphatidylinositol, phosphatidylethanolamine and 
phosphatidylserine.  
 
Studies relating to lipid biophysics, lipid sorting, and the effects of detergents on 
biological bilayer, shows existence of a particular type of microdomain that is rich in 
cholesterol and sphingolipids in the plasma membrane.  
 
I.6.2 Role of cholesterol in maintaining the membrane fluidity  
The importance of cholesterol in the functioning of cell membranes might be its ability to 
alter fundamental properties of the phospholipid bilayer and to interact directly with 
specific membrane proteins. Cholesterol is known to undergo spontaneous flipping 
between the two leaflets and preferentially interacts with sphingolipids in the outer leaflet 
rather than the unsaturated phospholipids in the inner leaflet. This way it plays a crucial 
role in segregating saturated phospholipids and sphingolipids from unsaturated 
phospholipids in bilayer membranes.  
 
 
Gel Liquid disordered (Id) Liquid ordered (Io) 
Fig 11. Different phases of the lipid bilayer (Brown and London, 1998) 
 
The need for high levels of cholesterol in the plasma membranes and its effect on the 
physical properties of the lipid bilayers showed that the pure phospholipid bilayers can 
exist in two states, a solid or “gel” state, and a fluid or “liquid” state. The solid gel phase 
is not thought to be of physiological revelance. However, the fluid structure of liquid 
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bilayers is profoundly altered by the addition of high levels of cholesterol. The rigid 
sterol causes the lipid acyl chains to become closely packed or compacted, and the 
bilayer to be thickened. Because the long rigid cholesterol molecule is arranged 
perpendicular to the bilayer, this organizing effect is highly directional. The high 
cholesterol bilayer is thus termed “liquid-ordered” (Io), in contrast to the “liquid-
disordered” (Id) state without cholesterol (Brown and London, 1998). 
  
The insolubility of Io microdomains in non-ionic detergents at low temperatures has been 
extensively used for their isolation. The term “lipid raft” was introduced to refer to a sub-
population of cellular membranes, isolated by their insolubility in non-ionic detergents at 
4°C that are enriched in cholesterol, sphingomyelin, and glycolipids such as GM1 
ganglioside and display a light buoyant density in sucrose gradients. The lipid raft model 
therefore proposes that the cholesterol and sphingolipids of the outer leaflet of the plasma 
membrane are not evenly distributed, but rather cluster into Io domains that float in an Id 
bilayer. In the liquid-crystalline state of lipid bilayers, packing is loose and lateral 
diffusion is relatively rapid which implies that all plasma membrane proteins are like 
“icebergs in a sea of lipid,” uniformly dispersed in the lipid solvent, subjected to random 
mixing. Transmembrane proteins in the lipid bilayer would either reside in, or be 
excluded from, rafts depending on partitioning imparted by their physical properties. In 
the case of the outer leaflet of the bilayer, it is suggested that a major resident of rafts are 
proteins attached to the bilayer by covalent linkage to glycosylphosphatidylinositiol 
(GPI) lipid anchors.  
 
I.6.3 Functional revelance of lipid rafts  
The functional revelance of the raft model comes from the proposal that the sphingolipid 
and cholesterol-rich domains in the outer leaflet are connected to lipid domains in the 
inner leaflet. The components of signal transduction pathways, in particular G-proteins 
and nonreceptor tyrosine-kinases are anchored to the inner leaflet of the plasma 
membrane by virtue of multiple acyl chains, selectively partition into this inner leaflet 
part of the raft. This would allow rafts to act as “signalling platforms” that couple events 
on the outside of the cell with signalling pathways inside the cell, and indeed this has 
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been suggested to be their most important functions. Rafts have been proposed to play a 
role in signalling by, amongst others, T cell receptors, B cell receptors, IgE receptors, 
neurotrophic factors, growth factors, chemokines, interleukins and insulin.  
 
fig 12.Composition of lipids observed in the plasma membrane of mammals, 
nematodes, insects and fungi. 
 
GPCRs localized in lipid raft or caveolae 
Most of the receptors are localized in caveolae, as caveolae membranes are highly 
enriched in cholesterol and glycosphingolipids as rafts. Detergent extraction and density 
gradient centrifugation of the caveolae membranes results in the associated proteins in the 
same subcellular fractions as that of DRMs. The caveolar localisation is further verified 
by electron microscopy morphological appearance as 50-100nm diameter flask-shaped 
invaginations located at or near the plasma membrane of the cell. It has been reported that 
GPCRs co-immunoprecipite caveolin.. 
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List of GPCRs localised to lipid rafts and/caveolae (adopted from (Chini and Parenti, 
2004)) 
Receptor Enrichment in 
DRMs 
Enrichment in 
‘caveolar fractions’ 
Reference 
Angiotensin AT1 Yes <10% Yes <10% (Ishizaka et al., 1998) 
(Ushio-Fukai et al., 
2001) 
(Leclerc et al., 2002) 
(Wyse et al., 2003) 
Bradykinin B1 - No (Lamb et al., 2002) 
Bradykinin B2 - Yes (de Weerd and Leeb-
Lundberg, 1997) 
(Haasemann et al., 1998) 
(Ju et al., 2000) 
(Lamb et al., 2002) 
Ca sensing Yes - (Kifor et al., 1998) 
(Kifor et al., 2003) 
mGluR Variable result - (Becher et al., 2001) 
(Eroglu et al., 2003) 
Cholecystokinin 
CCK 
Yes - (Roettger et al., 1995) 
Sphingosine EDG-
1 
- Yes (Igarashi and Michel, 
2000) 
Endothelins ETAA Yes - (Chun et al., 1994) 
(Okamoto et al., 1998a) 
Endothelins ETAB Yes Yes (Teixeira et al., 1999) 
(Yamaguchi et al., 2003) 
Metabotropic 
GABAB 
Yes - (Becher et al., 2001) 
Gonadptropin Yes Yes (Navratil et al., 2003) 
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releasing hormone 
GnRH 
(Pawson et al., 2003) 
Oxytocin OTR Yes < 10% Yes < 10% (Gimpl and Fahrenholz, 
2000) 
(Guzzi et al., 2002) 
Somatostatin SST2  - Yes (Krisch et al., 1998) 
(Mentlein et al., 2001) 
Serotonin 5HT2 - Yes (Dreja et al., 2002) 
Thyrotrophin TRH - Yes (Drmota et al., 1999) 
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Aim and outline of work 
 
For years membrane proteins have been the most interesting and challenging field of 
work possessing enormous medical importance. G-protein coupled receptors (GPCRs) 
play a pivotal role in many physiological functions. The bottleneck lies especially in the 
structure determination and characterization of GPCRs. Owing to the lack of a robust 
system, structure determination of GPCRs still remain a dream.  
 
The first part of the current study is focused upon employing molecular cloning strategies 
to over-express the metabotropic GABAB1b receptor (rat) in the recombinant baculovirus 
(RBV) and E.coli system. In this study attempts are made to optimize the expression and 
purification of the ligand binding extracellular domain of the metabotropic GABAB1b 
receptor (GBR1bNT) at molecular level by computational and experimental studies. This 
information aimed to be useful in designing vectors which contain fusion partners or 
signal peptides, which would improve the GBR1bNT expression and purification. 
 
Two expression systems, RBV or E.coli, have been considered for the GBR1bNT 
expression purposes. Different biochemical strategies will be applied to optimize the 
expression and purification of GBR1bNT. 
 
The second part of the study was aimed at understanding the regulation of Drosophila 
metabotropic glutamate receptor (DmGluRA). The study will be focused biochemically 
characterizing the putative role of cholesterol binding motif (pCBM) in DmGluRA 
regulation. Attempts will be made to obtain the minimal domain requirements of the 
DmGluRA that is capable of glutamate binding with the same affinity as observed in the 
full length protein. 
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II. Materials and methods 
 
II.1 Materials 
II.1.1 Chemicals 
All chemicals were of analytical grade and were purchased from Sigma, Fluka or 
Merck laboratories if not stated otherwise. 
 
II.1.2 Enzymes and other proteins 
Restriction endonucleases, NEB buffers and T4-DNA ligase New England Biolabs 
High fidelity DNA polymerase system Roche applied science 
Complete® protease inhibitors cocktail Roche applied science 
 
II.1.3 Kits and chemicals 
QIAquick Gel Extraction kit Qiagen 
QIAprep Spin Miniprep kit Qiagen 
TA cloning kit Invitrogen 
BaculoGold DNA kit Pharmingen 
Bicinchoninic acid assay kit Sigma 
L-[3H]-Glutamate Amersham Pharmacia 
Silver staining kit Sigma 
Ethylene glycol monomethyl ether Sigma 
Triton X-100 Serva 
 
II.1.4 Instruments and equipments 
Automated DNA sequencing MWG Biotech 
Neubauer chamber Hecht-Assistant 
Beckmann liquid scintillation counter Packard Instruments 
ZetaSizer S1000 HAS Malvern instruments 
Model J-180 CD spectropolarimeter Jasco 
Electrophoretic system BioRad 
Ultra-clearTM ultracentrifugation tubes  Beckmann Instruments  
Hoefer vacuum filtration setup Amersham Pharmacia 
Nitrocellulose membranes Schleicher and Schuell 
Extruder Avestin 
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II.1.5 Stock solutions 
All stock solutions were prepared as described in (Sambrook 2001). 
IPTG stock solution 100mM 
Ampicillin stock solution 100 mg/mL 
Kanamycin stock solution 50 mg/mL 
Chloramphenicol stock solution 50 mg/mL in ethanol 
 
II.1.6 DNA and Protein ladders 
DNA ladder 
DNA ladder 100 bp DNA ladder 
1 kb Plus DNA ladder 
 
New England Biolabs 
Gene rulerTM  
Protein ladder 
Rainbow marker 
Broad Range marker 
 
Amersham Pharmacia 
BioRad 
 
II.1.7 Competent cell strains of E.coli for cloning 
Chemically competent NOVABlue cells and SOC medium Novagen 
Electrocompetent DH5 cells prepared in-house 
 
II.1.8 Antibodies 
Primary antibodies 
Anti penta-His antibody (Mouse) (1:1000 dilution)  
Anti-DGR (Rabbit) (1:2500 dilution) 
 
Qiagen 
Produced in-house 
Secondary antibodies 
Anti-rabbit IgG, Horse radish peroxidase (HRP) linked 
whole antibody  
Anti-mouse IgG, Horse radish peroxidase linked whole 
antibody 
Amersham Pharmacia 
 
Sigma 
 
II.1.9 Plasmids 
PCR2.1  Invitrogen  
pVL1393  BD biosciences 
pEVMOD  
pCDNA3.1-GPI  
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II.1.10 DNA sample preparation buffers 
6X Sample buffer for 
DNA (Fermentas) 
0.25% Bromophenol blue, 40% sucrose, 60mM Tris-HCl, 
pH 7.4 and 6mM EDTA. 
 
II.1.11 Media 
Lauria-Bertani broth 
(LB) 
Prepared as per the manufacturer’s instructions. 1L 
contained 10g of NaCl, 10g of Bacto-Trypton and 5g of 
yeast extract. pH was adjusted to 7.4. For plates, 15 g/L 
agar was added to the preparation. 
II.1.12 Buffers 
10X Phosphate Buffered 
Saline (PBS) 
1.36 M NaCl, 357mM Na2HPO4, 143mM KH2PO4 and 
30mM KCl. PBS was adjusted to pH 7.4.  
1X TBE buffer 
 
11g Tris base, 5.5g of Boric acid and 4mL of 0.5M EDTA 
pH 8.0 in 1L MilliQ water. 
 
II.1.13 Solution and reagents  for Sodium Dodecyl Sulphate – Polyacrylamide Gel 
Electrophoresis (SDS-PAGE and western blotting 
2X denaturing SDS-
PAGE buffer 
60mM Tris-HCl pH 6.8, 8M Urea, 5% Sodium dodecyl 
sulphate, 0.25% sodium deoxycholate, 10% ß-
mercaptoethanol and Bromophenol blue. 
  
10% APS 2g APS in 20mL water 
10% TEMED  1mL in 10mL water 
Resolving gel buffer  375mM Tris-HCl pH 8.8 and 0.1 % SDS 
Stacking gel buffer  125mM Tris-HCl pH 6.8 and 0.1% SDS 
  
Staining solution 100mL Methanol, 20mL glacial acetic acid,  0.8g 
Coomassie blue R-250 in 100mL MilliQ water 
Destaining solution 50mL ethanol and 70% Acetic acid in 1L of MilliQ water 
  
10X Transfer buffer 19g Tris base and 90g glycine, and adjusted to 1L solution 
with MilliQ water. 
PBST buffer 300µL Tween 20 in 100mL of 1X PBS 
Blocking buffer 3% skimmed milk powder in PBST buffer 
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II.1.14 Insect cell strains in the Recombinant BaculoVirus (RBV) system 
II.1.14.1  Medium and Buffer 
SF900-II and TNM-FH 
(Hinks media) Gibco 
Was prepared according to the manufacturer’s protocol 
and was supplemented with Penicillin (100 mg/mL and 
Streptomycin (100 mg/mL) antibiotic. 
Transfection buffer 25mM Hepes, 140mM NaCl and 125mM CaCl2 pH 7.1. 
 
II.1.14.2 Insect cell lines 
 
 Insect species Cell line 
Spodoptera frugiperda Sf9 
Spodoptera frugiperda Sf9 
Spodoptera frugiperda SF+ 
Trichoplusia ni HighFive 
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II.2 Materials for the work involving molecular cloning strategies to improve the 
expression and purification of ligand binding extracellular domain of rat 
metabotropic GABAB1b receptor in E.coli expression system 
 
II.2.1 Vectors for GBR1bNT over-expression 
Tags  
Vector 
 
Promoter 
 
Selection N-term C-term 
Fusion partners 
(N-term) 
pETM 11 T7-lac Kan 6-His 6-His - 
pETM 30 T7-lac Kan 6-His 6-His GST 
pETM 50 T7-lac Kan 6-His 6-His DsbA 
pETM 52 T7-lac Kan 6-His 6-His DsbA (leaderless) 
pETM 60 T7-lac Kan 6-His 6-His NusA 
pET 15b-GST T7-lac Amp - 6-His GST 
Kan – Kanamycin Amp – Ampicillin 
 
II.2.2 Host strains for GBR1bNT over-expression  
BL21(DE3)  
BL21(DE3) pLysS 
C43(DE3) 
Rosetta (DE3) pLysS 
Tuner 
 
 
II.2.3Buffers for  column chromatography 
 
Lysis buffer 50mM Tris pH 8.0, 300mM NaCl, 0.2 % Triton X-100, 1mM 
PMSF, 5 % Glycerol and Complete protease inhibitors. 
 
II.2.4 Buffers for purification using Glutathione S-Transferase (GST) column 
GST wash buffer 136mM NaCl, 35.7mM Na2HPO4, 14.3mM KH2PO4, 3mM 
KCl and protease inhibitors. 
GST elution buffer 136mM NaCl, 35.7mM Na2HPO4, 14.3mM KH2PO4, 3mM 
KCl, 10mM Glutathione and protease inhibitors. 
TEV buffer 50mM Tris pH 8.0, 500mM EDTA and 1mM DTT. 
 
II.2.5 Buffers for the purification using Nickel column 
Buffer A 50mM Tris,  300mM NaCl, 10 % Glycerol and 4mM MgCl2. 
pH adjusted to 8.0 
Buffer B 50mM Tris,  300mM NaCl, 10 % Glycerol, 4mM MgCl2 and 
500mM Imidazole. pH adjusted to 8.0 
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Dialysis buffer 50mM Tris, 300mM NaCl, 10 % Glycerol and 2mM MgCl2. 
pH adjusted to 8.0 
 
II.2.6 Buffers for purification using ceramic hydroxyl apatite column (CHT) 
Equilibration buffer 
(Buffer Q) 
20mM potassium phosphate buffer pH 6.0 
Wash buffer 
(Buffer W) 
20mM potassium phosphate buffer pH 6.0 and 500mM NaCl. 
Elution buffer 
(Buffer E) 
100mM Potassium phosphate buffer  pH 8.0 and 300mM NaCl 
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II.3 Materials for the work involving biochemical characterization of the 
cholesterol binding motif and determination of the minimal construct required 
for maintaining the high affinity state for binding glutamate in DmGluRA 
 
II.3.1Buffer for homogenization of Sf9 cells 
Homogenization buffer 50mM Sodium phosphate buffer pH 7.4, 300mM NaCl, 2mM 
MgCl2, 1mM EGTA, 250mM Sucrose containing protease 
inhibitors. 
 
II.3.2 Buffer for enrichment of plasma membranes 
TNE buffer 50mM sodium phosphate buffer pH 7.4, 300mM NaCl, 2mM 
MgCl2 and 1mM EGTA containing protease inhibitors. 
 
II.3.3 Buffers for L-[3H]-Glutamate binding assays 
Binding buffer 50mM Tris HCl pH 7.4 and 0.2% BSA  
Buffer for filter saturation 50mM Tris HCl pH 7.4 and 1%BSA 
“No salt” buffer 50mM Tris-HCl pH 7.4  
“Salt” buffer 50mM Tris-HCl pH 7.4 and 500mM NaCl 
 
II.3.4 Buffer for raft isolation from insect cells 
TXNE buffer 1% TritonX-100, 50mM sodium-phosphate buffer pH 7.4, 
300mM NaCl, 2mM MgCl2, 1mM EGTA and 2 tablets of 
protease inhibitors for 25mL buffer (to be added before use) 
 
II.3.5 Buffer for Liposome floatation assay 
20mM phosphate buffer pH 7.5, 150mM NaCl, 2mM MgCl2 
and 240mM Sucrose 
Assay buffer 
 
II.3.6 Synthetic peptides 
The synthetic peptides for circular dichroism studies were synthesized from JPT peptide 
technologies GmbH. 
Peptide Name Peptide sequence 
Pep611-624 H-SCYALDIQYMKWNS-NH2 
Pep602-624 H-GLWPYADKLSCYALDIQYMKWNS-NH2 
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II.4 Methods 
 
II.4.1 Polymerase Chain Reaction (PCR) 
All primers were diluted in sterile MilliQ water to a stock of 100µM and stored at -
20°C. The DNA concentration was determined using spectrophotometer reading at 
A260.  
 
The following reaction mixture was set up for all PCRs. 
Template (10 ng/µL)    2 µL 
100 µΜ forward primer   1.5 µL 
100 µΜ reverse primer   1.5 µL 
100mM dNTP mix    1 µL 
Expand high fidelity (3 units/µL)  1 µL 
10X Expand high fidelity buffer  5 µL 
Sterile MilliQ water     volume made up to 50 µL 
 
The samples were prepared in thin-walled PCR tubes and the reaction was carried out 
in a thermocycler PCR machine. The temperature cycle was setup as per the standard 
protocol. 
 
Initial denaturation 92°-94°C 5 min 
Denaturing  92°-94°C 1 min  
Annealing  50°-54°C 30-35 sec 
Elongation  72°C  90-120 sec 
Final Elongation 72°C  10 min 
 
50µL of the PCR product mixed with 6X tracking dye was observed on a 1% agarose 
gel containing ethidium bromide. 1 kb Plus DNA ladder was used to determine the 
molecular size of the PCR amplified product after electrophoresis in 1X TBE buffer at 
100 volts. The electrophoresed gel was visualized under a transilluminator and 
photographed.  
 
 
25-30 cycles 
Chapter 2                                                                                   Materials and methods 
 
 39 
II.4.2 Restriction enzyme digestion of the vector and the PCR product 
The minipreps plasmid DNA was prepared by following the protocol and buffers 
provided by QIAprep spin miniprep kit. The cells were pelleted by centrifugation at 
4000 rpm at 4°C for 10 min, and resuspended in 250 µL of Buffer P1 containing 
RNase. The resuspended cells were lysed by the addition of 250 µL of Buffer P2, 
followed by careful mixing of the contents. The lysates were neutralized by the 
addition of 300 µL of Buffer N3. The supernatant was cleared from the cell lysate by 
centrifugation; the supernatants were loaded onto the binding column and spun down. 
The flowthrough was discarded, and the columns were washed with Buffer PE. In the 
last wash, centrifugation was performed for 1 min to remove the traces of ethanol. 
The plasmids were eluted with 30 µL sterile MilliQ water.  
 
The PCR amplified product was extracted from the gel matrix using the QIAGEN Gel 
extraction kit, the purified PCR product was eluted in 30 µL sterile MilliQ water from 
the agarose resin.  
 
The plasmid and the PCR products for ligation were digested using appropriate 
restriction enzymes. Typically, a restriction enzyme digestion setup consists of  
 
Plasmid DNA/PCR product  1 µg 
Restriction enzyme 10 units/µl 1 µL 
Appropriate buffer 10X  2 µL 
Sterile MilliQ water    volume made up to 20 µL 
 
The microfuge tubes were incubated for 1 hr at 37°C. After incubation the digestion 
mixture was resolved on 1% agarose gel. 
 
II.4.3 Ligation and transformation of the constructs into competent cells 
The appropriate bands of the digested plasmid and the PCR products were gel purified 
and ligated using T4 DNA ligase enzyme. The ligation reaction was set up as follows 
at 18°C for 12-16 hrs. 
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Digested Plasmid DNA: PCR product ratio 1:15 and 1:30 (by volume) 
T4 DNA ligase enzyme 400 units/µL  1 µL 
10X Ligase buffer     2 µL 
Sterile MilliQ water     volume made up to 20 µL 
 
For a bacterial transformation, about 2µL of ligation mixture was mixed with 100µL 
of competent cells and incubated on ice for at least 30 min. The mixture was heat 
shocked at 42°C for 30 secs, followed by incubation on ice for 2 min. A volume of 
250 µL pre-warmed SOC medium was added to the transformation mixture followed 
by incubation at 37°C for 30min on a shaker. The cells were plated on LB agar plates 
containing appropriate antibiotic as selection marker and incubated at 37°C for 12-16 
hrs. About 10-15 colonies were randomly picked to check for any recombinant clones 
and inoculated into 4mL of LB media containing antibiotic in 15mL falcon tubes. The 
cultures were incubated at 37°C for 12-16 hr on a shaker. 
 
The minipreps of the clones were prepared and all recombinant plasmids were 
identified and verified by restriction digestion with appropriate enzymes. The 
constructs were sequenced to check for mutations using following primers designed 
for verifying constructs cloned in the multiple cloning site of the pVL1393 vector. 
 
Primers Sequence 
Pvl_for 5'-TAA AAT GAT AAC CAT CTC GC-3' 
Pvl_rev 5'-TGA AGA GAG TGA GTT TTT GG-3' 
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II.5 Cell culture: Recombinant baculovirus system 
Baculovirus are a diverse group of viruses that are found mostly in insects which 
represent their natural host and they are not known to have any non-anthropod hosts 
(O’Reilly et al., 1992). The baculovirus DNA is of 80-200 kilobase pairs (kbp) 
double-stranded, covalently closed, and circular. The most commonly used 
baculovirus is Autographa californica multiple nuclear polyhedrosis virus 
(AcMNPV), which belongs to the family baculoviridae. The properties of insect cell 
lines for baculovirus propagation include growth rate, ability to support virus 
replication and plaque formation, ability to grow in both monolayer and suspension 
cultures. Most commonly used cell line is the Sf9 cell line, derived from Spodoptera 
frugiperda pupal ovarian tissue. The insect baculovirus expression system provides a 
eukaryotic environment that is favourable for the proper folding, disulphide bond 
formation, oligomerisation and posttranslational modification of the protein essential 
for the biological functionality of a large number of foreign proteins. 
 
The general procedure used was adapted from Baculovirus and cloning techniques 
described by (O'Reilly, 1994). All cell counts were carried out under a light 
microscope using a Neubauer chamber. 
 
II.5.1 Maintenance and adaptation of Sf9, HighFive (Hi5) and SF+ cells 
The Sf9, Hi5 and SF+ cells double every 18 to 24 hr and were maintained in 
erlenmeyer flasks as suspensions in Sf900-II medium with 10% fetal calf serum 
(FCS) or 75 cm2 tissue culture flasks as monolayer culture (in TNM-FH medium). 
The monolayers were grown to 80 to 90% confluency and finally diluted to 30% 
confluency. The suspension cultures were routinely grown to a cell density of 4 to 
4.2x106 cells permL and diluted to a final density of 0.3 to 0.4 x106 cells per mL. All 
cell lines were incubated at 27 °C on a flat surface incase of monlayers or stirred at 80 
rpm incase of suspension cultures. The maintenance of the culture is summarize as 
follows: 
Cell line Culture type Growth medium 
Sf9 Monolayer TNM-FH with 10% FCS 
Sf9 Suspension Sf900-II (serum free medium) 
SF+ Suspension Sf900-II (serum free medium) 
HighFive Monolayer TNM-FH with 10% FCS 
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II.5.2 Production of recombinant baculovirus by co-transfection 
The linearized AcNPV genome and pVL1393 constructs were co-transfected into Sf9 
cells (monolayers) by calcium phosphate co-precipitation as described (O'Reilly, 
1994). 
  
A 6 cm diameter tissue culture dish was seeded with 1 x 106 Sf9 cells/ml in 3mL of 
TNM-FH medium containing 10 % (v/v) fetal calf serum (FCS) and incubated at 
27°C for 2 hr to let the cells attach.   
 
The transfection mix was prepared in a microfuge tube by mixing 0.5 µg Baculo Gold 
DNA and 2 µg transfer plasmid in 750µL of transfection buffer. The medium was 
carefully removed from the dish containing Sf9 cells and 750µL of fresh medium was 
added.  The transfection mix was transferred drop-wise onto the cells with gentle 
rocking. The culture dish was sealed with parafilm and was incubated at 27°C. 
Following 4 hr of incubation, the transfection mix was removed from the culture dish 
and 4mL of fresh TNM-FH medium supplemented with 10 % (v/v) FCS was added. 
Cells were incubated for 3  to  4  days  until  cytopathic  effects  (lack  of  cell  
growth,  floating  cells,  nuclear enlargement, cell lysis) were apparent. Cell culture 
supernatant were collected in 2mL sterile amber colored microfuge tubes and 
maintained as primary viral stock (1°VS) and stored at 4°C. The cell pellet was 
washed twice with PBS. Samples of total cells were prepared for SDS-PAGE 
electrophoresis followed by western blot analysis to check the protein expression of 
the recombinant truncation constructs. 
 
II.5.2.1 Sample preparation for SDS-PAGE 
The total cells or plasma membrane obtained from expression of DmGluRA 
truncation constructs were prepared for SDS-PAGE by addition of 2X denaturing 
SDS-PAGE buffer followed by incubation for 30 min at 40°C or left overnight at 
room temperature. For soluble proteins, samples were boiled with 2X SDS-PAGE 
denaturing buffer at 98°C for 3 min. 
Gels for SDS-PAGE were prepared according to the guidelines of Molecular cloning 
(Sambrook 2001). 8% and 10% separation gels were used in this experimental work. 
The electrophoresed gels were either silver stained or Coomassie blue dye stained or 
used for western blot analysis. 
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 II.5.2.2 SDS-PAGE for electrophoretic separation of proteins 
Resolving gel 8% 10%  Stacking gel  
Resolving gel 
buffer pH 8.8 
2500µL  2500µL   Stacking gel 
buffer pH  6.8 
1250µL  
30% Acrylamide  1330µL  1670µL   30% Acrylamide 310µL  
Water 1050µL  714µL   Water 840µL  
10% APS 75µL  75µL   APS 75µL  
10% TEMED 45µL  45µL   TEMED 30µL  
 
II.5.2.3 Coomassie blue staining 
Proteins resolved on polyacrylamide gels were fixed and stained in staining solution 
(Sambrook 2001). After rinsing the gel briefly in water, the gel was destained in the 
destaining solution, which eliminates the blue background while the proteins retain 
the blue dye. Gels were either dried on Whatmann filter paper or on gelatin sheets. 
 
II.5.2.4 Silver staining 
Silver staining was carried out on electrophoresed SDS-PAGE gels following the 
protocol given by the manufacturer.  
 
II.5.2.5 Western Blot analysis 
The proteins resolved on polyacrylamide gels were electro-transferred to PVDF 
membranes 0.45 µm pore size membranes (Immobilon-P) with the aid of 
electroblotting apparatus. The PVDF membrane was activated by briefly rinsing with 
methanol prior to transfer. The “sandwich” was prepared as described in Molecular 
cloning (Sambrook 2001). Protein transfer from the gel to the membrane was carried 
out at 130 mA at constant current for 70 min.  
The membrane was blocked with blocking buffer for 1 hr. The membrane was washed 
once with PBST and then incubated with primary antibody (1:2500 dilution of anti-
DGR or 1:1000 of anti penta-His in blocking buffer) for 10-16 hr in the cold room. 
The membrane was washed thrice with PBST and incubated with HRP-linked 
secondary antibody (1:1000 dilution of anti-rabbit IgG, whole molecule in blocking 
buffer) for 1 hr at room temperature. The membrane was washed again thrice and 
developed using ECL western blotting detection system. 
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II.5.3 Purification of Recombinant Virus – End point dilution cloning 
The required recombinant virus obtained from the 1°VS by calcium phosphate co-
precipitation was selected and purified by the end-point dilution cloning technique as 
described (O'Reilly, 1994). 
  
The dilution of the primary viral stock was prepared as follows: 
Firstly, the virus was diluted in series in 10 sterile microfuge tubes as shown in 
Scheme 1 to obtain a final virus dilution of 10-5, 10-6, 3x10-7, 10-7, 3x10-8, 10-8, 3x10-9 
and 10-9. Then prepared about 30mL of a Sf9 cell suspension in TNM-FH medium at a 
density of 104 Sf9 cells/mL and distributed 2250 µL it into 8 sterile 15mL Falcon 
tubes. One falcon tube containing TNM-FH medium was kept as “control”. To the 8 
Falcon-tubes (microfuge tubes 3-10) added 250µL from the respective dilution (with 
the diluted virus). The total content (2500µL ) was mix thoroughly.  
 
A 96-well plate was labeled as per the scheme shown below; distributed about 100µL 
in to 22 wells for a given dilution. To the “Control” tube, 250µL medium (instead of 
virus) was added and distributed it as a control into the column in the 96-well plate 
shown as shaded part in the scheme. The plates were then sealed with parafilm. 
 
Scheme 1: Dilution of primary viral stock 
Medium (µL) 900  900  900  900  700  600  700  600  700  600 
Virus (µL)   10  100  100  100  300  300  300  300  300  300 
Label 1 2 3 4 5 6 7 8 9 10 
Virus-solution (µL) 250 250 250 250 250 250 250 250 
Cell-suspension (µL) 2250 2250 2250 2250 2250 2250 2250 2250 
final virus dilution 10-5 10-6 3x10-7 10-7 3x10-8 10-8 3x10-9 10-9 
 
96-well plate for selection of the recombinant clone 
  1 2 3 4 5 6 7 8 9 10 11 12    1 2 3 4 5 6 7 8 9 10 11 12 
A 100µL  ... ...           A             3 
10-5 
 
B ... ...            
7 
3x10-8 B             
C ...             C             4 
10-6 D              
8 
10-8 D             
E              E             5 
3x10-7 F              
9 
3x10-9 F             
G              G             6 
10-7 H              
10 
10-9 H             
96-plates were left for approximately 7 days at 27°C for sufficient infection. The 
contents in the well were observed under a light microscope and the number of wells 
that contained infected cells of each dilution was counted and the percentage was 
calculated. 
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According to the Poisson distribution, the proportion (p) of wells receiving either 0 or 
1 infectious unit at a mean concentration of virus (µ) of 1 is given by the equation 
P = µe-µ = e-1 = 0.367 
Thus, at an Multiplicity of Infection (MOI) of 1, 36% was assumed to have been 
infected with a single particle of virus. About 5 clones were chosen and seeded in a 6-
well microtiter plate containing 2x106 Sf9-cells/mL. The 96 well plates were left in 
the incubator for 1h at 27°C. Added 2mL fresh medium, sealed with parafilm and 
incubated for 5-7 days at 27°C.  
 
The contents were centrifuged and the supernatant was labeled as primary pure virus 
stock (1°pVS) along with the clone number. A sample of the cell pellet was prepared 
for Western blotting to check the protein expression of the recombinant truncation 
constructs. 
 
II.5.4 Preparation of high titre working stocks – secondary and tertiary stocks 
The secondary virus stocks were prepared by mixing 500µL of the 1°pVS with 
100mL of 2x106 Sf9 cells/mL in a 500mL spinner flask. The infection was carried out 
for 5-7 days at 27°C until all the cells were infected and lysed to ensure maximal virus 
yield. The contents were centrifuged; supernatant was collected in an amber colored 
glass-bottle, labeled as “2°pVS” (secondary pure virus stock) and stored at 4°C. 
 
The tertiary virus stocks “3°pVS” were similarly prepared by infecting 500mL of 
2x106 Sf9 cells/mL in a spinner flask with 1mL of the 2°pVS. The 3°pVS was 
maintained as the working stock after the determination of the titer values. 
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II.5.5 Determination of viral titre – End point dilution assay 
To start a protein expression in the baculovirus system it is mandatory to determine 
the titre value or plaque forming units/mL (pfu/mL) of the working stock to be 
reproducible from stock to stock in the infection kinetics and stoichiometry. This 
value is achieved by a method called End point dilution assay (EPD assay) as 
described in O’Reilly. In the EPD assay, Hi5 cells were used in monolayers instead of 
Sf9 monolayers. Since Hi5 cells are fibroblasts and enable easy of identification of 
infected cells. The dilution scheme for the endpoint dilution is as follows. 
 
Medium (µL) 900  900  900  900  900  900  900  900  900  900  
virus (µL) 100  100  100  100  100  100  100  100  100  100  
           
virus-solution (µL) 250 250 250 250 250 250 250 250 
Cell-suspension (µL) 2250 2250 2250 2250 2250 2250 2250 2250 
final virus dilution 10-4 10-5 10-6 10-7 10-8 10-9 10-10 10-11 
  1 2 3 4 5 6 7 8 9 10 11 12    1 2 3 4 5 6 7 8 9 10 11 12 
A 100µL  ... ...           A             10-4 
B ... ...            
10-8 
B             
C ...             C             10-5 
D              
10-9 
D             
E              E             10-6 
F              
10-10 
F             
G              G             10-7 
H              
10-11 
H             
 
The cells were observed under a light microscope from third day post-infection until a 
clear discrimination of infected and uninfected cells was achieved. The infected wells 
for each dilution were counted and the percentage was calculated. The following 
formula was applied to determine the pfu/mL of the working stocks. The dilution is 
calculated by linear interpolation between the infection rates observed at the given 
dilutions. 
 
First the proportionate distance (PD) of 50% response from the response above 50% is 
calculated using the formula: 
  
 
TCID50 = P - (A – 50) / (A – B) 
TCID50x 0,69 = pfu/ml  
TCID50 =50% tissue culture infectious dose  A = percentage of infected wells above 
50% threshold 
P is log of the dilution causing an infection 
greater than 50% wells (A) 
 B = percentage of infected wells below 
50% threhold 
II.5.6 Growth and expression studies 
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In the Baculovirus system, the optimal protein expression is dependent on the 
following parameters. 
- Cell-type (Sf9/SF+ in monolayer/suspension) 
- Multiplicity of infection (MOI) 
- Duration of infection 
Multiplicity of infection (MOI) is defined as the average number of viruses that 
infects a single Sf9/SF+ cell. It is determined using the following formula: 
 
MOI (pfu/cell) = 
Vol of viral inoculum required (mL) x titre of the virus (per mL)
Number of cells 
MOI (pfu/cell) x 
Vol of viral inoculum required (mL) =
titre of the virus (per mL)
Number of cells 
(OR)
 
 
After determination of the titre values of the viral stocks, test expressions were setup 
to determine the conditions for optimal recombinant protein expression. The 
expressions were performed in 100mL SF+ suspension cultures at a cell density of 2 x 
106 SF+ cells/mL. The cells were infected with recombinant virus at a MOI of 1,2,3,5 
and 10 at 27°C. The infected cells were counted after 24, 36, 48, 60, 72 and 96 hr post 
infection. Samples of cells and supernatants at mentioned time points were prepared 
for analyzing expression in western blots. After the determination of optimal 
conditions, large scale protein expression was setup.  
 
II.5.7 Purification of proteins expressed and secreted by SF+ cells to the insect 
cell medium 
The protein expression by SF+ cells posed difficulties in purification of proteins 
expressed and secreted to the Sf900-II medium owing to the media ingredients (such 
as aminoacids and salts) which inhibit the chelation of the His-tag to the Nickel ion 
and also the high loading volumes (500 ml-1 L) of the medium containing the 
secreted protein.  
 
Hence the purification of secreted protein in the medium was conducted in 2 stages. 
The first stage involved a Ceramic hydroxy apatite (CHT) column, where the Sf900-II 
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medium was replaced with Buffer E. The CHT column served the purpose of 
concentrating the protein to a lower loading volume into the Nickel-sepharose bed and 
as a buffer exchanger compatible with the Ni-sepharose column. The eluate from the 
CHT column was loaded on to the Ni-sepharose column. 
 
Stage 1 : CHT column
Stage 2 : Ni column
CHT resin ir
1L Insect
cell medium
~400 mL of 
eluate in
Buffer E
 f 
l t i
ff r 
Ni resini ir
15-20 mL of 
eluate
-  f 
l t
 
Fig. 13. Stages of purification of proteins secreted to the insect cell medium. 
Stage 1.Concentration and exchange of secreted proteins in insect cell medium to 
Buffer E on a ceramic hydroxyl apatite column (CHT).  
Stage 2. Purification of secreted proteins on a Ni-sepharose column. 
 
The experimental setup for the purification was carried out as shown in the fig.13. 1L 
of 2x106 SF+ cells/mL in suspension were infected with virus stock expressing DGX 
at MOI of 3 for 72-96 hr (until 70% cells were observed infected and lysed under light 
microscope). Culture supernatant was clarified by centrifugation and the supernatant 
was collected and filtered through a steritop vacuum filtration setup (0.22 µm 
poresize).  
 
II.5.7.1 Ceramic hydroxy apatite purification (CHT purification) 
All purification procedures were carried out in the cold room. The CHT column was 
prepared and equilibrated with 200mL of Buffer Q. The filtered supernatant was 
loaded into the equilibrated CHT column after addition of protease inhibitors and 
buffered with potassium phosphate buffer pH 6.0 to a final concentration of 20mM. 
The loaded column was washed until baseline (approx. 300 mL) with Buffer W and 
eluted with Buffer E. 
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II.5.7.2 Nickel column purification 
The eluate from the CHT column was prepared for loading into the Ni-sepharose 
column after addition of Buffer B to a final Imidazole concentration of 10mM. 
  
The loaded column was washed with buffer containing 10mM Imidazole until 
baseline. The Nickel bound protein was eluted from the column by a gradual increase 
in the Imidazole concentration (50, 75, 100, 150, 200, 250 and 500mM) and collected 
in 2mL fractions. Western blot was preformed on all the elution fractions where the 
peak was observed in the chromatogram. The fractions containing the required protein 
were pooled, concentrated on an membrane filter and dialyzed in 2L of dialysis buffer 
overnight in the cold room.  
 
The amount of protein obtained was determined by the absorbance of the sample at 
wavelength 280 nm. The extinction coefficients were theoretically calculated. 50 µL 
aliquots were prepared, flash frozen in liquid nitrogen and stored at -80°C.  
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II.6 Methods for molecular cloning strategies to improve the 
expression and purification of extracellular domain of GBR1bNT 
(rat) in RBV and E. coli system 
 
II.6.1 Expression of extracellular domain of GABA 1b receptor (GBR1bNT) in 
the insect cells 
 
II.6.1.1 Molecular constructs 
The GABA 1b receptor (GABABR) cDNA cloned in pVL1392-Mel vector was used 
as a template for obtaining the GABABR construct containing only the extracellular 
ligand binding domain lacking the native signal peptide. The GABABR was 
terminated at 1332 bp to obtain the GBR1bNT construct (the GBR1bNT spans from 
88-1332 bp containing a C-terminal 8-His tag). All constructs for expression of 
GBR1bNT were cloned into the transfer vector, pVL1393. Recombinant Baculovirus 
production and protein expression in the RBV system were conducted as previously 
described (see Materials and methods, Section II.5). 
 
8 pVL1392-Mel-GBR1bNT8H
8
8
pVL1393-DGRsp-GBR1bNT8H
pVL1393-cGH -GBR1bNT8H
Signal peptide TEV cleavage site 8 8-His tag
Fusion partner
8 pVL1393-cGH
GBR1bNT
 
Fig. 14. Molecular constructs considered for the study of expression and 
purification of GBR1bNT in the RBV system.  
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II.6.1.1a Preparations of pVL1392-Mel-GBR1bNT construct 
The pVL1392-Mel-GBR1bNT construct was previously prepared in the lab by 
cloning the PCR amplified GBR1bNT into the PstI/EcoRI MCS region of pVL1392-
Mel vector preceeded by the Mellitin signal sequence.  
 
II.6.1.1b Preparations of pVL1393-DGRsp-GBR1bNT construct 
For the pVL1393-DGRsp-GBR1bNT construct, the native signal peptide of 
GBR1bNT was replaced with DmGluRA signal peptide (DGRsp, 29 residues). The 
DGRsp complementary oligonucleotides were designed such that the forward primer 
(DGR_sp_rev) contained the BamHI overhang at the 5’ end and XbaI cleaved 
sequence at the 3’ end. The reverse primer (DGR_sp_for) contained BamHI cleaved 
sequence at 3’ end and overhang of XbaI cleavage sequence at the 5’ end.  
Primers Sequence 
DGR_sp_for 5’-GATCC A CCA TGA AAC AGA AAA ATA ATA ACG GAA CAA TTT 
TAG TCG TCG TGA TGG TTT TAT CCT GGA GTC GAG TAG TAG ACT 
TAA AAA GT T-3’ 
DGR_sp_rev 5’- CTAGA A CTT TTT AAG TCT ACT ACT CGA CTC CAG GAT AAA 
ACC ATC ACG ACG ACT AAA ATT GTT CCG TTA TTA TTT TTC TGT 
TTC ATG GT G-3’ 
 
The primers were annealed prior to ligation by mixing 900 µmol of  each primer and 
cycling it 5 times between temperature 92 °C (2 min) and 72 °C (5 min); and finally 
let the reaction proceed at 72 °C for 10 min. The 90 bp DGRsp insert was ligated into 
BamHI/XbaI digested pVL1393 vector to obtain the pVL1393-DGRsp plasmid.  
 
To obtain the pVL1393-DGRsp-GBR1bNT construct, the PCR product (TEV-
GBR1bNT) containing a TEV protease cleaveage site was amplified using 
Xba1_tev_gbr1b_for and cgh_corr_rev primers, using pETM11-GBR1bNT as 
template. TEV-GBR1bNT PCR product was digested with XbaI/NotI and ligated into 
XbaI/NotI digested pVL1393-DGRsp plasmid. The plasmid constructs were 
transformed into competent cells, plated on LB agar plates and the minipreps of 
colonies were verified by restriction enzyme digestion and sequencing for the 
recombinant clone (pVL1393-DGRsp-GBR1bNT). 
Primers Sequence 
Xba1_tev_gbr1b_for 5’-ATT CAG TTT CTA GAG GCG GCA TGA GCG ATT ACG ACA TCC 
-3’ 
cgh_corr_rev 5’-AAG CGA AGC GGC CGC TCA GTG ATG GTG ATG GTG ATG 
TCT AGA GAT GGT GCA GTT GCT CTC -3’ 
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II.6.1.1c Preparation of pVL1393-cGH and pVL1393-cGH-GBR1bNT constructs 
The pEVmod vector containing the coding sequence of cGH was a kind gift from 
laboratories of D.N.Foster (University of Minnesota, USA). The coding sequence of 
cGH was amplified from pEVmod vector using cgh_for and cgh_rev primers. The 
primers were designed in such a way that the PCR product of cGH at the 5’-end 
contained SmaI restriction site followed by Kozak translation initiation sequence (both 
included by cgh_for primer) and the 3’-end contained XbaI-8His-Stop-NotI (included 
by cgh_rev). The PCR product of cGH was cloned into SmaI/NotI MCS region of 
pVL1393 transfer vector. The resulting plasmid construct served as pVL1393-cGH 
construct. The TEV-GBR1bNT PCR product (see Materials and methods, section 
II.6.1.1b) was digested with XbaI/NotI and ligated into XbaI/NotI digested pVL1393-
cGH plasmid to obtain the pVL1393-cGH-GBR1bNT construct. 
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II.6.2 Methods for the work involving molecular cloning strategies to improve 
the expression and purification of ligand binding extracellular domain of rat 
metabotropic GABAB1b receptor in E.coli expression system 
 
II.6.2.1 Expression of the extracellular domain (ECD) of GABA 1b receptor 
(GBR1bNT) in the E.coli system 
 
II.6.2.1a Plasmids for protein expression in E.coli 
All plasmids were of pBR322 vector origin and contained a TEV protease cleavage 
sequence proceeded by the His tag / fusion partner at the N-terminus of GBR1bNT 
construct or the His-tag is fused to the C-terminus of GBR1bNT construct. 
 
II.6.2.1b Molecular cloning of GBR1bNT constructs in E.coli 
All molecular cloning strategies were conducted as previously described in the 
Materials and methods, Section II.4. The PCR was carried out by using pVL1392-
Mel-GBR1bNT (GABA 1b receptor truncated at 1332 bp and lacks the native signal 
peptide) as the template using the primers, 5’-
ATTCATCTCCATGGGGTCTCACTCCCCTCATCTC-3’ (gbr1bnt_for, forward 
primer) and 5’-AAGCGAAGCGGCCGCTCAGTGATGTGATGGTG-3’ 
(gbr1bnt_rev, reverse primer). All GBR1bNT PCR products were cloned into the 
NcoI/NotI multiple cloning site (MCS) of the pETM series (pETM11, pETM30, 
pETM50, pETM52 and pETM60 plasmids) for over-expression in E.coli. For 
pET15b-GST-GBR1bNT construct, pETM30-GBR1bNT was digested with 
XbaI/XhoI to obtain the GST-GBR1bNT insert and re-ligated in to the XbaI/XhoI 
digested pET15b vector.   
 
II.6.2.1c Expression of GBR1bNT in the total cells of E.coli 
In all test expression setups were carried out in 3mL LB medium (containing 
appropriate antibiotic) inoculated with a single bacterial colony transformed with the 
plasmid containing GBR1bNT. The bacterial culture was incubated at 37 °C on a 
circular rotor until the OD600 reached range of 0.6 - 0.8. About 1.5mL was transferred 
to a fresh falcon tube followed by induction with IPTG at a final concentration of 
1mM. The cultures were let to induce with IPTG for 6 hr at 30 °C. The cells were 
harvested by centrifugation. Samples of total cells under IPTG uninduced and induced 
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were prepared for SDS-PAGE analysis. The SDS-PAGE resolved total cells were 
stained with Coomassie blue contained in the staining solution to see the levels of 
protein expression. 
 
II.6.2.1d Large scale over-expression and purification of GBR1bNT in E.coli 
After optimisation of expression parameters such as expression vector, expression 
host, concentration of IPTG for induction, induction time and temperature, a large 
scale production (1 L) of GBR1bNT from E.coli was carried out under the optimised 
conditions.  
 
50mL LB medium containing appropriate antibiotic were inoculated with a single 
bacterial colony and incubated overnight at 37°C with shaking (280 rpm) in a 100mL 
flask. 10mL of the overnight culture was washed with PBS and resuspended in fresh 
LB medium. This served as a preinoculum to inoculate 1L of medium for a large scale 
over expression of GBR1bNT incubated at 37°C with shaking until the OD600 reached 
0.6-0.8 value. The cells were then induced with IPTG to a final concentration of 
0.1mM for 3 hr at 30°C or for 16 hr at 18°C. The IPTG induced cells were harvested 
and lysed by sonification in the Lysis buffer on ice for 5 min followed by 5 passes 
through the Emulsiflex (Microfluidiser was used in the later part of the work for cell 
lysis). The cell lysate was centrifuged on a high-speed vacuum centrifuge at 108, 000 
xg for 15 min on a T647.5 rotor. The supernatant containing the soluble form of 
GBR1bNT was applied to a pre-equilibrated Ni-sepharose column or a GST column 
depending on the tag fused to the construct.  
 
The loaded Ni-sepharose column was washed with buffer containing predetermined 
minimal concentration of Imidazole sufficient to remove the nonspecifically bound 
proteins to the column. In a Ni-sepharose column, the proteins were eluted from the 
bound column by a gradual step increase in the Imidazole concentration achieved by 
proportional mixing of Buffer A and Buffer B (containing 500mM Imidazole). In case 
of a GST column, the GST-tagged protein bound to the resin was resuspended in 2mL 
of TEV buffer. The cleavage reaction was carried out by incubating the GST-
GBR1bNT protein bound resin with 20 µg of TEV protease for 12-16 hrs at 4 °C. 
Samples at different stages of purification and after TEV cleavage were resolved on a 
SDS-PAGE and stained with Coomassie Blue dye.  
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II.7 Biochemical characterization of the cholesterol binding motif 
and determination of the minimal construct required for maintaining 
the high affinity state for binding glutamate in DmGluRA 
 
II.7.1 Molecular constructs 
DmGluRA cDNA cloned in the pRK7 vector (Parmentier et al., 1996) was used as the 
template for all PCR amplifications of truncation constructs. For all truncation 
constructs of DmGluRA, the same forward primer (DGR_for_1, table 1) was used. 
Apart from the 18-25 complimentary base pair region, both forward and reverse 
primer contained the following features. The forward primer comprised of a BamHI 
restriction enzyme cleavage site followed by 5’ Kozak translation initiation sequence 
(5’-CCACC-3’), (Parmentier et al., 1996). The reverse primers (table 1) comprised of 
an EcoRI restriction enzyme cleavage site followed by a 5’-TTA-3’ (stop codon) and 
coding sequence for flag tag.  The reverse primers coding for the DmGluRA truncated 
constructs were prepared by introducing a 5’-TTA-3’ (stop codon) after 1989 bp 
(DGRTM1), 2214 bp (DGRTM3) and 2451 bp (DGRTM5) of DmGluRA cDNA. The 
PCR products were ligated into the PCR2.1 vector then subcloned into the 
BamHI/EcoRI multiple cloning region of the pVL1393 transfer vector.   
 
 
Fig. 15. Schematic representation of the truncation constructs of DmGluRA 
cDNA cloned into the pVL1393 vector.  
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Table 1. Amplification of the truncation constructs – Polymerase Chain reaction 
Construct Primers 
DGRTM1 DGR_for_1        : 5’-CTA GAG GAT CCA CCA TGA AAC AG-3’ 
DGR_TM1_rev : 5’-CCG GAA TTC TTA CTG ATC GTC ATC GTC CTT GTA   
ATC CTC TCG TCC TGA TGC TCT TAC C-3’ 
DGRTM3 DGR_for_1        : 5’-CTA GAG GAT CCA CCA TGA AAC AG-3’ 
DGR_TM3_rev : 5’-CCG GAA TTC TTA CTG ATC GTC ATC GTC CTT GTA 
ATC TTG TGA TTG TGG ACT AAT ATA CTT AAG-3’ 
DGRTM5 DGR_for_1        : 5’-CTA GAG GAT CCA CCA TGA AAC AG-3’ 
DGR_TM5_rev : 5’-CCG GAA TTC TTA CTG ATC GTC ATC GTC CTT GTA 
ATC CTT CGA CTC ATT AAA GTT TTC AGG-3’ 
DGXd12ct DGR_for_1        : 5’-CTA GAG GAT CCA CCA TGA AAC AG-3’ 
DGXd12ct_rev  : 5’-AAG CGA AGC GGC CGC TCT AGA TTA GAA TTC GCA 
GGA GAG CTT GTC AGC-3’ 
DGXd12ct-
GPI 
DGR_for_1        : 5’-CTA GAG GAT CCA CCA TGA AAC AG-3’ 
DGXd12ct_rev  : 5’-AAG CGA AGC GGC CGC TCT AGA TTA GAA TTC GCA 
GGA GAG CTT GTC AGC-3’ 
 
Incase of DGXd12ct and DGXd12ct-GPI constructs, the PCR products were directly 
cloned into the pVL1393 vector as follows. The PCR amplified DGXd12ct construct 
contained the restriction sites EcoRI-stop-XbaI-NotI in the 3’-end as included by the 
reverse primer (as shown in the table). The DGXd12ct PCR product construct was 
cloned into the BamHI/NotI MCS of pVL1393 transfer vector. The resulting plasmid 
(pVL1393-DGXd12ct) was digested with EcoRI/XbaI restriction endonuclease 
enzymes and ligated at the 3’ end with a GPI anchor isolated from EcoRI/XbaI 
restriction site of pCDNA3.1-GPI vector containing the GPI coding sequence. The 
GPI coding sequence was a kind gift from Costagliola (Cornelius et al., 2001). It is a 
170 bp fragment encoding the motif required for GPI addition at the C-terminus of 
mouse Thy-1 and contained in the plasmid pCDNA3.1-GPI. The constructs were 
prepared as shown in the fig. 16. 
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DGX
NotI
Stop
XbaI
EcoRI
BamHI
pVL1393 vector
NotI
EcoRI
BamHI
Stop
XbaI
DGXd12ct
pVL1393 vector
NotIBamHI
Stop
XbaI
DGXd12ct
EcoRI
pCDNA3.1 vector
Stop
XbaI
EcoRI
GPI
pVL1393 vector
NotIBamHI
DGXd12ct
EcoRI
Stop
XbaI
GPI
 
 
Fig. 16. Cloning strategy for preparation of DGXd12ct and DGXd12ct-GPI 
constructs in the pVL1393 vector for recombinant virus production 
 
 
 
 
PCR amplification of DGXb12ct 
Digestion with BamHI/NotI 
and ligation 
Digestion with 
EcoRI/XbaI 
and ligation 
Digestion with 
EcoRI/XbaI 
and ligation 
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II.7. 2 Preparation and enrichment of plasma membranes from Sf9 cells 
 
The Sf9 cells were harvested by centrifugation. The cell pellet was washed twice with 
PBS and resuspended in equal volume of ice cold homogenization buffer containing 
protease inhibitors. The resuspended cells were homogenized in a pre-cooled Dounce 
glass homogenizer (20 strokes) on ice. The homogenate was centrifuged at 300xg for 
10 min at 4°C, to remove the nuclei or any unbroken cells.  
 
The plasma membranes were pelleted by ultracentrifugation of the postnuclear 
supernatant at 40,000xg for 30min at 4°C. The membranes were washed with 
homogenization buffer. The crude membranes were further purified and enriched by 
density gradient ultracentrifugation using an OptiprepTM step gradient. 
 
II.7.3 Purification and enrichment of plasma membranes by density gradient 
ultracentrifugation  
 
The crude membranes were resuspended in minimum volume of TNE buffer. The 
buffers for setting up the gradient were prepared as follows: 
 
The stepwise gradient was laid carefully in the following order (as shown in the fig. 
17) into 11x60 mm Ultra-clearTM ultracentrifugation tubes 
40% layer Mixed 350µL membranes with 700µL of OptiprepTM solution (60%) 
30% layer 1.9mL of 30% Optibuffer 
5% layer 0.4mL of 5% Optibuffer 
 
 
fig. 17. Density gradients in 
ultracentrifugation tube for 
enrichment of plasma 
membranes. 
 
30% Optibuffer 5mL OptiprepTM (60%) + 5mL TNE buffer 
5% Optibuffer 160µL OptiprepTM (60%) + 1.76mL TNE buffer 
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Plasma membrane enriched fraction formed a dense band at the 30-5% interface after 
3 hr of centrifugation at 105,000xg at 4°C in a Beckmann SW60 rotor. The enriched 
fractions were washed twice with ice cold homogenization buffer. 
 
50µL aliquots of plasma membranes were distributed in microfuge tubes, flash frozen 
under liquid nitrogen and stored at -80°C. The membranes were detected for protein 
of interest by western blotting; quantified for total membrane protein content by BCA 
assay. The frozen aliquots of membranes were used for other experimental work such 
as ligand binding trials and isolation of detergent resistant membranes (DRMs) by 1% 
Triton X-100 detergent. 
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II.7.4 Total membrane protein content determination by Bicinchoninic acid 
Assay (BCA) 
The total membrane protein content was determined using the BCA kit for protein 
determination. The BCA working reagent was prepared by mixing 50 parts of Reagent 
A (Bicinchoninic Acid Solution) with 1 part of Reagent B (4% (w/v) CuSO4 · 5H2O 
Solution). A standard curve with BSA (1 mg/mL) was prepared to determine the 
protein concentration in the unknown samples.  
 
 The standard assay was setup as shown in the following table 
 
Tube 
no 
Water  
(µL) 
BSA (1mg/mL) 
(µL) 
BCA working 
reagent (mL) 
1 100 0 2 
2 80 20 2 
3 60 40 2 
4 40 60 2 
5 20 80 2 
6 0 100 2 
7 100 µl (q.s.) Unknown 1 2 
8 100 µl (q.s.) Unknown 2 2 
Standard curve with BSA for BCA assay
0
0,1
0,2
0,3
0,4
0,5
0,6
0,7
0,8
0,9
BSA (in µg)
O
D 
56
2
OD 562 0 0,192 0,359 0,527 0,685 0,848
0 20 40 60 80 100
 
Fig 18 
 
Blank was prepared by mixing 2mL BCA working reagent with 100µL buffer or 
water. The contents were vortexed for thorough mixing and incubated at 37 °C for 30 
min. The absorbance of the solution was measured at 562 nm. The protein 
concentration was determined by comparison of the absorbance of the unknown 
samples to the standard curve prepared using the BSA protein standards. 
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II.7.5 Radiolabeled ligand Binding Assay – Homologous competition experiment 
Saturation binding experiment is a method applied to determine the receptor number 
and its affinity. In one of the methods, the radioligand concentration is constant, and 
competes for binding with the same unlabeled ligand. Since the radiolabeled and 
unlabeled ligands are chemically identical, the method is called a homologous 
competition experiment.  
In a homologous competition experiment, the graph is plotted for the % specific 
binding obtained versus the logarithm of concentration of the unlabeled ligand. The 
curve obtained is a sigmoid curve wherein the top of the curve is a plateau at a value 
equal to radioligand binding in the absence of the competing unlabeled drug. The 
concentration of unlabeled drug that produces radioligand binding half way between 
the upper and lower plateaus is called the IC50 (inhibitory concentration 50%) or 
EC50 (effective concentration 50%). 
The dissociation constant for the unlabeled ligand for the receptor is often referred to 
as the Ki rather than Kd because it is obtained from inhibition experiments rather than 
saturation experiments. The Ki value for the unlabeled ligand can be obtained from 
the IC50 value using the Cheng-Prusoff equation, whereL is the concentration of 
radioactive ligand used and Kd is the affinity of the radioactive ligand for the receptor. 
 
 
The bottom of the curve is a plateau equal to nonspecific binding. In addition to 
binding to receptors of interest, radioligands also bind to other sites. Binding of the 
receptor of interest is called specific binding, while binding to other sites is regarded 
as nonspecific binding.  
Nonspecific binding represents: 
• Interaction of the ligand with the biological membranes. The nonspecific 
binding depends on the charge and hydrophobicity of the ligand.  
• Binding to receptors, transporters or other proteins not of interest for the study. 
• Binding to the filters used to separate bound from free ligand. 
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Non-specific binding is detected by measuring radiolabeled ligand binding in the 
presence of a saturating concentration of an unlabeled ligand bound to the receptor. 
Under those conditions, virtually all the receptors are occupied by the unlabeled drug 
so the radioligand can only bind to the nonspecific sites. This forms the plateau at the 
bottom of the curve; subtract the nonspecific binding from the total binding at that 
concentration to calculate the specific radioligand binding to receptors. 
 
Binding studies were performed with L-[3H] Glutamate on all truncation constructs in 
triplicate setups and each setup too made in triplicates. The experimental setup for L-
[3H]-Glutamate binding studies was carried out as shown in the table 2. About 20 µg 
of Sf9 membranes were incubated with 3.4 µM of L-[3H]-Glutamate in a volume of 50 
µL of binding buffer to which increasing concentrations of unlabeled L-Glutamate 
(10-3 to 10-8 M) were added as shown in the table below. The contents were briefly 
mixed by vortexing and incubated at 25 °C for 60 min on a shaker.  
 
Table 2 : Experimental setup for radioligand binding assay  
Sno Binding 
buffer (µL) 
Unlabeled  
L-Glutamate 
[³H] 
L-Glutamate 
Membranes 
2mg/mL 
Tubes Label 
1 32.6 µL 0 3.4 µM 10 µL 1    13   25 
2 
3 
30.6 µL 
31.6 µL 
1x10-8 M 
5x10-8 M 
3.4 µM 
3.4 µM 
10 µL 
10 µL 
2    14   26 
3    15   27 
4 
5 
30.6 µL 
31.6 µL 
1x10-7 M 
5x10-7 M 
3.4 µM 
3.4 µM 
10 µL 
10 µL 
4    16   28 
5    17   29 
6 
7 
30.6 µL 
31.6 µL 
1x10-6 M 
5x10-6 M 
3.4 µM 
3.4 µM 
10 µL 
10 µL 
6    18   30 
7    19   31 
8 
9 
30.6 µL 
31.6 µL 
1x10-5 M 
5x10-5 M 
3.4 µM 
3.4 µM 
10 µL 
10 µL 
8    20   32 
9    21   33 
10 
11 
30.6 µL 
31.6 µL 
1x10-4 M 
5x10-4 M 
3.4 µM 
3.4 µM 
10 µL 
10 µL 
10  22   34 
11  23   35 
12 30.6 µL 1x10-3 M 3.4 µM 10 µL 12  24   36 
  
Salt and No salt buffers were prepared for harvesting the filters and were maintained 
ice cold. The assay was terminated by dilution with 1mL of ice cold No salt buffer. 
The bound ligand was separated from the free ligand by rapid filtration over  
nitrocellulose membrane filter (NC45, poresize 45 µm, 25 mm diameter) presoaked 
with Buffer for filter saturation using a vacuum filtration setup. The filters were 
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washed once with 2mL of ice cold No salt buffer and 2mL of ice cold Salt buffer.  The 
filters were placed in scintillation vials and dried at room temperature. The filters 
were dissolved in 600 µL ethylene glycol monomethyl ether solvent with thorough 
vortexing and after 10 min about 10mL of Scintillation cocktail was added. The 
radioactivity in the filters was measured for 1 min on a liquid scintillation counter. 
Data analysis of the binding experiments was performed using the GraphPad program. 
  
All DPM values were converted into % specific binding using the following formula: 
% Specific binding =
(DPM – Nonspecific binding)
(Total binding – Nonspecific binding)
x 100
 
 
The IC50 values and Standard Error of Mean (SEM) were determined, analyzed and 
plotted. 
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II.7.6 Isolation of light density detergent resistant membranes (ld-DRMs) – by 
1% Triton X-100 detergent treatment   
 
About 800 µg of enriched plasma membranes prepared from Sf9 cells expressing the 
protein of interest were extracted with 250 µL ice-cold TXNE buffer on ice for 15 
min. The extraction was carried out under ice cold conditions (pipettes, tips, Pasteur 
pipettes, etc used for the experiments were maintained cold).  
 
The gradient buffers were prepared using OptiprepTM as follows: 
 
The extraction mixture was taken in 11x 60mm ultracentrifugation tubes and the 
gradient was prepared as follows 
40% layer Extraction mixture with 500µL of OptiprepTM solution (60%) 
30% layer 1.2mL of 30% Optibuffer solution  
5% layer 0.4mL of 5% Optibuffer solution  
 
The gradients were centrifuged for 2 hr at 4°C at 259,182xg on a Beckmann TLS55 
rotor. 350 µL fractions were collected from the top and analyzed on a western blot.  
 
30% Optibuffer 7mL OptiprepTM (60%) + 7mL TXNE buffer 
5% Optibuffer 160µL OptiprepTM (60%) + 1.76mL TXNE buffer 
 
Fig. 19. the Gradient setup in an 
ultracentrifugation tube and sample 
fractions. 
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II.7.7 Preparation of liposomes for floatation assay ` 
 
Ratios (mol %) Lipid Mol wt 
(Da) Raft liposomes Non-raft liposomes 
DOPC 
DPPC 
Cholesterol 
786.15 
734 
386.6 
30 
30 
40 
60 
- 
40 
 
DOPC 
 
Dioleoyl phosphatidyl choline 
DPPC Dipalmitoyl phosphatidyl choline 
 
Liposomes of raft and non-raft composition were prepared by dehydration-rehydration 
process in glass tubes previously rinsed with chloroform. Briefly, the lipids dissolved 
in chloroform were transferred to the glass tube. The solvent was removed under mild 
nitrogen stream to a thin film before being finally resuspended in the Assay buffer 
(250 µL). The mixture was vortexed for 30 sec and was subjected to 10 cycles of 
freezing (liquid nitrogen, -196.4°C) and thawing (50°C in a water bath). 
 
The liposome suspension was sized by extrusion through two stacked polycarbonate 
membranes (pore size 100 nm) by 21 passes using an extruder. The liposomes were 
verified for homogeneity using dynamic light scattering and were used for protein 
interaction study by floatation assay with DGX or Circular dichroism. 
 
II.7.8 Liposome size determination by dynamic light scattering 
The mean diameter and particle size distribution of the liposomes were determined 
using a Dynamic Light Scattering (DLS). The measurements were made at 10 mW 
maximum, output He Ne; 633 nm. This technique measures the particle diffusion due 
to Brownian motion and relates this to the size of the particle. The parameter 
calculated is defined as the translational diffusion coefficient (D).  
 
The particle size is then calculated from D using the Stoke-Einstein equation;  
d(H)=(kT)/(3piηD) 
Where 
d(H) is the hydrodynamic diameter k is the Boltzman’s constant 
D is the translational diffusion coeffiecient T is the absolute temperature 
η is the viscosity 
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The DLS equipment produces a correlation of the particle position decay based on its 
movement. Since a large particle diffuses slower than a smaller one, the decays are 
different and a mathematical model correlates its decay to the size of the particle. 
 
Measurements were performed at a constant temperature (25°C) because the viscosity 
of a liquid is related to its temperature. Samples were diluted in the Assay buffer and 6 
measurements of 10 seconds each were performed. The mode chosen was continuous 
and the detection angle at 90°. The detection modes available were based on intensity, 
volume and number of the liposomes. 6 recordings were made for each of the 
liposome samples. 
 
II.7.9 Liposome floatation assay  
10 µg of purified protein was incubated with Raft and Non-raft liposomes (500 µg) 
for 10 min at 37°C in an ultracentrifugation tube. Floatation assay was carried out by 
subjecting the proteoliposome mixture in a gradient ultracentrifugation. The gradient 
buffers were prepared using OptiprepTM as follows: 
 
The step gradients were prepared in the following order in an ultracentrifugation tube 
as shown in the table 
 
The gradients were ultracentrifuged on a TLS55 rotor at 166,000xg for 3 hrs. The 
samples were collected carefully in four fractions (600, 400, 400 and 600 µL) from 
the top.  
 
II.7.9.1 Protein precipitation by 10% Trichloro acetic acid (TCA) 
For Western blot analysis the fractions needed to be concentrated. The fractions 
collected were diluted to 900 µL with water and 100 µg of Bovine serum albumin 
(BSA) was added to aid mass precipitation. 110 µL Trichloro acetic acid (TCA, 90%) 
was added to the samples and left on ice for 5 min to precipitate. The contents were 
50% Optibuffer 2mL of OptiprepTM solution (60%) + 480 µL Assay buffer (1X) 
30% Optibuffer 2mL of OptiprepTM solution (60%) + 1mL Assay buffer (5X) + 
1.5mL MilliQ water  
50% layer Proteoliposome with 360µL of Optibuffer solution (50%)  
30% layer 1160µL of 30% Optibuffer solution  
0% layer 450µL of Assay Buffer 1x  
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centrifuged at 13,000 rpm for 10 min. The pellet was washed twice with 500 µL of 
70% ethanol in PBS to remove any residual TCA and vacuum dried. Samples for 
western blot was prepared by the addition of 1X denaturing SDS loading buffer. 
 
II.7.10 Conformational changes of peptides with liposomes – Circular Dichroism 
spectra analysis  
 
The interactions of Pep602-624 and Pep611-624 with liposomes prepared of “raft” 
composition were determined by circular dichroism. The peptide samples were 
solubilised in MilliQ water to a concentration of 2 mg/mL. The samples contained 50 
µM peptides with or without “raft” liposomes (10mM) in 50mM phosphate buffer pH 
7.4. Samples comprising buffer or raft “liposomes” without peptide were used for 
background correction. CD spectra were obtained at room temperature (25°C) in a 
1mm circular quartz cell and a spectropolarimeter. Each spectrum was recorded from 
190 to 250 nm with step resolution of 1 nm. For each determination, data were 
smoothed, back-ground subtracted and converted into mean residue molar ellipticity 
[] (deg.cm2/dmol). 
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III. Results 
III.1 Expression and purification of extracellular domain (ECD) of 
the Rat metabotropic GABAB1b receptor (GBR1bNT) in the 
Recombinant Baculovirus system (RBV) and E.coli 
 
Metabotropic GABAB receptors (GABABR) are heterodimeric receptor and composed 
of GABAB1b and GABAB2 subunits involved in the inhibitory effects at the neural 
synapses. It was shown that the N-terminal extracellular domain (ECD) of the 
GABAB1 subunit alone is sufficient of bind GABA with the same affinity like the 
heterodimeric receptor complex, whereas the N-terminal ECD of the GABAB2 
subunit cannot bind GABA.  
  
The ligand binding ECD of both metabotropic glutamate receptors (mGluR), 
GABAB1b share common structure features, being in the same class of GPCRs and 
are homologous to the leucine, isoleucine and valine binding protein (LIVbp). Among 
the three, the ECD of mGluR and LIVbp are expressible as soluble proteins and the 
X-ray crystal structure of both resembled the venus fly trap structure (Kunishima et 
al., 2000).  But incase of the ECD of GABAB1b, there were not many successes in the 
overexpression and purification of this domain.  
 
The current study was focussed upon developing strategies and tools to over-express 
and purify the rat ECD of GABAB1b (GBR1bNT) in the recombinant baculovirus 
(RBV) system and E.coli expression systems. Both experimental and computational 
approaches were applied to design strategies for over-expression and purification of 
GBR1bNT in these expression systems.   
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III.1.1 Expression and purification of GBR1bNT in the RBV system 
III.1.1.1 Expression and purification of pVL1392-Mel-GBR1bNT expressed in 
SF+ cells using a Ni-sepharose column 
 
The expression of the ECD of GBR1bNT was first attempted under the control of 
Mellitin secretion signal peptide. In this construct, the native signal peptide of 
GABAB1bR was replaced with that of Mellitin secretion signal peptide for expression 
and secretion of GBR1bNT to the medium since the melltin signal peptide is native to 
the insect cells.  
 
From the kinetics study, the protein expression to the medium was determined to be 
optimal at a MOI of 3 for 72-96 hrs. A large scale expression (in 1L) of the culture 
was setup to purify the GBR1bNT expressed and secreted to the medium. The 
expression and purification protocol was followed as described in the material and 
methods. About 1L of 2x106 SF+ cells/mL in suspension culture was infected with 
pVL1392-Mel-GBR1bNT virus for 72-96 hrs at a MOI of 3. Culture supernatant was 
clarified by centrifugation; the supernatant was loaded on a CHT column followed by 
a Nickel-sepharose column.  
 
A purification setup was carried out on the Ni-bound GBR1bNT to establish the 
purification strategy. The column was washed with different concentration of 
Imidazole (20mM, 50mM, 75mM and 250mM) in 20mL fractions. About 1.7mL of 
the elution fractions were precipitated by 10% TCA and washed with 70% ethanol in 
PBS. The samples were prepared by treating the pellet with 100µL of 2X denaturing 
SDS loading buffer.  
 
From the silver stained gel of the samples prepared from different Imidazole 
concentration (20mM, 50mM, 75mM and 250mM) a faint band for GBR1bNT was 
observed around 50kDa as indicated by the red arrow (as shown in the fig. 20).  
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Fig.20. Silver stained SDS-PAGE of 
GBR1bNT purified on a Ni-column 
Fractions obtained from wash steps of the Ni-
column with 20mM, 50mM, 75mM and 
250mM Imidazole were collected. About 10 µL 
of the sample was electrophoresed on a 10% 
SDS-PAGE and silver stained (using the silver 
staining kit). A faint brown single band was 
observed at the expected molecular size 
(50kDa) of GBR1bNT (as indicated by red 
arrow). 
 
From the first attempt of GBR1bNT expression under the control of mellitin signal 
only low amounts of GBR1bNT could be purified. The possible reasons are that either 
the mellitin signal peptide suitable for the secretion of GBR1bNT or that the 
GBR1bNT was poorly expressed and retained within the cell.  
 
Inspite, GBR1bNT construct lacking the RXXR-endoplasmic reticulum retention 
motif at the C-terminus of the GABAB1b subunit and the native signal peptide replace 
by a mellitin signal peptide still failed to express good amounts of the proteins.  
 
GBR1bNT is homologous to the ECD of mGluR that belongs to the same receptor 
class for which the X-ray crystal structure is solved. The next attempts are to study the 
GBR1bNT at a sequence level and derive a relationship between the ECD of mGluR 
and GBR1bNT 
 
III.1.1.2 Sequence analysis and molecular modelling studies on GBR1bNT – a 
computational approach 
Inorder to compare the primary sequence of ECD of mGluR and GBR1bNT, PERL 
scripts were written to fasten the purpose. The primary protein sequence of the ECD 
of mGluR for which the crystal structure was solved (from residue 36 to 505) was 
aligned with GBR1bNT (from residue 30 to 445).  
The amino acid composition of aligned ECD of mGluR and GBR1bNT was clustered 
depending upon the physicochemical parameters. The clusters were carefully 
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examined and compared with each other, the residues that were present more in 
number are shaded in grey (as shown in the Fig. 21).  
  
Fig. 21. A cluster depiction of amino acids composition of the ECD of mGluR 
(left panel) and GBR1bNT (right panel) based on physiochemical properties of 
the amino acids. The residues that are found to be more in number are shaded in 
grey boxes. 
 
Incase of composition analysis of mGluR ECD, residues alanine, serine, asparagine, 
aspartate, valine and glutamine were found more in number (7, 6, 7, 8, 4 and 
respectively) in comparison to the GBR1bNT. This indicates that mGluR contained 
more of small and polar residues in comparison to the ECD of GBR1bNT.  
 
Incase of composition of GBR1bNT, residues proline, threonine, glutamate, 
methionine, phenyl alanine, tyrosine, tryptophan and arginine were found more in 
number (5, 4, 6, 6, 3, 3, 4 and 6 respectively) in comparison to the ECD of mGluR.  
 
Inspite of comparing 469 residues of ECD of mGluR aligned with 415 residues of 
ECD of GBR1bNT, still GBR1bNT contained more of bulky and branched 
hydrophobic residues rendering GBR1bNT hydrophobic.   
  
This interesting difference between the physicochemical compositions of amino acids 
further raised the interest to study the receptor at structure level. Homology modelling 
was performed on the aligned sequences of the ECD of mGluR and GBR1bNT. PERL 
scripts were self writtern and compiled on the LINUX workstation to carry out the 
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modelling process. The GBR1bNT model was obtained by transferring the atomic 
coordinates of ECD of mGluR (PDB code: 1EWK) to the corresponding aligned 
residue of GBR1bNT using the PERL script. Energy minimizations were carried out 
using generate.inp, model_minimize.inp and model_anneal.inp modules of the CNS 
package (Rice and Brunger, 1994) and the script was modified to obtain 15 best 
energy minimised structure. The root mean square deviation (RMSD) between the 
mGluR structures template (1EWK) and the 15 GBR1bNT models were found to be 
1.85±0.05. the structure were further verified using ProCheck (Laskowski et al., 
1993). 
 
The representative structure of the GBR1bNT model was superposed on the mGluR 
structure template (see middle panel of Fig. 22). Upon careful examination of the 
superposed structures it was observed that there was a significant difference in the 
secondary structure at the N-terminus of GBR1bNT. The first 45 residues of mGluR 
structure template contained a well ordered secondary structure of Sheet-Helix-Helix 
(see right panel of Fig. 22) inspite having 4 proline residues. Incase of 
correspondingly aligned GBR1bNT (see top panel of Fig. 22), the 45 residue stretch 
contained a very disordered structure with random coils and formed a helix structure 
after 30 residues (see left panel of Fig. 22). This unstructured region was found 
immediately after the signal peptide cleavage site and contained 7 proline residues at 
position 33, 36, 38, 40, 43, 44 and 46 postions.  
 
From the computational modelling studies it was inferred that GBR1bNT apart from 
being hydrophobic contained proline-rich disordered region just after the signal 
peptide cleavage site that might hinder the expression and secretion of GBR1bNT. 
Therefore, new constructs were considered that can surpass these observed hindrances 
and express the protein in good amounts. 
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III.1.1.3 Recombinant virus production for constructs pVL1393-DGRsp-
GBR1bNT, pVL1393-cGH and pVL1393-cGH-GBR1bNT in the RBV system 
In the previous attempt, only low yields of GBR1bNT was obtained (see fig. 20), 
inspite of expression driven under the control of native mellitin signal peptide. 
Therefore, the pVL1393-DGRsp-GBR1bNT construct was prepared. In the pVL1393-
DGRsp-GBR1bNT construct, the native signal peptide of GABAB1bR was replaced 
with the Drosophila metabotropic glutamate receptor A (DmGluRA) signal peptide, 
in place of the mellitin signal peptide as studied before. The rationale behind 
considering the DmGluRA signal peptide is that, the signal peptide is native to the 
insect cells; moreover in the studies by Eroglu it was reported that the ligand binding 
domain (DG14c construct in pVL1393, Cagla Eroglu, PhD thesis, 2002) of 
DmGluRA was well-expressed in the insect cells yielding quantities for crystallization 
trials. 
 
From the inferences made from the computational modelling studies, the pVL1393-
cGH-GBR1bNT construct was prepared. In the pVL1393-cGH-GBR1bNT construct, 
the expression and secretion of GBR1bNT was attempted by tagging chicken growth 
hormone (cGH) at the N-terminus of GBR1bNT. The rationale behind preparing the 
construct is proline-rich region observed unstructured at the N-terminus when 
modelled on mGluR template and energy minimised (see Fig. 22). Further at the N-
terminus apart from being proline-rich it contained several bulky and hydrophobic 
residues that might interfere with the expression of GBR1bNT when expressed alone. 
It was reported that the human growth hormone (hGH) was used as a fusion partner 
for over expression, purification and 3D-structure determination of cysteine rich 
domain (CRD) of secreted Frizzled related protein 3 (sFRP-3) in chinese hamster 
ovary cells (CHO cells) (Dann et al., 2001). In another work it was reported that cGH 
was well expressed in the RBV system (Foster et al., 1997). So the cGH that was 
well-expressed in the RBV system was considered as the fusion partner for the 
expression and secretion of GBR1bNT. The pVL1393-cGH construct was prepared as 
a control to compare the expression levels of cGH, when expressed alone or when 
tagged with GBR1bNT.  
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Recombinant viruses for pVL1393-DGRsp-GBR1bNT, pVL1393-cGH and pVL-
cGH-GBR1bNT were produced following the procedure as described in the materials 
and methods. The recombinant clones were tested for protein expression by western 
blot analysis (see fig. 23).  
 
A. Clones for DGRsp-GBR1bNT expression B. Clones for cGH-GBR1bNT expression 
Fig. 23. Recombinant clones for virus production of pVL1393-DGRsp-
GBR1bNT and pVL-cGH-GBR1bNT constructs in Sf9 cells. Western blot 
analysis on total cell samples of Sf9 cells infected with recombinant viral clones of 
pVL1393-DGRsp-GBR1bNT and pVL1393-cGH-GBR1bNT constructs.  The 
electroblotted PVDF membrane were incubated with anti-pentaHis (1:1000) as 
primary antibody. Thick bands of expression were observed at around 55 kDa for 
DGRsp-GBR1bNT (left) and 75 kDa for cGH-GBR1bNT (right) protein 
expression.  
 
From the Western blot, Fig. 23A, a thick band was observed at around 60 kDa that 
corresponded to the molecular weight of the expressed DGRsp-GBR1bNT in all the 
clones. Clone D1 expressed cGH-GBR1bNT was selected for further production of 
baculovirus stocks. Similarly, in Fig. 23B, a thick band was observed at around 
80kDa that corresponded to the expressed cGH-GBR1bNT in the all the clones. Clone 
E8 was selected for futher production of baculovirus stocks. 
 
The titre values were determined for the viral stocks of the constructs by End point 
dilution and they are as follows: 
Construct  
Name 
Titer value 
(Pfu/ml) 
Theoretical 
mol wt 
DGRsp-GBR1bNT 1.5 x 108 ~55 kDa 
cGH-GBR1bNT 1.33 x 108 ~75 kDa 
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III.1.1.4 Optimization of expression and purification of pVL1393-DGRsp-
GBR1bNT expressed in SF+ cells using Ni-sepharose column 
 
The DGRsp-GBR1bNT (GBR1bNT with the DmGluRA signal peptide) expression 
was carried out in 1L of 2x106 SF+ cells/mL suspension culture infected with 
pVL1393-DGRsp-GBR1bNT virus at MOI of 3 for 72-96 hrs. The purification 
protocol was carried out as described in the Materials and methods, section II.2.5.7.1 
for CHT column purification. 
 
The Ni-bound DGRsp-GBR1bNT was eluted from the column by a gradual increase 
in the Imidazole concentration (10, 20, 30, 50, 75, 100, 150, 200, 250 and 500mM) 
and collected in 2mL fractions. A chromatogram was obtained plotting the protein 
concentration under UV 280nm (Blue line) against the % Imidazole concentration of 
Buffer B (purple line) (as shown in the fig. 24, left).  A single peak was obtained in 
the elution profile at 10% Imidazole concentration of Buffer B (50mM Imidazole). 
Western blot analysis on the fractions collected at the peak (fractions labelled 1-10) 
were incubated with anti-pentaHis antibody (1:1000). Bands were observed at 
molecular weights around 60 kDa (corresponding to the molecular weight of purified 
DGRsp-GBR1bNT (as indicated by an arrow in the fig. 24, right) and a contaminant 
bound to the Ni-sepharose column around 100 kDa (as indicated by a dashed line in 
fig. 24, right).  The fractions from 6-10 containing Dsp-GBR1bNT protein were 
pooled, concentrated on an Amicon filter (30 kDa) and dialyzed in 2L of dialysis 
buffer overnight in the cold room.  
 
The total protein content of purified DGRsp-GBR1bNT was determined by the 
absorbance of the sample at 280 nm.  Extinction coefficients were theoretically 
calculated (73210 M-1 cm-1) and it was found that about 1.3 mg of purified DGRsp-
GBR1bNT was obtained from 1L of expression volume. 50 µL aliquots were 
prepared, flash frozen in liquid nitrogen and stored at -80 °C.  
 
From this experimental setup it was observed that good amount of purified DGRsp-
GBR1bNT were obtained that can be used for ligand binding trials with [3H]-GABA 
and [3H]-CGP54626A. 
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Fig. 24. Purification of DGRsp-GBR1bNT expressed in SF+ cells using Ni-
sepharose column. Left, Elution profile of DGRsp-GBR1bNT monitored at UV 280 
(blue line) and % Imidazole concentration (purple line) are shown. Right, Western 
blot on the elution fractions from the Ni column. 10 µl of each fraction was 
electroblotted in PVDF membrane and incubated with anti-mouse antibody. DGRsp-
GBR1bNT was observed at around 60kDa as pointed by the arrow in fractions 
6,7,8,9 and 10. there was another band of higher molecular weight observed at 100 
kDa indicated by dashed arrow. 
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III.2 Over-expression and purification of GBR1bNT in the E.coli 
system 
III.2.1 Molecular constructs 
The expression vectors considered in the study were of pBR322 vector origin and 
tagged at the N-terminus with fusion proteins (see table, below) for better soluble 
over-expression in the cytoplasm. The vector contained 6-His tag at the C-terminus 
for the ease of purification using a Ni-sepharose column or to detect it on western 
blots using an anti-pentaHis antibody. The host strains used for the study were 
selected based on the features possessed by the strain in handling over-expression of 
GBR1bNT in more soluble form. 
Tags and fusion partners  
Vector N-term C-term 
pETM 11 - 6-His 
pETM 30 GST 6-His 
pETM 50 DsbA 6-His 
pETM 52 DsbA (leaderless) 6-His 
pETM 60 NusA 6-His 
pET15b-GST GST 6-His 
 
The constructs considered for the study and the molecular weight of the expressed 
GBR1bNT with its fusion partner is summarized in the table, below : 
Table no. 3 : GBR1bNT cloned into different vectors and their 
molecular weights 
 
Vector 
Name of the 
expressed protein 
Theoretical  
Mol wt*  
pETM 11+GBR1bNT GBR1bNT ~ 50 kDa 
pETM 30+GBR1bNT GST-GBR1bNT ~ 76 kDa 
pETM 50+GBR1bNT DsbA-GBR1bNT ~ 72 kDa 
pETM 52+GBR1bNT DsbA2-GBR1bNT ~ 72 kDa 
pETM 60+GBR1bNT NusA-GBR1bNT ~ 105 Da 
pET 15b-GST+GBR1bNT GST-GBR1bNT ~ 76 kDa 
* Molecular weight of fusion partner and GBR1Bnt 
 
The GBR1bNT over-expression in E.coli and optimization of purification was carried 
out in following stages: 
1. Selection of the expression vector. 
2. Selection of the expression host. 
3. Efficiency of the purification column. 
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4. Improvement of the soluble expression and efficient purification. 
 
III.2.2 Expression of GBR1bNT cloned in different vectors and transformed into 
BL21(DE3) strain – to select appropriate expression vector 
 
The intial screen was carried out for the selection of a suitable vector capable of 
overexpressing GBR1bNT in E.coli. The PCR amplified GBR1bNT was ligated into 
the pETM series (pETM11, pETM30, pETM50, pETM52 and pETM60 plasmids) as 
mentioned in the table no. 3 and transformed into BL21(DE3) strain. The Expression 
was carried out as described in the materials in the methods using 1mM IPTG. About 
10 µL of samples from total cells of BL21(DE3) were analyzed on a SDS-PAGE 
(10%) after staining with Coomassie blue. The stained gel was photographed on a 
BioRad gel documentation system.  
 
No expression was observed in the total cells under uninduced conditions containing 
the plasmid. In case of 1mM IPTG induced conditions, bands of over-expression were 
observed corresponding to the expected molecular weights (see fig. 25).  Under IPTG 
induced conditions of pETM11+GBR1bNT construct, a thick band was observed at 
around 50 kDa (for GBR1bNT); for pETM30+GBR1bNT at around 76 kDa (for GST-
GBR1bNT); for pETM50+GBR1bNT, no bands were observed for DsbA-GBR1bNT 
as the IPTG induction resulted to be toxic as there was no growth observed in the 
cells; for pETM52+GBR1bNT, band was observed at around 72 kDa (for DsbA2-
GBR1bNT), a triplet samples were loaded as a counter check over the loading 
volumes and incase of pETM60+GBR1bNT, the band was observed at around 105 
kDa (for NusA-GBR1bNT). 
 
From the test expression, it was observed that there was a good expression of 
GBR1bNT in the total cells. The next step is to verify whether the expression 
observed in total cells are present in soluble form in the cytoplasm of E.coli or not and 
whether it was purified using the Ni-sepharose column. 
 
 Chapter 3                                                                                                           Results 
 
 80 
 
 
 
Fig 25. Expression of GBR1bNT cloned in pETM series in BL21(DE3) strain of 
E.coli and induced with 1mM IPTG. UI – Uninduced; I – Induced 
10µL of total cells loaded in 10% SDS-PAGE stained with Coomassie blue and 
photographed on BioRad gel documentation system. Bands of over-expression under 
1mM IPTG induced (I) condition was observed for GBR1bNT cloned into pETM11, 
pETM30, pETM52 and pETM60 vectors. No bands of over-expression were 
observed in the any of the plasmids under IPTG uninduced (UI) conditions and in 
induced conditions for GBR1bNT cloned in pETM50 vector. 
 
III.2.3 Optimization of purification of GBR1bNT cloned in pETM60 (containing 
NusA fusion partner) vector and expressed in BL21(DE3) strain– to verify 
soluble expression of GBR1bNT 
 An efficient over-expression of GBR1bNT was observed in total cells transformed 
with the plasmids pETM11, pETM30 and pETM60 containing the GBR1bNT 
construct. pETM60+GBR1bNT plasmid was chosen to optimise the purification of 
NusA-GBR1bNT.  
 
Expression was carried out in 1L and was induced with 0.1mM IPTG at 30 °C for 3 
hrs. Cell pellet was lysed in the lysis buffer by sonification and passing through 
Emulsiflex. Cell lysate was centrifuged and supernatant was loaded in a Ni-sepharose 
column. The column was washed with 30mM Imidazole and eluted with 125mM 
Imidazole collected in 1.5mL fractions. Samples were prepared and resolved on a 
SDS-PAGE.  
 
About 10µL of TCA precipitated sample was resolved on a 10% SDS-PAGE gel.  
Bands were observed corresponding to the expected size of the purified NusA-
GBR1bNT (approx 105 kDa) as indicated by a black arrow in the fig.26. There was 
other protein bands at lower molecular weight as indicated by a dashed arrow in the 
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fig. 26 which could be contaminants bound to the Ni-sepharose column during 
purification. 
 
Fig. 26. Purification of NusA-GBR1bNT (pETM60+GBR1bNT expressed in 
BL21(DE3)) on a Ni-sepharose column. 
L – Load; W – Wash.  
10µL of TCA precipitated elution fraction loaded in 10% SDS-PAGE wells, 
Coomassie blue stained and documented in a BioRad Gel documentation system.  
The eluted NusA-GBR1bNT (~105 kDa) as indicated by an arrow and its 
degradation products (as indicated by dashed arrow) were observed upon 
Coomassie blue staining. 
 
A considerable amount of NusA-GBR1bNT was found in the soluble form in the 
0.1mM IPTG induced pETM60+GBR1bNT plasmid transformed BL21(DE3) cells. 
The supernatant containing the soluble expression of NusA-GBR1bNT thus obtained 
was purified in a Ni-sepharose column but it yielded low quantities. 
 
III.2.4 Expression of GBR1bNT cloned in pETM11 and pETM60 vector 
(containing NusA as fusion partner) and transformed into different strains of E. 
coli – to select appropriate expression host to improve the over-expression 
 
In order to improve the soluble expression of GBR1bNT, pETM11+GBR1bNT and 
pETM60+GBR1bNT plasmids were transformed into BL21(DE3)pLysS, C43(DE3) 
and Rosetta(DE3)pLysS strains. There are several factors involved for not obtaining a 
good amount of soluble expression. To name a few the reasons could be 
 
1. The E.coli has a thick cell wall that so the induced cells would have remained 
unbroken inspite of treatment with lysis buffer, passage through emulsiflex and 
sonification. This problem can be overcome by overexpressing GBR1bNT in 
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BL21(DE3)pLysS strain. This strain carries an extra plasmid pACYC184 encoding T7 
lysozome gene that can disrupt the inner membrane enabling rapid lysis of cells. 
 
2. The GBR1bNT being hydrophobic (see fig. 21) would have adhered to the inner 
walls of the membrane and resistant to 500mM NaCl in the lysis buffer. This problem 
could be overcome by overexpressing GBR1bNT in C43(DE3) strain as C43(DE3) 
cells. 
 
3. Finally, GBR1bNT being an eukaryotic protein contains codons that are rarely used 
by E.coli, this leads to a poor transcription of the mRNA. This problem could be 
overcome by overexpressing GBR1bNT in Rosetta(DE3)pLysS strain that contains 
tRNA genes for AGG, AGA, AUA, CUA, CCC, GGA on a Col-E1 compatible 
chloramphenicol-resistant plasmid. 
  
A Expression was carried out on these strains upon IPTG induction. 10µL of total cell 
samples were loaded on a 10% SDS-PAGE, Coomassie stained and documented on a 
gel documentation system.  
 
Except in the case of plasmids pETM11+GBR1bNT and pETM60+GBR1bNT 
transformed into BL21(DE3)pLysS strain, bands of over-expression upon IPTG 
induction were observed in other cases. In pETM11+GBR1bNT transformed into 
C43(DE3) and Rosetta(DE3)pLysS, a band around 50 kDa (GBR1bNT) was observed 
and in pETM60-GBR1bNT constructs transformed in to Rosetta(DE3)pLysS and 
C43(DE3), the band was observed around 105 kDa (NusA-GBR1bNT) at 0.1mM 
IPTG induced conditions as shown in the fig 27. 
 
 Chapter 3                                                                                                           Results 
 
 83 
 
Fig. 27. Expression of GBR1bNT cloned into pETM11 and pETM60, 
transformed into BL21(DE3)pLysS, C43(DE3) and Rosetta(DE3)pLysS) 
strains of E.coli and induced with 0.1mM IPTG. 10µL of total cells loaded in 
10% SDS-PAGE stained with Coomassie blue and photographed on BioRad gel 
documentation system. Under 0.1mM IPTG induced (I) conditions, Bands of over-
expression was observed in total cells of C43(DE3) and Rosetta(DE3)pLysS strains 
transformed with pETM11+GBR1bNT and pETM60+GBR1bNT plasmids. No 
bands of over-expression were observed in the any of the plasmids under IPTG 
uninduced conditions and in either of the plasmids transformed into 
BL21(DE3)pLysS. 
UI – Uninduced; I – Induced 
 
III.2.5 Purification of GBR1bNT cloned in pETM60 (containing NusA as fusion 
partner) vector and expressed in C43(DE3) strain 
C43(DE3) strain of E.coli is used  exclusively for expressing recombinant proteins 
toxic for other strains of E.coli and has proven to be efficient in expressing membrane 
proteins or highly hydrophobic proteins. Hence, the pETM60+GBR1bNT plasmid 
transformed into C43(DE3) strain was selected for optimising the purification.  
 
About 1L culture was induced with 0.1mM IPTG at an OD600 of 0.8 – 1.0 and 
harvested after 16 hrs at 18 °C post-induction. The cells were lysed in the lysis buffer 
by sonification and passing through Emulsiflex. The cell lysate was centrifuged and 
the supernatant was loaded on a Ni-sepharose column. The column was washed with 
20mL of buffer containing different concentration of Imidazole (30mM, 50mM, 
70mM, 100mM, 150mM, 200mM and 250mM). Samples were prepared for every 
fraction and 10 µl of each sample was electrophoresed on a 10% SDS-PAGE and 
stained with Coomassie blue dye. 
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Fig. 28. Purification of GBR1bNT cloned into pETM60 vector and expressed 
in C43(DE3) strain.  
L = Load; FT = Flow through; 1-7 = Elution fractions with Imidazole concentration 
at 30, 50, 70, 100, 150, 200, 250mM respectively. The arrow indicates the band that 
corresponds to the NusA-GBR1bNT protein (105 kDa). 
 
From the fig. 28 it was observed that Ni-bound NusA-GBR1bNT contained non-
specific proteins and was difficult to purify as a single component at wash steps 
containing high concentration of Imidazole (see Lanes marked 4,5,6 and 7 in the fig. 
28). Moreover, only a faint band was observed for NusA-GBR1bNT (at around 105 
kDa indicated by an arrow in the fig. 28). After trials of purification optimization with 
NusA-GBR1bNT expressed in C43(DE3) and BL21(DE3), it was observed that Ni-
sepharose column was not effective for NusA-GBR1bNT purification.  
 
III.2.6 Expression of GBR1bNT cloned in pETM30 vector (containing GST as 
fusion partner) and expressed in different strains– to select appropriate 
expression host  
The Ni-sepharose column was not efficient in the purification of GBR1bNT 
containing 8-His tag. Hence the pETM30+GBR1bNT plasmid tagged with GST 
fusion protein N-terminally was selected and GST-GBR1bNT protein was purified 
using a GST column.  
 
The pETM30+GBR1bNT plasmid was checked for over-expression of GST-
GBR1bNT protein in the total cells upon induction with 0.1mM IPTG in BL21(DE3), 
C43(DE3) and Rosetta(DE3)pLysS strains. 10µL of the total cell samples were 
electrophoresed on a 10% SDS-PAGE gel.  
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In the Coomassie blue stained SDS-PAGE of the total cell samples, a 77 kDa band 
corresponding to GST-GBR1bNT protein (as indicated by arrow in the fig. 29) was 
found for the 0.1mM IPTG induced BL21(DE3) and Rosetta (DE3)pLysS strains, 
whereas no bands for GST-GBR1bNT bands were seen upon 0.1mM IPTG induction 
in C43(DE3) strain. This data suggests that BL21(DE3) is suitable for overexpression. 
 
Fig. 29. Expression of GBR1bNT 
cloned in pETM30 vector (containing 
GST as fusion protein) and 
transformed into different strains of 
E. coli.  
UI- Uninduced 
I-Induced 
A 76kDa band was observed under the 
induced condition of BL21(DE3) and 
Rosetta(DE3)pLysS. 
 
 
III.2.7 Purification of GST-GBR1bNT (pETM30-GBR1bNT vector) in 
BL21(DE3) strain of E.coli 
From the expression test carried out on pETM30+GBR1bNT plasmid transformed in 
BL21(DE3) and Rosetta(DE3) pLysS strains, the plasmid in BL21(DE3) was chosen 
for expression in 1L culture and purification. 
 
About 1L culture of BL21(DE3) containing pETM30+GBR1bNT plasmid was grown 
to a OD600 of 0.8-1.0 and induced with 0.05mM IPTG at 18 °C for 12-16 hrs. The 
culture was harvested post-induction by centrifugation. The cell pellet was lysed  
using a Microfluidiser®. The supernatant obtained by ultracentrifugation of the cell 
lysate was loaded into the GST-sepharose column, pre-equilibrated with lysis buffer. 
The column was washed thrice with GST wash buffer.  
 
The GST-GBR1bNT protein bound to the resin was resuspended in 2mL of TEV 
buffer. The cleavage reaction was carried out by incubating the GST-GBR1bNT 
protein bound resin with 20 µg of TEV protease for 12-16 hrs at 4 °C. Samples at 
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different stages of purification and TEV cleavage were resolved on a SDS-PAGE and 
stained with Coomassie Blue dye.  
 
From the Coomassie blue stained gel, it was observed that major proportion of GST-
GBR1bNT protein expression remained insoluble in the cell pellet. But, the soluble 
portion obtained in from the supernatant of the cell lysate was well-purified using a 
GST-sepharose column. On a Coomassie blue stained gel, a 77 kDa band was 
observed as indicated by an arrow in the fig.30, left. The GST-GBR1bNT protein 
contained a TEV protease cleavage site. So, the band observed in the SDS-PAGE was 
verified for GST-GBR1bNT by digestion with TEV protease. The samples were 
resolved on a SDS-PAGE. From the digestion pattern showed 3 bands (fig 30, right) 
with band 1 corresponding to TEV undigested GST-GBR1bNT (around 77 kDa); 
band 2 corresponding to cleaved GBR1bNT (around 50 kDa) and band 3 
corresponding to the TEV protease (around 29 kDa), cleaved GST and the 
contaminant observed during elution (see fig 30, right). Together, this data suggests 
that GST-GBR1bNT can be effieciently purified using GST column. 
 
 
Fig. 30. Expression and purification of GST-GBR1bNT (pETM30-GBR1bNT 
vector) in BL21(DE3) strain of E.coli 
P – Pellet;L – Load; FT – Flow through; W – Wash 
Left, A fat band corresponding to the overexpression of GBR1bNT was observed in 
the pellet(P) and load (L). A good amount of GST-GBR1bNT was observed at the 
expected 79 kDa (indicated by an arrow) and another band bound unspecfically to 
the columncat 30 kDa.  
Right, The TEV cleavage pattern show Band 1-  at 76 kDa indicates the uncleaved 
GST-GBR1bNT. Band 2 – at 50 kDa indicates the cleaved GBR1bNT. Band 3 – at 
30 kDa indicates the TEV protease, GST (cleaved) and the contaminant found in 
the elution, See fig. 30, left. 
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III.2.8 Expression and purification of GST-GBR1bNT (pET15b-GST-GBR1bNT 
vector) in Tuner strain of E.coli – to improve the soluble expression 
From the previous trial it was observed that the GST-sepharose column was effective 
for GST-GBR1bNT protein purification but the limiting factor was obtaining 
sufficient expression of GST-GBR1bNT protein in the soluble fraction. Though the 
induction was carried out at minimal parameters such as 0.05mM IPTG for 12-16 hrs 
at 18°C still most of the over-expression was observed in the pellet due to unregulated 
IPTG induction. A regulated low level expression might enhance the solubility of the 
expressed proteins. So, the expression of GST-GBR1bNT protein in Tuner strain that 
contains such a characteristic was studied.  
 
Tuner strains contain a lac permease (lacY) mutation that allows uniform entry of 
IPTG into the cells and produces a concentration-dependent, homogeneous level of 
induction. The expression levels can be regulated to a wide range by adjusting the 
concentration of IPTG. The Tuner cells contained kanamycin marker to enable its 
selection, so the GST-GBR1bNT construct was recloned into pET15b vector 
containing an ampicillin selection marker. 
 
The expression was carried out in a 1L culture and incubated at 37 °C to an OD600 of 
0.8-1.0. The culture was induced with 0.1mM IPTG for 12-16 hrs at 15 °C. The 
induced cell culture was lysed in the lysis buffer using a Microfluidiser®. The rest of 
the GST-sepharose purification protocols were carried out as described before.  
Samples were prepared for SDS-PAGE electrophoresis and stained with Coomassie 
Blue dye. A single band was observed at around 77 kDa corresponding to GST-
GBR1bNT protein (as indicated by arrow in the fig 31). The elution fractions were 
pooled, concentrated and dialysed. There was good improvement in the amounts of 
GST-GBR1bNT protein expressed as a soluble protein. The soluble GST-GBR1bNT 
protein was purified effectively using the GST-sepharose column. The amount of 
GST-GBR1bNT purified was estimated by BCA assay and was found to be about 
1mg/L of culture volume.  
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Fig. 31. Expression and purification of GST-GBR1bNT (pET15b-GST-
GBR1bNT vector) in Tuner strain of E.coli  
A band was observed at 77kDa (as indicated by arrow) that corresponds to the 
molecular weight of GST-GBR1bNT. The Load (L) still considerable amount of 
soluble GBR1bNT. The Elution fraction shows bands for well-purified GBR1bNT. 
 
From this experiment, it was concluded that a good amount of purified GBR1bNT can 
be obtained upon expressing the GBR1bNT in pET15b-GST vector and transforming 
the plasmids in Tuner cells. The expressed protein can be purified using a GST 
column. 
 
After several trials of optimizations, with the vector, host strain and column used for 
purification good expression of GBR1bNT was obtained. The complete optimisation 
process has been described in the following scheme. The vectors or host strains that 
are used are in blue boxes, the strain that failed to give expression in yellow boxes. 
And the final strategy that gave a good result is given below.  
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Scheme 2. A diagramatic representation of the expression and purification 
optimisation of GBR1bNT in E.coli  
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III.3 Results for the biochemical characterization of the 
cholesterol binding motif and determination of the minimal 
construct required for maintaining the high affinity state for 
binding glutamate in Drosophila metabotropic glutamate 
receptor (DmGluRA) 
 
Previously it was reported by (Eroglu et al., 2003) that the high-affinity glutamate 
binding to DmGluRA was regulated by its association with lipid rafts. The DmGluRA 
expressed in the membranes of Sf9 cells had much higher affinity when compared to 
the DmGluRA expressed in the photoreceptor cells (PRC) of the fly eye (Eroglu et al., 
2002). Mass spectrometric analysis on the lipid composition of DmGluRA virus 
infected Sf9 membranes and DmGluRA expressed PRC shows that there is a 
significant difference in the sterol content. The Sf9 membranes were enriched in 
cholesterol, forming lipid microdomains (or rafts), which are insoluble and extractable 
by treatment with Triton X-100 detergent, whereas the PRC contained ergosterol, 
which is unfavourable for raft formation. The high affinity state of the DmGluRA 
expressed in the PRC of fly eye was recovered by reconstituting the solubilised 
receptor in liposomes of raft composition. 
 
(Li and Papadopoulos, 1998) reported a low consensus putative cholesterol binding 
motif (L/V-[X]1-5-Y-[X]1-5-R/K) in the transmembrane region of the peripheral 
benzodiazepine receptor. By site-directed mutagenesis and truncated constructs of the 
receptor showed that this motif was essential for regulation of binding of 
benzodiazepine to the receptor. Such motifs were observed in other proteins such as 
the mammalian cytochrome P450s, apolipoprotein A-I (mouse), caveolin (mouse), 
human hedgehog, Annexin II (rat), cholesterol oxidase (streptpcoccus), cholesterol 
7α-monooxygenase (Mouse), cholesterol dehydrogenase (Nocardia), bile salt 
activated lipase (Human) and acyl-CoA cholesterol acyltransferase (Rabbit) but not 
much functional data is available to understand the role of the putative cholesterol 
binding motif (pCBM) in these proteins.  
 
The role of the pCBM was further supported by the work carried out to study 
cholesterol binding at the cholesterol recognition amino acid consensus (CRAC) of 
the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an 
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HIV TAT-CRAC peptide (Li et al., 2001). In another biophysical and on-ionic 
studies, on the interaction of pneumolysin (a toxin and major virulence factor of the 
bacterium Streptococcus pneumoniae containing 4 of these motifs) with cholesterol 
showed that pneumolysin lyses cells whose walls contain cholesterol (Nollmann et al., 
2004).  
 
It is understood that the high affinity status of DmGluRA to glutamate is strictly 
regulated by membrane cholesterol and that the putative cholesterol-binding motif 
observed in different transmembrane helices could play a pivotal role in the selectivity 
of cholesterol.  
 
The current study would be focused on the biochemical characterize the putative 
cholesterol binding motif observed in the DmGluRA and to obtain the minimal 
construct that is sufficient to maintain the receptor in high affinity state. 
 
III.3.1 Molecular constructs 
4 hits for putative cholesterol-binding motif (L/V-[X]1-5-Y-[X]1-5-R/K) were observed 
upon scanning through the primary sequence of DmGluRA. The following 
considerations were made in designing the constructs: 
• The topology of the receptor on the membrane,  
• Orientation of cholesterol in the bilayer and  
• The accessibility of the residues in the motif to cholesterol. 
Three of the pCBM motifs were present in the transmembrane ™ helices (TM3, TM5 
and TM7) of the receptor and one was present in the linker region between ECD and 
TM1 (as shown in the fig 32).  
 
Table 3 : Details of the DmGluRA truncation constructs 
Construct Name Truncation 
point 
Construct size* 
(bp)  
C-term 
Tag 
No. of 
TMs# 
No. of 
pCBM 
DmGluRA$ Full length  2974 6-His 7 4 
DGRTM5 Lys 817 2451 flag 5 3 
DGRTM3 Gln 738 2214 flag 3 2 
DGRTM1 Glu 663 1989 flag 1 1 
* includes tag and stop codon pCBM – Putative cholesterol binding motif 
TM – Transmembrane $ Construct already prepared by (Eroglu et al., 2003)  
# includes the extracellular domain (ECD) 
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III.3.2 Virus production for the truncation constructs of DmGluRA in 
the Recombinant BaculoVirus (RBV) system 
 
The viral stocks of DmGluRA construct were readily available as the construct was 
prepared for the previous study by Eroglu, PhD thesis 2002. The constructs (DGRTM1, 
DGRTM3 and DGRTM5) were cloned into pVL1393 transfer vector and co-transfected 
in to Sf9 cells for recombinant virus production. A series of recombinant baculovirus 
production protocols such as clonal selection, primary recombinant viral stock, secondary 
viral stock and tertiary viral stock production were carried out as described in detail in the 
Materials and methods section II.5. The viral titre values of the tertiary stock determined 
by end point dilution method are as follows in Table 5: 
Table 5 Titre values for constructs 
Construct Titre value (Pfu/ml) 
DmGluRA$ 3.4 x 108 
DGRTM5 4.7 x 108 
DGRTM3 1.9 x 108 
DGRTM1 2.2 x 109 
$ 
- (Eroglu et al., 2003) 
 
The protein expressions in the total Sf9 cells were analyzed by performing a Western blot 
using anti-DGR (1:2500) as primary antibody (anti-DGR is polyclonal antibodies raised 
against the extracellular domain of DmGluRA in rabbit). It was determined that the Sf9 
cells infected by the recombinant viruses at a MOI of 3 for 2-3 days at 27°C yielded a 
good expression level in all constructs. Therefore, these parameters were maintained 
throughout the study involving expression of truncation constructs of DmGluRA in Sf9 
plasma membranes. 
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III.3.3 Preparation and purification of constructs expressed in plasma membranes 
of Sf9 cells 
 
The Sf900 medium was supplemented with 10% Fetal calf serum (FCS) in all expression 
setups for Sf9 membrane preparation to enrich the cholesterol content in the plasma 
membrane. Plasma membranes of Sf9 cells infected by the recombinant virus expressing 
different constructs were prepared as per the method described in the Materials and 
methods, section II.7.2. The post-nuclear supernatant was purified on a density gradient 
centrifugation to enrich the plasma membrane fraction. It should be noted that the 
membranes thus obtained by homogenization and gradient centrifugation still contain a 
small proportion of membrane from the ER. 
 
About 5 µg of total membrane protein (estimated by BCA assay) was resolved on a 8% 
SDS-PAGE and electroblotted on a PVDF membrane. Western blot analysis was 
performed on the electroblotted PVDF membrane using anti-DGR (rabbit, 1:2500 
dilutions) as primary antibody and HRP-linked whole antibody, anti-rabbit IgG as 
secondary antibody (1:1000). The results showed that all the constructs were well 
expressed in the plasma membrane fraction as shown in the figure 3.  
 
In the samples prepared for membranes containing DGRTM5 and DmGluRA, most of it 
aggregated in the wells owing to the greater hydrophobicity and resistance to the 
reducing agents leading to very faint signal at their corresponding molecular weight. 
Several trials of different loading volumes, different concentrations of ß-mercaptoethanol 
in the loading buffer and denaturation temperature did not make a significant difference 
in the intensity of signal (data not shown). 
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Construct 
name 
Theoretical 
Mol wt 
DGRTM1 ~ 74 kDa  
DGRTM3 ~ 82 kDa  
DGRTM5 ~ 92 kDa 
DmGluRA  ~ 109 kDa 
 
Fig. 33: Western blot on membranes of DGRTM1, DGRTM3, DGRTM5  and 
DmGluRA constructs expressed in RBV system (Sf9 cells). 
5 µg of total membrane protein (estimated by BCA assay) was loaded in a SDS-
PAGE (8% gel) for each construct and electroblotted on a PVDF membrane using 
anti-DGR (rabbit, 1:2500 dilutions) as primary antibody and HRP-linked whole 
antibody, anti-rabbit IgG as secondary antibody (1:1000).  
 
In the Western blots, two bands running at different molecular weights were observed in 
all constructs which could be a contamination of the pre-matured protein in the ER 
membranes generally obtained during plasma membrane preparation from cells.  
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III.3.4 The affinity of truncation constructs DGRTM5, DGRTM3 and DGRTM1 for 
glutamate is similar to the full length DmGluRA 
 
Glutamate binding studies were performed on DGRTM5, DGRTM3 and DGRTM1 using 
Radioligand Binding assay. All L-[3H]-Glutamate binding trials were conducted on the 
plasma membrane preparations of DGRTM5, DGRTM3 and DGRTM1. Every trial had 
triplicate setups and three such trials were conducted on the membrane preparation of the 
constructs. Homologous competition binding was performed by incubating the 
membranes with [3H]-glutamate along with increasing concentration of unlabeled 
glutamate. The percentage standard error of mean (SEM) was determined for the 
triplicate sample in each of the trials. The IC50 values were determined by applying 
nonlinear regression analysis of the GraphPad Prism software prescribed for kinetics 
model analysis. The reliability of the curve fit was tested by considering the values of 
statistical parameters such as 95% confidence interval and R2 values.  
 
The full length DmGluRa has a Kd value of 3.4 ± 1 µM, this is a very low value to 
conduct a binding trial and to obtain a concurrent value for every setup. The mean IC50 
value for glutamate binding studies on DmGluRA was found to be 4.9 ± 1.2 µM 
(Panneels et al., 2003).  
 
From the glutamate binding trials on DGRTM5 expressed membranes (containing 3 
pCBMs and 5 TM helices) the mean IC50 values was determined to be 2.8 ± 1.2 µM (fig. 
34). In DGRTM3 expressed membranes (containing 2 pCBMs and 3 TM helices) the 
mean IC50 values was determined to be 3.1 ± 1.5 µM (fig. 35) and in DGRTM1 
expressed membranes (containing only one pCBM and 1 TM helix) the mean IC50 values 
was determined to be 2.4 ± 0.35 µM (fig. 36). 
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Fig. 34. Homologous competitive binding of L-Glutamate on DGRTM5 expressed in 
Sf9 membranes. Competitive binding assay on DGRTM5 membranes showed similar 
affinity as observed in the wild-type DmGluRA membranes (IC50=4.9±.2 µM) (Panneels et 
al., 2003). Total binding in DGRTM5 expressed Sf9 membrane is 8160±1237 DPM and 
unspecific binding is 1660±148.2 DPM. The curves represent the mean of independent 
experiments (n = 3) with 3 triplicates in each experiment. 
 
Best-fit values Trial 1 Trial 2 Trial 3 
     BOTTOM  0 0 0 
     TOP  100 100 100 
     IC50 4.29x10-6 1.9x10-6 2.59x10-6 
     Log IC50 -5.36 -5.72 -5.58 
95% Confidence Intervals 
     IC50 1.9x10-6 to 9.29x10-6 9.29x10-7 to 3.69x10-6 1.29x10-6 to 5.49x10-6 
     Log IC50 -5.72 to -5.04 -6.04 to -5.44 -5.92 to -5.27 
Goodness of Fit 
     R² 0.8458 0.9068 0.9078 
 
Mean IC50 values of 3 trials with SEM 2.8 ± 1.2 µM 
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Fig.35. Homologous competitive binding of L-Glutamate on DGRTM3 expressed in 
Sf9 membranes. Competitive binding assay on DGRTM3 membranes showed similar 
affinity as observed in the DGRTM5 and wild-type DmGluRA membranes. Total binding in 
DGRTM3 expressed Sf9 membrane is 17128±2529 DPM and unspecific binding is 
1662±672 DPM. Curves represent the mean of independent experiments (n = 3) with 3 
triplicates in each experiment. 
 
Best-fit values Trial 1 Trial 2 Trial 3 
     BOTTOM  0 0 0 
     TOP  100 100 100 
     IC50 3.5x10-6 4.3x10-6 1.3x10-6 
     Log IC50 -5.46 -5.37 -5.89 
95% Confidence Intervals 
     IC50 2.6x10-6 to 4.6x10-6 2.6x10-6 to 7.04x10-6 6.1x10-7 to 3.0x10-6 
     Log IC50 -5.57 to -5.33 -5.57 to -5.15 -6.21 to -5.52 
Goodness of Fit 
     R² 0.9865 0.9545 0.8458 
 
Mean IC50 values of 3 trials with SEM 3.1 ± 1.5 µM 
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Fig. 36. Homologous competitive binding of L-Glutamate on DGRTM1 expressed in Sf9 
membranes. Competitive binding assay on DGRTM1 membranes showed similar affinity as 
observed in the DGRTM3, DGRTM5 and wild-type DmGluRA membranes. Total binding in 
DGRTM1 expressed Sf9 membrane is 14019±420.8 DPM and unspecific binding is 
2166±331.7 DPM. Curves represent the mean of independent experiments (n = 3) with 3 
triplicates in each experiment. 
Best-fit values Trial 1 Trial 2 Trial 3 
     BOTTOM  0 0 0 
     TOP  100 100 100 
     IC50 2.01x10-6 2.70x10-6 2.46x10-6 
     Log IC50 -5.70 -5.57 -5.61 
95% Confidence Intervals 
     IC50 9.1x10-7 to 4.47x10-6 2.01x10-6 to 3.64x10-6 1.39x10-6 to 4.35 x10-6 
     Log IC50 -6.04 to -5.35 -5.70 to -5.44 -5.86 to -5.36 
Goodness of Fit 
     R² 0.8670 0.9847 0.9463 
 
Mean IC50 values of 3 trials with SEM 2.4 ± 0.35 µM 
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III.3.4.1 Construct Vs Comparison of IC50 values 
 
From [3H]-Glutamate binding studies on all of the constructs expressed in Sf9 
membranes, it was observed from the mean IC50 values that DGRTM1 (2.4 ± 0.35 µM), 
DGRTM3 (3.1 ± 1.5 µM) and DGRTM5 (2.8 ± 1.2 µM) maintained similar affinity for 
glutamate as that of DmGluRA  (4.9 ± 1.2 )  (fig. 37) (Panneels et al., 2003).  
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Fig. 37. Histogram of DmGluRA construct on X-axis and IC50 values on the Y-axis. 
The histogram exhibits similar binding affinity of the receptor for glutamate in 
DGRTM1 (2.4 ± 0.35 µM), DGRTM3 (3.1 ± 1.5 µM) and DGRTM5 (2.8 ± 1.2 µM) 
constructs when compared to that of DmGluRa (4.9 ± 1.2 µM). 
 
Among DGRTM5, DGRTM3 and DGRTM1 constructs, DGRTM1 construct was the 
minimal construct that contained one pCBM and one TM helix, and was still capable of 
maintaining the high affinity state to glutamate binding. Hence, the next attempts are to 
see which part of the plasma membrane DGRTM1 is localized to or associated with to 
maintain the high affinity state. 
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III.3.5 Analysis of association of DGRTM1 with detergent resistant membranes 
(DRMs) from Sf9 cells – DGRTM1 was associated with DRMs 
 
The plasma membrane contains subdomains that contain high concentrations of 
cholesterol and glycosphingolipids. These subdomains are tightly packed are often 
referred to as Lipid rafts.  Several proteins involved in cell signalling, have been shown 
to be recruited and regulated in lipid rafts (Shenoy-Scaria et al., 1994). The lipid rafts are 
very often referred to as detergent resistant membranes (DRMs) as they exist in liquid-
ordered phase in the membrane at low temperatures and are resistant to extraction with 
weak on-ionic detergents such as TritonX-100 (Simons and Ikonen, 1997).  
 
In the studies on DmGluRA it was shown that the receptor was in low affinity state to 
glutamate binding when associated with non-rafts or non-DRMs favoured by membrane 
ergosterol found in the Drosophila fly eye whereas, it was found in the high affinity state 
when associated with rafts or DRMs favoured by cholesterol found in the Sf9 membrane 
(Eroglu et al., 2003).  
 
The DGRTM1 membrane extracted on ice using 1% Triton X-100 detergent was isolated 
from the detergent soluble components by a density gradient ultracentrifugation. The 
membranes that are resistant to 1% Triton X-100 treatment at 4 °C remained buoyant and 
floated to the 5-30% interface were regarded as light density DRMs; those resistant that 
floated to the 30-40% interface were regarded the heavy density membranes and the 
membrane proteins devoid of lipid members due to detergent solubilisation were pelleted.   
 
Western blot analysis on the six samples collected from the top layers showed signals for 
DGRTM1 in the 1st fraction (5-30% interface, Lane1 in the fig. 38) and in 3rd and 4th 
fractions  (30-40% interface, Lanes3 and 4 in fig. 38). 
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Fig. 38. Association of DGRTM1 in Triton X-100 extracted membranes (DRM) 
10 µL of each sample was loaded in a SDS-PAGE (10% gel) and electroblotted on a 
PVDF membrane using anti-DGR (rabbit, 1:2500 dilutions) as primary antibody and 
HRP-linked whole antibody, anti-rabbit IgG as secondary antibody (1:1000). 
 
From the [3H]-Glutamate binding studies and DRM association studies it was concluded 
that DGRTM1 maintains its high affinity state to L-Glutamate due to its association with 
DRMs. The next attempts are to find out whether the high affinity state for glutamate and 
DRM association is due to the pCBM or TM helix in DGRTM1. 
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III.3.6 Studies on DGX and DG14c constructs in the RBV system 
 
 
III.3.6.1 Description of DGX and DG14c constructs 
 
Viral stocks of DGX and DG14c were previously produced (PhD thesis by Cagla 
Eroglu), for expression of the extracellular domain (ECD) in the RBV system, as an 
attempt to over-express the ECD for structural studies. DmGluRA was terminated at 
residue Ser 624 to obtain the DGX construct which lacked the transmembrane domain. 
The DGX construct thus obtained contained the complete ECD with one cholesterol 
binding consensus at the C-terminus. The DG14c construct was terminated at Ser 586 
residue and lacked the cholesterol binding motif including the cysteine rich domain 
(CRD) in comparison with the DGX construct (as shown in the fig. 39). The  
 
Construct 
Name 
Truncation 
point 
No. of 
pCBM 
DG14c Ser 586 - 
DGX Ser 624 1 
 
 
Fig. 39. : Topology diagram showing the truncation constructs of DGX and DG14c 
GPCR topology adopted from GPCR database (http://www.gpcr.org). 
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III.3.6.2 DGX and DG14c secretion to the insect cell medium – DGX was poorly 
secreted to the medium 
 
In order to check the levels of secretion, Sf9 cells were infected with the recombinant 
virus of DGX and DG14c constructs at a MOI of 3 for 3-4 days until the total cells were 
lysed. Western blot analyzed for protein expression and secretion in the medium showed 
that DGX was found secreted in lower amounts, when compared to the DG14c secretion 
to the Sf900-II medium.  
 
Construct  Theoretical 
mol wt 
DGX  ~ 67 kDa 
DG14c ~62 kDa 
 
 
Fig. 40. Western blot of expression and secretion of DGX 
and DG14c to the medium. 
DGX and DG14c secreted to the Sf900-II medium (10µL ) 
were detected by incubating the electroblotted PVDF 
membrane with anti-DGR primary antibody. 
 
 
 
Both DGX and DG14c constructs contained the complete or part of DmGluRa ECD and 
still there was a comparable difference in the amounts secreted to the medium. The 
possible reasons for such low expression of DGX to the medium could be that either the 
total expression of DGX in the Sf9 cells itself were poor or it is localized/retained in the 
cellular compartments (such as the plasma membranes, endoplasmic reticulum or other 
cellular compartments).  
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III.3.6.3 Comparison of DGX and DG14c expression on Sf9 membranes – 
DGX was well-expressed in the plasma membranes 
 
DGX and DG14c were expressed in Sf9 cells at a MOI of 3 for 2-3 days until 70% of the 
cells were observed infected. Plasma membranes containing DG14c and DGX were 
prepared and Western blot on the samples showed double bands running at different 
molecular weights as before shown in fig 41. Upon comparison with the western blot for 
DGX and DG14c secreted to the medium, only single bands were observed (see fig. 40), 
where only the completely processed proteins are secreted to the medium. This 
observation further strengthens the assumption that the plasma membrane preparation 
might be contaminated with proteins from the ER membranes (containing some 
proportions of immature/unprocessed protein). 
 
Further, it was surprising to note that DGX construct without any TM was observed 
associated in the plasma membrane fraction in high quantities relative to that of DG14c 
membrane fraction. This also clearly explains the lower expression levels of DGX in 
medium. The next attempt was to verify whether the DGX and DG14c observed in the 
membrane fractions were capable of binding L-Glutamate. 
 
Fig. 41.  Membrane expression of  DGX and DG14c. 
5 µg of total membrane protein estimated by BCA assay 
was loaded in a SDS-PAGE (8% gel) for each construct 
and electroblotted on a PVDF membrane using anti-
DGR (rabbit, 1:2500 dilutions) as primary antibody and 
HRP-linked whole antibody, anti-rabbit IgG as 
secondary antibody (1:1000). Western blot shows high 
expression of DGX. 
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III.3.6.4 [3H]-Glutamate binding trials on DGX and DG14c expressed Sf9 
membranes 
[3H]-Glutamate binding was carried out on DGX and DG14c expressed and prepared Sf9 
membranes. The values were plotted with increasing concentration of unlabeled 
glutamate against the total counts measured from the bound [3H]-Glutamate. Statistical 
parameters were analyzed for the model curve. The model curve was a good fit and 
furher it was inferred that the DGX membranes had the similar affinity (2.3±0.85 µM) as 
that of the DmGluRA and its other truncated constructs as shown before (fig 42). In the 
case of DG14c expressing membranes no binding was observed which justifies that the 
signals observed particularly in the western blots for plasma membrane preparations were 
due to contamination from the ER where proteins are immature, unfolded and inactive.  
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Fig. 42. Homologous competitive binding curve on DGX and DG14c expressed-Sf9 
membranes.  
Competitive binding assay on 20-30 µg of BCA assay estimated DGX and DG14c DGX 
membranes showed similar affinity (IC50=2.3±0.85 µM) to that of DmGluRA and 
binding trials of DGRTM1, DGRTM3 and DGRTM5 membranes. Total binding in DGX 
expressed Sf9 membrane is 12960.3±1237 DPM and unspecific binding is 1286±127.4. 
DPM. No binding observed in case of membranes prepared from Sf9 cells infected with 
DG14c virus was found to be 1623.279±279 DPM and unspecific binding is 
881.7±154.2. DPM. Curves represent the mean of independent experiments (n = 3 for 
DGX and n=1 for DG14c).  
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From the binding studies and western blot of membrane preparations, it was evident that 
the DGX construct with pCBM was associated with the plasma membrane and still 
capable of binding L-glutamate.  
 
Experiments were designed simultaneously to see the role of pCBM. The set of 
experiments designed were to purify the DGX secreted to the supernatant and conducting 
a floatation assay on the purified protein to see if it has any affinity for liposomes and to 
conduct CD spectral studies on peptides containing pCBM incubated with liposomes to 
observe any conformational change. 
 
III.3.6.5 Purification of DGX secreted in the culture medium 
1L of 2 x 106 SF+ cells/mL was infected with recombinant DGX virus at a MOI of 3. 
Three-four days post-infection the culture was cleared from cells by centrifugation and 
filtered through 0.22 µm filter. The clarified supernatant was buffered to pH 6.0 using 
1M Potassium phosphate buffer pH 6.0 and loaded into the CHT column equilibrated 
with Buffer Q. The protein bound column was washed with Buffer W until baseline and 
eluted with 400mL of Buffer E (pH 8.0). The concentrated and buffer replaced elute was 
loaded on to the Ni-sepharose column at a flow rate of 1mL/min and monitored under 
UV 280 nm.  
 
A chromatogram was prepared plotting the protein concentration under UV 280 nm (Blue 
line) against the % Imidazole concentration in Buffer B (500mM) (purple line).  The 
elution profile showed a single peak at 15% Imidazole concentration in Buffer B (75mM 
Imidazole). Western blot analysis on the DGX fractions collected at the peak showed a 
band around 50 kDa corresponding to purified DGX (indicated by a red arrow in the fig 
43b) following CHT and Ni column. There were bands observed at around 100 kDa and 
35 kDa (indicated by black arrows in the fig. 43b), detected by the anti-DGR antibody 
used as primary antibody in the western blot analysis. The bands running at 100 kDa 
were assumed to be oligomers of DGX resistant to reduction of disulpide bridges by β-
mercaptoethanol and the 35 kDa band was to be degradation products of DGX, as there 
was a proportional change of these signals with respect to DGX signals detected by the 
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anti-DGR antibody. The elution fractions were pooled, concentrated and dialysed in the 
dialysis buffer. The DGX thus purified was obtained in amounts sufficient for liposome 
floatation studies. 
 
 
Fig. 43a : Chromatogram showing the elution profile of DGX from the Ni 
column  Elution profile of DGX monitored at UV 280 (blue line) and % Imidazole 
concentration (purple line) are shown. 
 
 
 
Fig. 43b : Western blot of  DGX fractions eluted at 75mM Imidazole 
Western blot on the elution fractions from the Ni column. 10 µl of each fraction was 
electroblotted in PVDF membrane and incubated with anti-DGR antibody. DGX band 
as pointed by the arrow. 
 
 Chapter 3                                                                                                                  Results 
 
109 
III.3.6.6 Dynamic Light Scattering (DLS) studies for validation of liposomes 
 
The liposomes of raft composition (DOPC:DPPC:Cholesterol, 30:30:40 mol%) and Non-
Raft composition (DOPC:Cholesterol, 60:40 mol%) were analyzed on a DLS for its 
particle size distribution under different parameters such as the intensity, volume and 
number. The liposomes prepared were of good quality under the parameters discussed 
ealier. The size distribution (by percent number) was determined by plotting the 
logarithm of liposome diameter on the X-axis versus the percent number of liposome for 
the given liposome diameter on the Y-axis. The system was monodisperse in both 
preparations with a polydispersity index of less than 0.7. Single peaks were obtained in 
both compositions, about 30% of liposome mixture contained liposomes of about 100 nm 
diameter and 32% of 125nm diameter in raft and non-raft compositions respectively. The 
liposome diameter ranged between 75-250 nm for raft composition. For the non-raft 
liposomes the range was from 100-350nm. 4-6 measurements of 10 min were carried out 
for each of the liposome compositions and particle size distribution were found to be 
reproducible in all measurements.   
 
 
Fig. 44. Determination of size distribution of raft and non-raft liposome 
preparation using DLS. 
 
The raft and non-raft liposomes thus prepared and analyzed were used for liposome 
floatation studies or CD spectra studies.
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III.3.6.7 Liposomes floatation studies on the purified DGX 
Raft and non-raft liposomes were prepared using extruder (of 100nm pore size 
polycarbonate membranes) were of good quality when analyzed in DLS.  The secreted 
and purified DGX was incubated with liposomes of non-raft and raft compositions. The 
setup containing the DGX alone without any liposome severed as “control”. The 
proteoliposome mixture were centrifuged and floated in a density gradient. The samples 
were collected as four fractions (600, 400, 400 and 600 µL) from the top to bottom and 
labeled from 1-4 respectively.  
 
 
 
 
Fig. 45. Western blot on samples of liposome floatation assay with secreted DGX 
The electroblotted PVDF membrane was incubated with anti-DGR (1:2500) and 
analysed. Bands were observed in the 1st lane of in (B) and (C) corresponding to the 
molecular weight of DGX which represents the DGX that floated to the first fraction. 
Bands in lane 3 and 4 in all (A), (B) and (C) represent the DGX that stayed at the bottom 
of the ultracentrifugation tube.   
(A) Secreted DGX alone with assay buffer (B) Secreted DGX with Non-raft liposomes 
(C) Secreted DGX with Raft liposomes 
  
In the western blot, signals in the first fraction (0-30% interface) signifies that DGX has 
affinity for both liposome composition that renders DGX buoyant and floats to the 0-30% 
interface upon ultracentrifugation. From the liposome floatation experiment it was 
inferred that the ECD of DGX posses affinity for lipid membranes.  
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III.3.7 Helical wheel depiction on 12 amino acid peptide region containing the 
pCBM1 in DmGluRA 
The 12 amino acid peptide region (from residue 613 – 624 containing the pCBM1) in 
DmGluRA were plotted on a helical wheel. The hydrophobic patch consisting residues 
Leu615, Tyr619, Trp622, and Lys621 were on one face of the helix that were capable of 
anchoring to the membrane. A few charged residues Q618 and K621 were also observed 
that might interact with the charged phospholipids. From such a distribution of the 
aminoacids on one face of the helical plot it was concluded that the 12 aminoacid peptide 
region was amphiphatic.  
 
  
Fig. 46. Helical wheel depiction of the 12 amino acid region.  Shows the 
distribution of amino acids typical of a amphipathic helix with the hydrophobic 
residues placed on one face containing the pCBM 
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III.3.8 CD spectrum analysis of the peptides 
 
Two peptides were synthesized to study the effect of Raft liposomes on the 
conformational change induced upon interaction with the liposomes.  The Pep611-624 and 
Pep602-624 peptide contained the residues ranging from 611 to 624 and 602 to 624 in 
DmGluRa respectively. About 50µM of the peptides (Pep602-624 and Pep611-624) were 
analyzed on the spectropolarimeter after incubation with 10mM liposomes of Raft 
composition in 50mM phosphate buffer pH 7.4. The spectrum for the data was 
interpreted after background correction obtained from the controls (such as reading from 
buffer alone and from the raft liposomes without peptide). The spectrum was plotted 
absorbance in x-axis against the ellipicity in the y-axis. CD spectra of Pep602-624 and 
Pep611-624 showed that there was no significant conformational change in the peptide upon 
its incubation with liposomes of raft compostition (DOPC:DPPC:Cholesterol, 30:30:40 
mol%).  
Pep611-624                            H-SCYALDIQYMKWNS-NH2 
Pep602-624 H-GLWPYADKLSCYALDIQYMKWNS-NH2 
 
Fig. 47. CD spectrum analysis on peptides (pep602-624 and pep611-624) 
containing the cholesterol binding motif 
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III.3.9 Studies on DGXd12ct and DGXd12ct-GPI constructs in the RBV system 
 
III.3.9.1 Recombinant virus production and expression of DGXd12ct and 
DGXd12ct-GPI constructs in the RBV system 
 
In order to see the effect of removal of pCBM, further constructs were prepared by 
truncating by 12 amino acids containing the pCBM at the C-terminus of DGX. The 
DGXd12ct construct was prepared by truncating the 12 amino acids at the C-terminus. 
Like the DGXd12ct construct, DGXd12ct-GPI construct also lacked the pCBM1 but was 
tagged with a GPI-anchor at the C-terminus of DGXd12ct construct. The DGXd12ct and 
DGXd12ct-GPI constructs cloned in pVL1393 transfer vector were co-transfected into 
Sf9 cells for recombinant virus production.  
 
The usual procedure for recombinant baculovirus production was followed as mentioned 
in the materials and methods section. Expression tests on the clones were done on the 
infected Sf9 cells by western blotting and detecting with anti-DGR antibody as primary 
antibody. 
 
Construct 
Name 
Truncation 
point 
Theoretical 
Mol wt 
C-term 
Tag 
Titer value 
(Pfu/mL) 
DGXd12ct Cys 612 ~ 69 kDa - 3.66x108 
DGXd12ct-GPI Cys 612 ~ 71 kDa flag 5.48x108 
 
DGXd12ct clones DGXd12ct-GPI clones 
C6 F9 H3 
 
A9 D4 F6 
 
 
Fig.48. Expression tests on clones of DGXd12ct and DGXd12ct-GPI for viral stock 
production. Three clones of each construct were selected for infection and the 
expression in total cells were analysed by Western blotting. In the Western blot, all 3 
clones showed good expression for DGXd12ct and DGXd12ct-GPI. 
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[3H]-Glutamate binding trials on DGXd21ct and DGXd12ct-GPI expressed Sf9 
membranes 
 
[3H]-Glutamate binding was carried out on DGXd12ct and DGXd21ct-GPI expressed and 
prepared Sf9 membranes. The values were plotted with increasing concentration of 
unlabeled glutamate against the total counts measured from the bound [3H]-Glutamate. 
The model curve was a good fit and further it was inferred that the DGXd12ct membrane 
no binding was observed whereas DGXd12ct-GPI membranes had the similar affinity 
(6.3±1.9 µM) as that of the DmGluRA and its other truncated constructs as shown before 
(fig 42).  
 
Fig. 49. Homologous competitive binding curve on DGXd12ct and DGXd12ct-
GPI expressed-Sf9 membranes. Competitive binding assay on DGXd12ct-GPI 
membranes showed the same affinity (IC50=6.3±1.9 µM) as observed in the DGX, 
DGRTM1, DGRTM3, DGRTM5 and wild-type DmGluRA membranes. Total binding 
in DGXd12ct-GPI expressed Sf9 membrane is 7140.7±1443.5 DPM and unspecific 
binding is 2808.7±327.2. No binding observed in case of membranes prepared from 
Sf9 cells infected with DGXd12ct virus. Total binding was found to be 1971.7±291.6 
DPM and unspecific binding is 1482.3±347.4.  Curves represent the mean of 
independent experiments (n = 3 for DGXd12ct-GPI and n=1 for DGXd12ct).  
 
From the binding curves, it can be concluded that the 12 amino acid pCBM containing 
peptide plays a majkor role in the activity of the receptor.  
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Discussion 
X-ray crystallography and NMR have been the well-established techniques till date 
that are employed for the structure determination and characterisation of the proteins. 
The major limitation for solving a structure by x-ray crystallography is the amount 
and the quality of protein required for the crystallization trials.   This is the primary 
reason for the slow pace of growth in the number of membrane protein structures 
solved. In recent years, several robust expression systems (prokaryotic and 
eukaryotic) have been developed; but the production of G-protein coupled receptors 
(GPCRs) in amounts that are sufficient for the structure characterization trials still 
remains a challenge. Certainly, it would be a difficult task to develop an expression 
system that contains all the necessary molecular mechanism to handle the protein 
expression of any kind. In recent years, interdisciplinary approaches have been 
applied to understand the protein characterization at molecular level with 
experimental data available and bioinformatics tools. The information so gathered 
significantly aids at various steps optimization of recombinant protein expression and 
purification. 
 
Molecular modelling studies can be used as a tool to design cloning strategies for 
high secretion levels of the ligand binding extracellular domain (GABAB1b) of the 
metabotropic GABAB receptor from Rattus norvegicus. Sequence analysis on the 
ECD of GABAB1b receptor were predicted to be homologous to the venus flytrap 
domain of the periplasmic binding proteins (Olah et al., 1993). The crystal structure 
of the ECD of the metabotropic glutamate receptor (mGluR) belonging to the same 
class C GPCRs contains the venus flytrap of ECD in its structure.  The crystal 
structure of mGluR was solved for the ECD in ligand (glutamate) bound and in un-
bound state (Kunishima et al., 2000). 
  
In the current study, a structure model of ECD of metabotropic GABAB receptor 
(GBR1bNT) was built using the structure coordinates of the ligand bound form of 
mGluR ECD (PDB code : 1EWK). The structure model obtained for GBR1bNT and 
the template (1EWK) was energy minimized under same conditions using the 
model_minimize and model_anneal (Rice and Brunger, 1994) modules of CNS 
package. During the energy minimization protocol, 15 representative energy 
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minimized structures were obtained. The models obtained were verified using 
Procheck program (Laskowski et al., 1993). The root mean square deviation (RMSD) 
between the template (1EWK) and the minimized structure was in the range of 
1.85±0.05. The model thus obtained was useful to understand the structural features 
of GBR1bNT. Structure comparison of the ECD of mGluR and GBR1bNT showed 
that GBR1bNT contained features that might interfere with the expression and 
secretion of proteins such as the proline-rich region at the N-terminus. 
 
In the current study, the ligand binding ECD of metabotropic GABAB receptor from 
Rattus norvegicus (GBR1bNT) was expressed and purified in insect cell system or 
recombinant virus system (RBV) and E.coli.  
 
The advantages of using a RBV in overexpressing proteins are that since it is an 
eukaryotic system it possess similar glycosylation patterns like that of the mammalian 
system leading to expression of a functional protein. The system has a disadvantage 
of being time consuming and expensive but the other advantage is that the expression 
can be scaled up to large volumes once the recombinant virus is optimised for 
multiplicity of infection (MOI), recombinant protein expression and other kinetic 
parameters. Appropriate application of strategies has improved high-level expression 
of proteins in the RBV system.  
 
GBR1bNT is a heterologous protein (from rat) to be expressed in the baculovirus 
system, so the native signal peptide was replaced with that of mellitin signal peptide, 
which is native to hymenopteran insect cells (Cagla). Mellitin is a secretory protein in 
the insect cells expressed in large quantities under the control of the mellitin signal 
peptide; moreover expression under the control of this peptide has shown to have 
improved the secretion of plant propain when expressed in the baculovirus system 
(Tessier et al., 1991).  
 
Initially, the GBR1bNT was attempted to be expressed in the RBV system under the 
control of the mellitin signal peptide. Low secreted levels of purified GBR1bNT were 
obtained that was only detectable by silver staining. Bioinformatics and 
computational modelling approaches were applied to understand GBR1bNT at 
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sequence and structure level in order to analyze the poor secretion levels of 
GBR1bNT.  
From the computational modelling studies of GBR1bNT, it is understood that 
GBR1bNT had a proline-rich domain immediately after the signal peptide region. 
This region was found to be unstructured and such a feature to be present at the start 
of the translation could be a problem in the proper folding of the protein. Previously, 
the 3D structure of ECD of frizzled receptor was solved by expressing the protein in 
the mammalian system with human growth hormone tagged at the N-terminus as the 
fusion partner (Dann et al., 2001). Also the chicken growth hormone (cGH) is known 
to be well expressed in the RBV system. With the following information a strategy 
was developed by preparing the pVL1393-cGH-GBR1bNT construct with cGH fused 
at the N-terminus of GBR1bNT to drive the expression. Tobacco etch virus cleavage 
site was included in the construct between cGH and GBR1bNT in order to obtain the 
GBR1bNT alone upon cleavage with TEV protease after purification. Another 
construct, pVL1393-cGH was prepared as a control over the cGH expression when 
expressed alone and when fused with GBR1bNT. Viral stocks are prepared and the 
protein expression levels are optimised.  
 
In parallel another strategy of secretion of GBR1bNT under the control of the 
DmGluRA signal peptide (DGRsp) was planned and the required constructs were 
prepared. The rationale behind this approach is that in the previous studies (Eroglu, 
Phd thesis, 2002) on the overexpression of DmGluRA ECD yielded good quantities 
of the secreted protein in the same expression system. So, the idea was to see if 
GBR1bNT could be secreted under the control of DGRsp (pVL1393-DGRsp-
GBR1bNT). 
 
Since secretion method involving expression of GBR1bNT fused with cGH at N 
terminus involves two addional steps of cleavage and subsequent purification of the 
cleaved GBR1bNT, the strategy of expression under the control of DGRsp was 
attempted first. Under the control of DGRsp good amounts of secreted GBR1bNT 
were obtained upon purification on a Ni-sepharose column.  
 
Although both mellitin and DGRsp are signal peptides of insect origin and native to 
the baculovirus system, the levels of secretion of GBR1bNT under the control of 
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DGRsp were higher in comparison to that of secretion under the control of mellitin 
signal peptide.  
 
Such observations have been made in earlier reports also. The human t-PA was found 
to be poorly expressed in the baculovirus system. To improve the levels of 
expression, instead of native signal peptide the human t-PA was expressed and 
secreted under the control of cecropin B and 64K signal peptides which are native to 
the insect cells (Jarvis and Summers, 1989). The result showed no significant effect in 
the expression or secretion of this chimera t-PA on the expression of t-PA with the 
native signal peptides (cecropin B and 64K).  
 
Thereby, the molecular mechanism behind the protein secretory pathway is unclear to 
derive a consensus for choosing a signal peptide to drive the expression of 
heterologous proteins in the insect cells.  
 
In the current study the vectors pVL1393-DGRsp and pVL1393-cGH plasmids (does 
not contain GBR1bNT) have been designed such that any gene of interest can be 
directly cloned downstream of either the DmGluRA signal peptide (DGRsp) or cGH 
as N-terminus fusion partner. A Tobacco etch virus (TEV) protease recognition site 
has been included after DGRsp or cGH, so that the expressed protein of interest can 
be cleaved by TEV protease.   
 
 
In the second part of the study, GBR1bNT expression was attempted in E.coli. E.coli 
system has a major disadvantage of being a prokaryotic system where post-translation 
modifications of protein are absent. But there are several other advantages for it being 
a expression system that is well studies, cost and time effective and ease of scaling up 
the expression. Several GPCRs have been expressed and purified in E.coli as 
inclusion bodies and have been shown functionally active (Baneres et al., 2005). 
Recently, the structure of the vasopressin receptor was solved by NMR by over-
expressing the protein in E.coli (Tian et al., 2005). 
 
The ECD of the metabotropic glutamate receptor for which the structure was solved 
(Kunishima et al., 2000) also undergoes glycosylation and was shown that receptor 
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was still functional without glycosylation upon expressing the protein with 
tunicamycin. GBR1bNT also undergoes glycosylation, so the over-expression in 
E.coli was attempted to study if functional protein was obtained. In a recent work, 
site-directed mutagenesis of the glycosylation sites in metabotropic GABAB1b 
receptor (GABAB1b) have shown that the ECD of GABAB1bR can be functionally 
active without any glycosylation (Deriu et al., 2005). 
 
In the present study, upon several trials of optimization of the expression and 
purification strategies, expression of pET15b-GST-GBR1bNT plasmid in Tuner cells 
of E.coli resulted in good expression of GST-GBR1bNT protein in soluble form, 
which was efficiently purified by GST sepharose column.  
 
Radioligand binding studies on the purified GST-GBR1bNT bound to GST beads and 
crystallisation trials on the functional GBR1bNT would be a worthy attempt. On the 
other hand optimization of expression and purification of secreted form of DGRsp-
GBR1bNT from insect cells that would be optimally glycosylated, may enable future 
studies of functional viability of the protein and subsequent crystallization for solving 
the 3D structure. 
 
Solving structure can aid understanding of protein function to a great extent. On the 
other even in absence of detailed structural data, biochemical studies give us 
important information on protein function and its biological relevance. Only one 
GPCR’s structure has been solved namely –  Bovine rhodopsin. 
 
The regulation of membrane proteins (or GPCRs) in the plasma membrane are not 
limited to the interactions within the residues of a protein or between protein-protein 
but also influenced by the lipid environment the protein is localized in. There are 
growing evidences about specific lipid or sterol requirement for the activity of 
membrane protein such as P-glycoprotein requires phosphatidyl choline and 
phosphatidyl ethanolamine for its activity (Sharom, 1997). The lac permease in E.coli 
requires cardiolipin for its conformational transition and ADP binding (Bogdanov et 
al., 1999). There are also crystal structures of membrane proteins reported where 
densities for lipids or sterols are observed interacting with the membrane protein.  
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The current study is focussed on relation between the DmGluRA affinity for its 
ligand glutamate and the local membrane composition. There are four putative 
cholesterol binding motifs (L/V-[X]1-5-Y-[X]1-5-R/K) in the transmembrane domain 
region of DmGluRA. During baculovirus expression studies it has been observed that 
Sf9 plasma membranes contain a rather low quantity of cholesterol and no 
phosphatidyl serine, whereas the phosphatidyl inositol is comparatively high. It has 
been shown that addition of cholesterol to the medium of infected Sf9 insect cells 
positively affected the properties resulting in an increase in high-affnity agonist 
binding sites for the recombinant oxytocin receptor (Gimpl et al., 1995). 
 
Studies by (Eroglu et al., 2002) show that when DmGluRA was expressed in the 
rhabdomeres of the fly eye containing ergosterol it possessed 10 fold lower glutamate 
binding affinity than the insect cell membrane containing cholesterol. Modification of 
the membrane cholesterol content in the rhabdomeres upon treatment with MßCD-
cholesterol complex and followed by glutamate binding studies surprisingly increased 
by 50 fold. These results show that cholesterol is a major requisite for DmGluRA to 
maintain its high affinity state.  Cholesterol has been reported to be important for the 
activity of other membrane proteins such as P-glycoprotein, Ca2 + ATPase  and 
Na+/K+-ATPase . 
 
The presence of the 4 putative low consensus cholesterol binding motif (L/V-[X1-5]-
Y-[X1-5]-R/K) on the transmembrane region DmGluRA raised the interest of 
investigating whether these motifs are involved in the regulation of the receptor. 
Truncation constructs of DmGluRA including one, two or three putative cholesterol 
binding motifs (pCBM) were made to study the role of the pCBM in maintaining the 
high affinity state of glutamate. Glutamate binding studies on the truncation 
constructs DGRTM1, DGRTM3 and DGRTM5 expressed in Sf9 plasma membranes 
maintained the high affinity state. This result showed that DmGluRA does not require 
all of the transmembrane helices for binding glutamate. It was further observed that 
among the above mentioned three constructs, the DGRTM1 construct containing the 
glutamate binding extracellular domain, only one pCBM and one transmembrane 
helix could be the minimal construct that maintained the high affinity for glutamate.  
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In case of the DG14c construct, only small amount of protein was observed in the 
membrane preparation. Glutamate binding trials on the membrane preparations of 
DG14c failed to produce any signal leading to a possibility that the membrane 
preparation could be contaminated with membranes of the endoplasmic reticulum 
where the proteins are generally unfolded.  
Binding studies were carried out on membrane preparations of SF9 cells infected with 
further truncated versions of the DmGluRA such as the DG14c construct (containing 
the extracellular domain lacking the cysteine rich domain) and DGX construct 
(containing the complete extracellular domain including one of the putative 
cholesterol binding motif at its C-terminus). The DGX protein was well expressed in 
the membranes and its affinity to bind glutamate as showed that the receptor is in the 
high affinity state.  
 
Upon careful observation of expression of DGX and DG14c constructs secreted to the 
medium, it was noted that the DGX protein was secreted to the medium in 
considerable amounts as well as purifiable on a Ni-Sepharose column. Results 
obtained from studies on DGX construct in liposome floatation studies exhibited 
interaction of DGX with liposomes. It may be inferred that DGX construct has a 
hydrophobic patch that enables it to interact with the liposomes.  
 
A 12 amino acid region from residue 613-624 of the DGX construct was subjected to 
a helical wheel depiction. The peptide distribution exhibited amphipathicity with long 
hydrophobic side chain residues along with the residues of pCBM on one face of the 
wheel and polar residues on the other face.  
 
The results obtained from the experiments on the DGX construct, such as, the 
glutamate binding studies, liposome floatation studies and with the helical wheel 
depiction were interesting. This observation let us speculate that there could be a 
hydrophobic patch in the ECD of the DmGluRA that interacts with the lipid bilayer; 
the amphipathic peptide region containing the pCBM possessed the features of 
residues that are capable of anchoring or interacting with the lipid bilayer. Therefore 
it was inferred that this peptide region containing the pCBM could be involved in 
maintaining the high affinity state of the receptor by interacting with the lipid bilayer.  
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The DRM isolation studies on 1% Triton X-100 detergent extracted (at 4°C) 
membranes containing DGRTM1 showed that the DGRTM1 were associated with 
DRMs or rafts and possessed similar high affinity state to bind glutamate due to its 
association with DRMs as inferred in the case of DmGluRA (Eroglu et al., 2003). 
Both DGX and DGRTM1 constructs contained the pCBM and DGX differed from 
the DGRTM1 construct by lacking a transmembrane helix following the pCBM. The 
binding studies on DGX and DGRTM1 constructs show similar high affinity state to 
bind glutamate. Hence, it was assumed that DGX is also associated with DRMs.  
 
It is an interesting observation that the ligand binding activity of DmGluRA is 
dependent on localization in DRM. In the present study, the high affinity glutamate 
binding activity of the receptor due to DRM association has been narrowed down to 
the region (1-624 of DmGluRA). This region contains one pCBM on an amphipathic 
12 amino acid region, which implies that one single pCBM might be sufficient for 
maintaining the high affinity status of the receptor. The DGX acts as minimal 
construct that is capable of binding the ligand.  
 
Binding studies with DGXd12ct exhibited no activity which indicates the important 
role of this 12 amino acid pCBM in ligand binding activity of DGX. Loss of activity 
may be attributed to either incapability of the DGXd12ct construct localising to raft 
which is necessary for functional viability of the receptor or inspite of localising to 
raft it loses the inherent activity. When binding study was performed using 
DGXd12ct-GPI construct containing a GPI anchor, the activity was restored. This 
gain of activity by incorporating GPI rules out the possibility that removing the 12 
amino acids affects the inherent receptor activity. From these observations, it may be 
concluded that 12 amino acid region plays an important role raft formation that is 
essential for ligand binding activity of DGX. Further experiments are required to 
confirm this interesting observation of narrowing down the minimal requirement for 
raft formation and as a result ligand binding activity of DmGluRA to the 12 amino 
acid region.  
As a futuristic prospective, site directed mutagenesis of the 12 amino acid region of 
DGX and performing ligand binding trials and photocholesterol crosslinking to these 
mutation construct will further narrow down the understanding of the receptor 
regulation to a residue level.  
V. BIBLIOGRAPHY 
 
Baneres JL, Mesnier D, Martin A, Joubert L, Dumuis A, Bockaert J (2005) Molecular 
characterization of a purified 5-HT4 receptor: a structural basis for drug 
efficacy. J Biol Chem 280:20253-20260. 
Baude A, Nusser Z, Roberts JD, Mulvihill E, McIlhinney RA, Somogyi P (1993) The 
metabotropic glutamate receptor (mGluR1 alpha) is concentrated at perisynaptic 
membrane of neuronal subpopulations as detected by immunogold reaction. 
Neuron 11:771-787. 
Becher A, White JH, McIlhinney RA (2001) The gamma-aminobutyric acid receptor B, 
but not the metabotropic glutamate receptor type-1, associates with lipid rafts in 
the rat cerebellum. J Neurochem 79:787-795. 
Belrhali H, Nollert P, Royant A, Menzel C, Rosenbusch JP, Landau EM, Pebay-Peyroula 
E (1999) Protein, lipid and water organization in bacteriorhodopsin crystals: a 
molecular view of the purple membrane at 1.9 A resolution. Structure Fold Des 
7:909-917. 
Berg S, Edman M, Li L, Wikstrom M, Wieslander A (2001) Sequence properties of the 
1,2-diacylglycerol 3-glucosyltransferase from Acholeplasma laidlawii 
membranes. Recognition of a large group of lipid glycosyltransferases in 
eubacteria and archaea. J Biol Chem 276:22056-22063. 
Bettler B, Kaupmann K, Bowery N (1998) GABAB receptors: drugs meet clones. Curr 
Opin Neurobiol 8:345-350. 
Beyer K, Nuscher B (1996) Specific cardiolipin binding interferes with labeling of 
sulfhydryl residues in the adenosine diphosphate/adenosine triphosphate carrier 
protein from beef heart mitochondria. Biochemistry 35:15784-15790. 
Bogdanov M, Dowhan W (1995) Phosphatidylethanolamine is required for in vivo 
function of the membrane-associated lactose permease of Escherichia coli. J 
Biol Chem 270:732-739. 
Bogdanov M, Dowhan W (1998) Phospholipid-assisted protein folding: 
phosphatidylethanolamine is required at a late step of the conformational 
maturation of the polytopic membrane protein lactose permease. Embo J 
17:5255-5264. 
Bogdanov M, Dowhan W (1999) Lipid-assisted protein folding. J Biol Chem 274:36827-
36830. 
Bogdanov M, Heacock PN, Dowhan W (2002) A polytopic membrane protein displays a 
reversible topology dependent on membrane lipid composition. Embo J 
21:2107-2116. 
Brown DA, London E (1998) Structure and origin of ordered lipid domains in biological 
membranes. J Membr Biol 164:103-114. 
Burger, K., G. Gimpl, et al. (2000). "Regulation of receptor function by cholesterol." Cell 
Mol Life Sci 57(11): 1577-92. 
Chen CC, Wilson TH (1984) The phospholipid requirement for activity of the lactose 
carrier of Escherichia coli. J Biol Chem 259:10150-10158. 
Chini B, Parenti M (2004) G-protein coupled receptors in lipid rafts and caveolae: how, 
when and why do they go there? J Mol Endocrinol 32:325-338. 
Chun M, Liyanage UK, Lisanti MP, Lodish HF (1994) Signal transduction of a G 
protein-coupled receptor in caveolae: colocalization of endothelin and its 
receptor with caveolin. Proc Natl Acad Sci U S A 91:11728-11732. 
Conn PJ, Pin JP (1997) Pharmacology and functions of metabotropic glutamate receptors. 
Annu Rev Pharmacol Toxicol 37:205-237. 
Cornelius, F. (2001). "Modulation of Na,K-ATPase and Na-ATPase activity by 
phospholipids and cholesterol. I. Steady-state kinetics." Biochemistry 40(30): 
8842-51. 
Couve A, Filippov AK, Connolly CN, Bettler B, Brown DA, Moss SJ (1998) Intracellular 
retention of recombinant GABAB receptors. J Biol Chem 273:26361-26367. 
Dann CE, Hsieh JC, Rattner A, Sharma D, Nathans J, Leahy DJ (2001) Insights into Wnt 
binding and signalling from the structures of two Frizzled cysteine-rich 
domains. Nature 412:86-90. 
de Cock H, Pasveer M, Tommassen J, Bouveret E (2001) Identification of phospholipids 
as new components that assist in the in vitro trimerization of a bacterial pore 
protein. Eur J Biochem 268:865-875. 
de Weerd WF, Leeb-Lundberg LM (1997) Bradykinin sequesters B2 bradykinin 
receptors and the receptor-coupled Galpha subunits Galphaq and Galphai in 
caveolae in DDT1 MF-2 smooth muscle cells. J Biol Chem 272:17858-17866. 
Delgado R, Barla R, Latorre R, Labarca P (1989) L-glutamate activates excitatory and 
inhibitory channels in Drosophila larval muscle. FEBS Lett 243:337-342. 
Deriu D, Gassmann M, Firbank S, Ristig D, Lampert C, Mosbacher J, Froestl W, 
Kaupmann K, Bettler B, Grutter MG (2005) Determination of the minimal 
functional ligand-binding domain of the GABAB1b receptor. Biochem J 
386:423-431. 
Ding, J., A. P. Starling, et al. (1994). "Binding sites for cholesterol on Ca(2+)-ATPase 
studied by using a cholesterol-containing phospholipid." Biochemistry 33(16): 
4974-9. 
Dreja K, Voldstedlund M, Vinten J, Tranum-Jensen J, Hellstrand P, Sward K (2002) 
Cholesterol depletion disrupts caveolae and differentially impairs agonist-
induced arterial contraction. Arterioscler Thromb Vasc Biol 22:1267-1272. 
Drmota T, Novotny J, Gould GW, Svoboda P, Milligan G (1999) Visualization of distinct 
patterns of subcellular redistribution of the thyrotropin-releasing hormone 
receptor-1 and gqalpha /G11alpha induced by agonist stimulation. Biochem J 
340 ( Pt 2):529-538. 
Duran A, Cabib E (1978) Solubilization and partial purification of yeast chitin synthetase. 
Confirmation of the zymogenic nature of the enzyme. J Biol Chem 253:4419-
4425. 
Easter A, Spruce AE (2002) Recombinant GABA(B) receptors formed from GABA(B1) 
and GABA(B2) subunits selectively inhibit N-type Ca(2+) channels in NG108-
15 cells. Eur J Pharmacol 440:17-25. 
Eroglu C, Brugger B, Wieland F, Sinning I (2003) Glutamate-binding affinity of 
Drosophila metabotropic glutamate receptor is modulated by association with 
lipid rafts. Proc Natl Acad Sci U S A 100:10219-10224. 
Eroglu C, Cronet P, Panneels V, Beaufils P, Sinning I (2002) Functional reconstitution of 
purified metabotropic glutamate receptor expressed in the fly eye. EMBO Rep 
3:491-496. 
Fernandez-Ballester, G., J. Castresana, et al. (1994). "Role of cholesterol as a structural 
and functional effector of the nicotinic acetylcholine receptor." Biochem Soc 
Trans 22(3): 776-80. 
Filippov AK, Couve A, Pangalos MN, Walsh FS, Brown DA, Moss SJ (2000) 
Heteromeric assembly of GABA(B)R1 and GABA(B)R2 receptor subunits 
inhibits Ca(2+) current in sympathetic neurons. J Neurosci 20:2867-2874. 
Flower DR (1999) Modelling G-protein-coupled receptors for drug design. Biochim 
Biophys Acta 1422:207-234. 
Foster DN, Proudman JA, Harmon SA, Foster LK (1997) Baculovirus-mediated 
expression of chicken growth hormone. Comp Biochem Physiol B Biochem 
Mol Biol 117:233-239. 
Gimpl G, Fahrenholz F (2000) Human oxytocin receptors in cholesterol-rich vs. 
cholesterol-poor microdomains of the plasma membrane. Eur J Biochem 
267:2483-2497. 
Gimpl G, Klein U, Reilander H, Fahrenholz F (1995) Expression of the human oxytocin 
receptor in baculovirus-infected insect cells: high-affinity binding is induced by 
a cholesterol-cyclodextrin complex. Biochemistry 34:13794-13801. 
Grisshammer R, Tate CG (1995) Overexpression of integral membrane proteins for 
structural studies. Q Rev Biophys 28:315-422. 
Grunewald S, Schupp BJ, Ikeda SR, Kuner R, Steigerwald F, Kornau HC, Kohr G (2002) 
Importance of the gamma-aminobutyric acid(B) receptor C-termini for G-
protein coupling. Mol Pharmacol 61:1070-1080. 
Guzzi F, Zanchetta D, Cassoni P, Guzzi V, Francolini M, Parenti M, Chini B (2002) 
Localization of the human oxytocin receptor in caveolin-1 enriched domains 
turns the receptor-mediated inhibition of cell growth into a proliferative 
response. Oncogene 21:1658-1667. 
Haasemann M, Cartaud J, Muller-Esterl W, Dunia I (1998) Agonist-induced 
redistribution of bradykinin B2 receptor in caveolae. J Cell Sci 111 ( Pt 7):917-
928. 
Hagio M, Gombos Z, Varkonyi Z, Masamoto K, Sato N, Tsuzuki M, Wada H (2000) 
Direct evidence for requirement of phosphatidylglycerol in photosystem II of 
photosynthesis. Plant Physiol 124:795-804. 
Hamm HE (1998) The many faces of G protein signaling. J Biol Chem 273:669-672. 
Hawrot E, Xiao Y, Shi QL, Norman D, Kirkitadze M, Barlow PN (1998) Demonstration 
of a tandem pair of complement protein modules in GABA(B) receptor 1a. 
FEBS Lett 432:103-108. 
Horn F, Vriend G, Cohen FE (2001) Collecting and harvesting biological data: the 
GPCRDB and NucleaRDB information systems. Nucleic Acids Res 29:346-
349. 
Houamed KM, Kuijper JL, Gilbert TL, Haldeman BA, O'Hara PJ, Mulvihill ER, Almers 
W, Hagen FS (1991) Cloning, expression, and gene structure of a G protein-
coupled glutamate receptor from rat brain. Science 252:1318-1321. 
Hunter GW, Negash S, Squier TC (1999) Phosphatidylethanolamine modulates Ca-
ATPase function and dynamics. Biochemistry 38:1356-1364. 
Igarashi J, Michel T (2000) Agonist-modulated targeting of the EDG-1 receptor to 
plasmalemmal caveolae. eNOS activation by sphingosine 1-phosphate and the 
role of caveolin-1 in sphingolipid signal transduction. J Biol Chem 275:32363-
32370. 
Ishizaka N, Griendling KK, Lassegue B, Alexander RW (1998) Angiotensin II type 1 
receptor: relationship with caveolae and caveolin after initial agonist 
stimulation. Hypertension 32:459-466. 
Iwata S, Ostermeier C, Ludwig B, Michel H (1995) Structure at 2.8 A resolution of 
cytochrome c oxidase from Paracoccus denitrificans. Nature 376:660-669. 
Jarvis DL, Summers MD (1989) Glycosylation and secretion of human tissue 
plasminogen activator in recombinant baculovirus-infected insect cells. Mol 
Cell Biol 9:214-223. 
Jordan P, Fromme P, Witt HT, Klukas O, Saenger W, Krauss N (2001) Three-
dimensional structure of cyanobacterial photosystem I at 2.5 A resolution. 
Nature 411:909-917. 
Joshi MK, Dracheva S, Mukhopadhyay AK, Bose S, Hendler RW (1998) Importance of 
specific native lipids in controlling the photocycle of bacteriorhodopsin. 
Biochemistry 37:14463-14470. 
Ju H, Venema VJ, Liang H, Harris MB, Zou R, Venema RC (2000) Bradykinin activates 
the Janus-activated kinase/signal transducers and activators of transcription 
(JAK/STAT) pathway in vascular endothelial cells: localization of JAK/STAT 
signalling proteins in plasmalemmal caveolae. Biochem J 351:257-264. 
Kadenbach B, Mende P, Kolbe HV, Stipani I, Palmieri F (1982) The mitochondrial 
phosphate carrier has an essential requirement for cardiolipin. FEBS Lett 
139:109-112. 
Kaupmann K, Huggel K, Heid J, Flor PJ, Bischoff S, Mickel SJ, McMaster G, Angst C, 
Bittiger H, Froestl W, Bettler B (1997) Expression cloning of GABA(B) 
receptors uncovers similarity to metabotropic glutamate receptors. Nature 
386:239-246. 
Kifor O, Diaz R, Butters R, Kifor I, Brown EM (1998) The calcium-sensing receptor is 
localized in caveolin-rich plasma membrane domains of bovine parathyroid 
cells. J Biol Chem 273:21708-21713. 
Kifor O, Kifor I, Moore FD, Jr., Butters RR, Jr., Brown EM (2003) m-Calpain 
colocalizes with the calcium-sensing receptor (CaR) in caveolae in parathyroid 
cells and participates in degradation of the CaR. J Biol Chem 278:31167-31176. 
Klein, U., G. Gimpl, et al. (1995). "Alteration of the myometrial plasma membrane 
cholesterol content with beta-cyclodextrin modulates the binding affinity of the 
oxytocin receptor." Biochemistry 34(42): 13784-93. 
Kozak, S. L., S. E. Kuhmann, et al. (1999). "Roles of CD4 and coreceptors in binding, 
endocytosis, and proteolysis of gp120 envelope glycoproteins derived from 
human immunodeficiency virus type 1." J Biol Chem 274(33): 23499-507. 
Krisch B, Feindt J, Mentlein R (1998) Immunoelectronmicroscopic analysis of the 
ligand-induced internalization of the somatostatin receptor subtype 2 in cultured 
human glioma cells. J Histochem Cytochem 46:1233-1242. 
Kruse O, Hankamer B, Konczak C, Gerle C, Morris E, Radunz A, Schmid GH, Barber J 
(2000) Phosphatidylglycerol is involved in the dimerization of photosystem II. J 
Biol Chem 275:6509-6514. 
Kuner, R., G. Kohr, et al. (1999). "Role of heteromer formation in GABAB receptor 
function." Science 283(5398): 74-7. 
Kunishima N, Shimada Y, Tsuji Y, Sato T, Yamamoto M, Kumasaka T, Nakanishi S, 
Jingami H, Morikawa K (2000) Structural basis of glutamate recognition by a 
dimeric metabotropic glutamate receptor. Nature 407:971-977. 
Lamb ME, Zhang C, Shea T, Kyle DJ, Leeb-Lundberg LM (2002) Human B1 and B2 
bradykinin receptors and their agonists target caveolae-related lipid rafts to 
different degrees in HEK293 cells. Biochemistry 41:14340-14347. 
Lange C, Nett JH, Trumpower BL, Hunte C (2001) Specific roles of protein-phospholipid 
interactions in the yeast cytochrome bc1 complex structure. Embo J 20:6591-
6600. 
Laskowski RA, Moss DS, Thornton JM (1993) Main-chain bond lengths and bond angles 
in protein structures. J Mol Biol 231:1049-1067. 
Leclerc PC, Auger-Messier M, Lanctot PM, Escher E, Leduc R, Guillemette G (2002) A 
polyaromatic caveolin-binding-like motif in the cytoplasmic tail of the type 1 
receptor for angiotensin II plays an important role in receptor trafficking and 
signaling. Endocrinology 143:4702-4710. 
Lee AG (1998) How lipids interact with an intrinsic membrane protein: the case of the 
calcium pump. Biochim Biophys Acta 1376:381-390. 
Li H, Papadopoulos V (1998) Peripheral-type benzodiazepine receptor function in 
cholesterol transport. Identification of a putative cholesterol 
recognition/interaction amino acid sequence and consensus pattern. 
Endocrinology 139:4991-4997. 
Li H, Yao Z, Degenhardt B, Teper G, Papadopoulos V (2001) Cholesterol binding at the 
cholesterol recognition/ interaction amino acid consensus (CRAC) of the 
peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an 
HIV TAT-CRAC peptide. Proc Natl Acad Sci U S A 98:1267-1272. 
Liang Y, Fotiadis D, Filipek S, Saperstein DA, Palczewski K, Engel A (2003) 
Organization of the G protein-coupled receptors rhodopsin and opsin in native 
membranes. J Biol Chem 278:21655-21662. 
Luecke H, Schobert B, Richter HT, Cartailler JP, Lanyi JK (1999) Structure of 
bacteriorhodopsin at 1.55 A resolution. J Mol Biol 291:899-911. 
Malitschek B, Schweizer C, Keir M, Heid J, Froestl W, Mosbacher J, Kuhn R, Henley J, 
Joly C, Pin JP, Kaupmann K, Bettler B (1999) The N-terminal domain of 
gamma-aminobutyric Acid(B) receptors is sufficient to specify agonist and 
antagonist binding. Mol Pharmacol 56:448-454. 
Margeta-Mitrovic M, Jan YN, Jan LY (2000) A trafficking checkpoint controls 
GABA(B) receptor heterodimerization. Neuron 27:97-106. 
Marinissen MJ, Gutkind JS (2001) G-protein-coupled receptors and signaling networks: 
emerging paradigms. Trends Pharmacol Sci 22:368-376. 
Marshall FH, Jones KA, Kaupmann K, Bettler B (1999) GABAB receptors - the first 
7TM heterodimers. Trends Pharmacol Sci 20:396-399. 
Masu M, Tanabe Y, Tsuchida K, Shigemoto R, Nakanishi S (1991) Sequence and 
expression of a metabotropic glutamate receptor. Nature 349:760-765. 
McAuley KE, Fyfe PK, Ridge JP, Isaacs NW, Cogdell RJ, Jones MR (1999) Structural 
details of an interaction between cardiolipin and an integral membrane protein. 
Proc Natl Acad Sci U S A 96:14706-14711. 
Mentlein R, Held-Feindt J, Krisch B (2001) Topology of the signal transduction of the G 
protein-coupled somatostatin receptor sst2 in human glioma cells. Cell Tissue 
Res 303:27-34. 
Nakanishi S (1994) Metabotropic glutamate receptors: synaptic transmission, modulation, 
and plasticity. Neuron 13:1031-1037. 
Nalecz KA, Bolli R, Wojtczak L, Azzi A (1986) The monocarboxylate carrier from 
bovine heart mitochondria: partial purification and its substrate-transporting 
properties in a reconstituted system. Biochim Biophys Acta 851:29-37. 
Navratil AM, Bliss SP, Berghorn KA, Haughian JM, Farmerie TA, Graham JK, Clay 
CM, Roberson MS (2003) Constitutive localization of the gonadotropin-
releasing hormone (GnRH) receptor to low density membrane microdomains is 
necessary for GnRH signaling to ERK. J Biol Chem 278:31593-31602. 
Nguyen, D. H. and D. Taub (2002). "CXCR4 function requires membrane cholesterol: 
implications for HIV infection." J Immunol 168(8): 4121-6. 
Nollmann M, Gilbert R, Mitchell T, Sferrazza M, Byron O (2004) The role of cholesterol 
in the activity of pneumolysin, a bacterial protein toxin. Biophys J 86:3141-
3151. 
Okamoto T, Schlegel A, Scherer PE, Lisanti MP (1998a) Caveolins, a family of 
scaffolding proteins for organizing "preassembled signaling complexes" at the 
plasma membrane. J Biol Chem 273:5419-5422. 
Okamoto T, Sekiyama N, Otsu M, Shimada Y, Sato A, Nakanishi S, Jingami H (1998b) 
Expression and purification of the extracellular ligand binding region of 
metabotropic glutamate receptor subtype 1. J Biol Chem 273:13089-13096. 
Okamoto, T., A. Schlegel, et al. (1998). "Caveolins, a family of scaffolding proteins for 
organizing "preassembled signaling complexes" at the plasma membrane." J 
Biol Chem 273(10): 5419-22. 
Olah GA, Trakhanov S, Trewhella J, Quiocho FA (1993) Leucine/isoleucine/valine-
binding protein contracts upon binding of ligand. J Biol Chem 268:16241-
16247. 
O'Reilly, M., Luckow. (1994). Baculovirus expression vectors - A Laboratory Manual. 
Oxford. 
Pagano A, Rovelli G, Mosbacher J, Lohmann T, Duthey B, Stauffer D, Ristig D, Schuler 
V, Meigel I, Lampert C, Stein T, Prezeau L, Blahos J, Pin J, Froestl W, Kuhn R, 
Heid J, Kaupmann K, Bettler B (2001) C-terminal interaction is essential for 
surface trafficking but not for heteromeric assembly of GABA(b) receptors. J 
Neurosci 21:1189-1202. 
Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, 
Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M (2000) Crystal 
structure of rhodopsin: A G protein-coupled receptor. Science 289:739-745. 
Pang, L., M. Graziano, et al. (1999). "Membrane cholesterol modulates galanin-GalR2 
interaction." Biochemistry 38(37): 12003-11. 
Panneels V, Eroglu C, Cronet P, Sinning I (2003) Pharmacological characterization and 
immunoaffinity purification of metabotropic glutamate receptor from 
Drosophila overexpressed in Sf9 cells. Protein Expr Purif 30:275-282. 
Parmentier ML, Pin JP, Bockaert J, Grau Y (1996) Cloning and functional expression of 
a Drosophila metabotropic glutamate receptor expressed in the embryonic CNS. 
J Neurosci 16:6687-6694. 
Pawson AJ, Maudsley SR, Lopes J, Katz AA, Sun YM, Davidson JS, Millar RP (2003) 
Multiple determinants for rapid agonist-induced internalization of a 
nonmammalian gonadotropin-releasing hormone receptor: a putative 
palmitoylation site and threonine doublet within the carboxyl-terminal tail Are 
critical. Endocrinology 144:3860-3871. 
Percherancier, Y., B. Lagane, et al. (2003). "HIV-1 entry into T-cells is not dependent on 
CD4 and CCR5 localization to sphingolipid-enriched, detergent-resistant, raft 
membrane domains." J Biol Chem 278(5): 3153-61. 
Pfaff T, Malitschek B, Kaupmann K, Prezeau L, Pin JP, Bettler B, Karschin A (1999) 
Alternative splicing generates a novel isoform of the rat metabotropic 
GABA(B)R1 receptor. Eur J Neurosci 11:2874-2882. 
Pin, J. P., C. Joly, et al. (1994). "Domains involved in the specificity of G protein 
activation in phospholipase C-coupled metabotropic glutamate receptors." 
Embo J 13(2): 342-8. 
Quiocho FA, Ledvina PS (1996) Atomic structure and specificity of bacterial periplasmic 
receptors for active transport and chemotaxis: variation of common themes. Mol 
Microbiol 20:17-25. 
Rice LM, Brunger AT (1994) Torsion angle dynamics: reduced variable conformational 
sampling enhances crystallographic structure refinement. Proteins 19:277-290. 
Rietveld AG, Koorengevel MC, de Kruijff B (1995) Non-bilayer lipids are required for 
efficient protein transport across the plasma membrane of Escherichia coli. 
Embo J 14:5506-5513. 
Robbins MJ, Ciruela F, Rhodes A, McIlhinney RA (1999) Characterization of the 
dimerization of metabotropic glutamate receptors using an N-terminal 
truncation of mGluR1alpha. J Neurochem 72:2539-2547. 
Robinson NC (1982) Specificity and binding affinity of phospholipids to the high-affinity 
cardiolipin sites of beef heart cytochrome c oxidase. Biochemistry 21:184-188. 
Roettger BF, Rentsch RU, Pinon D, Holicky E, Hadac E, Larkin JM, Miller LJ (1995) 
Dual pathways of internalization of the cholecystokinin receptor. J Cell Biol 
128:1029-1041. 
Romano C, Miller JK, Hyrc K, Dikranian S, Mennerick S, Takeuchi Y, Goldberg MP, 
O'Malley KL (2001) Covalent and noncovalent interactions mediate 
metabotropic glutamate receptor mGlu5 dimerization. Mol Pharmacol 59:46-53. 
Rothnie, A., D. Theron, et al. (2001). "The importance of cholesterol in maintenance of 
P-glycoprotein activity and its membrane perturbing influence." Eur Biophys J 
30(6): 430-42. 
Sambrook , J. a. R., D (2001). Molecular cloning - A laboratory manual. CSHL, CSHL 
press. 
Scanlon, S. M., D. C. Williams, et al. (2001). "Membrane cholesterol modulates 
serotonin transporter activity." Biochemistry 40(35): 10507-13. 
Schlame M, Rua D, Greenberg ML (2000) The biosynthesis and functional role of 
cardiolipin. Prog Lipid Res 39:257-288. 
Schuster CM, Ultsch A, Schloss P, Cox JA, Schmitt B, Betz H (1991) Molecular cloning 
of an invertebrate glutamate receptor subunit expressed in Drosophila muscle. 
Science 254:112-114. 
Scott DB, Blanpied TA, Swanson GT, Zhang C, Ehlers MD (2001) An NMDA receptor 
ER retention signal regulated by phosphorylation and alternative splicing. J 
Neurosci 21:3063-3072. 
Sharom FJ (1997) The P-glycoprotein multidrug transporter: interactions with membrane 
lipids, and their modulation of activity. Biochem Soc Trans 25:1088-1096. 
Shenoy-Scaria AM, Dietzen DJ, Kwong J, Link DC, Lublin DM (1994) Cysteine3 of Src 
family protein tyrosine kinase determines palmitoylation and localization in 
caveolae. J Cell Biol 126:353-363. 
Shouffani, A. and B. I. Kanner (1990). "Cholesterol is required for the reconstruction of 
the sodium- and chloride-coupled, gamma-aminobutyric acid transporter from 
rat brain." J Biol Chem 265(11): 6002-8. 
Simons K, Ikonen E (1997) Functional rafts in cell membranes. Nature 387:569-572. 
Spiegel AM, Weinstein LS (2004) Inherited diseases involving g proteins and g protein-
coupled receptors. Annu Rev Med 55:27-39. 
Tanabe Y, Masu M, Ishii T, Shigemoto R, Nakanishi S (1992) A family of metabotropic 
glutamate receptors. Neuron 8:169-179. 
Tanabe, Y., M. Masu, et al. (1992). "A family of metabotropic glutamate receptors." 
Neuron 8(1): 169-79. 
Teixeira A, Chaverot N, Schroder C, Strosberg AD, Couraud PO, Cazaubon S (1999) 
Requirement of caveolae microdomains in extracellular signal-regulated kinase 
and focal adhesion kinase activation induced by endothelin-1 in primary 
astrocytes. J Neurochem 72:120-128. 
Tian C, Breyer RM, Kim HJ, Karra MD, Friedman DB, Karpay A, Sanders CR (2005) 
Solution NMR spectroscopy of the human vasopressin V2 receptor, a G protein-
coupled receptor. J Am Chem Soc 127:8010-8011. 
Tlapak-Simmons VL, Baggenstoss BA, Clyne T, Weigel PH (1999) Purification and lipid 
dependence of the recombinant hyaluronan synthases from Streptococcus 
pyogenes and Streptococcus equisimilis. J Biol Chem 274:4239-4245. 
Ushio-Fukai M, Hilenski L, Santanam N, Becker PL, Ma Y, Griendling KK, Alexander 
RW (2001) Cholesterol depletion inhibits epidermal growth factor receptor 
transactivation by angiotensin II in vascular smooth muscle cells: role of 
cholesterol-rich microdomains and focal adhesions in angiotensin II signaling. J 
Biol Chem 276:48269-48275. 
van der Does C, Swaving J, van Klompenburg W, Driessen AJ (2000) Non-bilayer lipids 
stimulate the activity of the reconstituted bacterial protein translocase. J Biol 
Chem 275:2472-2478. 
van der Heide T, Stuart MC, Poolman B (2001) On the osmotic signal and osmosensing 
mechanism of an ABC transport system for glycine betaine. Embo J 20:7022-
7032. 
Varsanyi M, Tolle HG, Heilmeyer MG, Jr., Dawson RM, Irvine RF (1983) Activation of 
sarcoplasmic reticular Ca2+ transport ATPase by phosphorylation of an 
associated phosphatidylinositol. Embo J 2:1543-1548. 
Weiss, H. M. and R. Grisshammer (2002). "Purification and characterization of the 
human adenosine A(2a) receptor functionally expressed in Escherichia coli." 
Eur J Biochem 269(1): 82-92. 
Wyse BD, Prior IA, Qian H, Morrow IC, Nixon S, Muncke C, Kurzchalia TV, Thomas 
WG, Parton RG, Hancock JF (2003) Caveolin interacts with the angiotensin II 
type 1 receptor during exocytic transport but not at the plasma membrane. J Biol 
Chem 278:23738-23746. 
Yamaguchi T, Murata Y, Fujiyoshi Y, Doi T (2003) Regulated interaction of endothelin 
B receptor with caveolin-1. Eur J Biochem 270:1816-1827. 
Zerangue N, Schwappach B, Jan YN, Jan LY (1999) A new ER trafficking signal 
regulates the subunit stoichiometry of plasma membrane K(ATP) channels. 
Neuron 22:537-548. 
 
